bobz personal page - To The Moon

bobz

bobz

No personal profile

22Follow

1Followers

0Topic

0Badge

2021-07-21

nice

What If This Is The Economic End-Cycle

2021-07-01

airbnb good buy!

2 Great Stocks You Can Buy on Sale

2021-06-29

going stronk please like and comment

Nvidia shares rose more than 5% to a new high

2021-06-22

oh no

Sorry, the original content has been removed

2021-06-20

wow, excited for this news

New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End

2021-06-17

so truee

Stocks usually fall during Powell’s press conference and Cramer thinks it may happen again

2021-06-15

[Smile]

This cannabis stock is a new Reddit favorite

2021-06-14

nicee

Novavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants

2021-06-10

Great!

Grab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm

2021-06-09

sick

Sorry, the original content has been removed

2021-06-08

liked

Apple is encroaching on Facebook’s territory like never before with new social features

2021-06-02

d

30 Top Stock Picks That Billionaires Love

2021-05-28

d

Wall Street ekes out gain as weekly jobless claims fall

2021-05-28

g

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3579171490775446","uuid":"3579171490775446","gmtCreate":1616077688107,"gmtModify":1623160570987,"name":"bobz","pinyin":"bobz","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":22,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"60.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":178889385,"gmtCreate":1626796890347,"gmtModify":1703765468547,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/178889385","repostId":"1184882386","repostType":4,"repost":{"id":"1184882386","kind":"news","pubTimestamp":1626790245,"share":"https://ttm.financial/m/news/1184882386?lang=&edition=fundamental","pubTime":"2021-07-20 22:10","market":"us","language":"en","title":"What If This Is The Economic End-Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1184882386","media":"zerohedge","summary":"A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged","content":"<p>A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-20% drop in stocks, summarized the current economic state simply as \"mid cycle\"...</p>\n<p><img src=\"https://static.tigerbbs.com/d95f296e4d1300cd3c95485a2333d270\" tg-width=\"906\" tg-height=\"571\" width=\"100%\" height=\"auto\">... which of course is the best place to be, as the initial euphoric surge higher in stocks tapers to a slow and steady grind as the economy chugs along at a modest pace.</p>\n<p>But what if he is wrong? After all, yesterday the NBER determined that the covid recession - at just 2 months - was the fastest on record (even as 14 million Americans are out of a job and still collect unemployment benefits) and we are already well into the mid cycle, if not approaching the end.</p>\n<p><img src=\"https://static.tigerbbs.com/e47d11bc07779a51cede0a73e7ddf627\" tg-width=\"971\" tg-height=\"562\" width=\"100%\" height=\"auto\">Also it is none other than Wilson's own employer Morgan Stanley, which has also said recently that this cycle will be \"<b>hotter but shorter</b>\" than usual.</p>\n<p><img src=\"https://static.tigerbbs.com/41879c4f66b33597ee236bdd52841004\" tg-width=\"904\" tg-height=\"490\" width=\"100%\" height=\"auto\"></p>\n<p>Does it not stand to reason then, that the economic cycle is now so truncated - courtesy of $30 trillion in global stimulus - that we have blasted right through the midcycle phase and are now nearing the end?</p>\n<p>That is the question Deutsche Bank's credit strategist Jim Reid asked overnight, when he described this recovery as \"undoubtedly the most unusual in history with many sectors of the economy already running ahead of their pre-recession trend\" even though several serviced based ones are still well behind though. More importantly, according to Reid and DB economists,<i>the output and employment gap will likely close in the next couple of quarters which will be the quickest for both in observable economic history.</i></p>\n<p>Reid then takes a look at where real GDP, nominal GDP, CPI, unemployment, retail sales, equities, household wealth, housing, treasuries and commodities are against all other recoveries for most variables goes back over 100 years. The chart below shows real GDP and as Reid explains, \"for most of these, this current post covid recovery is near the top\"<b>making this recovery neck and neck with the fastest post-WWII expansion.</b></p>\n<p><img src=\"https://static.tigerbbs.com/48279d702e3f7b92c743f063b26661ad\" tg-width=\"868\" tg-height=\"411\" width=\"100%\" height=\"auto\">As Reid puts it, \"clearly this cycle saw a big drawdown due to the pandemic but so did the GFC and its notable that the post-GFC recovery was around the weakest at the same stage\" which begs the question: \"should this be seen as the start of a new cycle or a continuation of the last cycle after a period of covid related hibernation?<b>The answer to this will give us clues as to how long this cycle lasts, future Fed activity, and on the inflationary consequences of the current strong rebound.\"</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What If This Is The Economic End-Cycle</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat If This Is The Economic End-Cycle\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 22:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/what-if-economic-end-cycle><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-...</p>\n\n<a href=\"https://www.zerohedge.com/markets/what-if-economic-end-cycle\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/what-if-economic-end-cycle","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184882386","content_text":"A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-20% drop in stocks, summarized the current economic state simply as \"mid cycle\"...\n... which of course is the best place to be, as the initial euphoric surge higher in stocks tapers to a slow and steady grind as the economy chugs along at a modest pace.\nBut what if he is wrong? After all, yesterday the NBER determined that the covid recession - at just 2 months - was the fastest on record (even as 14 million Americans are out of a job and still collect unemployment benefits) and we are already well into the mid cycle, if not approaching the end.\nAlso it is none other than Wilson's own employer Morgan Stanley, which has also said recently that this cycle will be \"hotter but shorter\" than usual.\n\nDoes it not stand to reason then, that the economic cycle is now so truncated - courtesy of $30 trillion in global stimulus - that we have blasted right through the midcycle phase and are now nearing the end?\nThat is the question Deutsche Bank's credit strategist Jim Reid asked overnight, when he described this recovery as \"undoubtedly the most unusual in history with many sectors of the economy already running ahead of their pre-recession trend\" even though several serviced based ones are still well behind though. More importantly, according to Reid and DB economists,the output and employment gap will likely close in the next couple of quarters which will be the quickest for both in observable economic history.\nReid then takes a look at where real GDP, nominal GDP, CPI, unemployment, retail sales, equities, household wealth, housing, treasuries and commodities are against all other recoveries for most variables goes back over 100 years. The chart below shows real GDP and as Reid explains, \"for most of these, this current post covid recovery is near the top\"making this recovery neck and neck with the fastest post-WWII expansion.\nAs Reid puts it, \"clearly this cycle saw a big drawdown due to the pandemic but so did the GFC and its notable that the post-GFC recovery was around the weakest at the same stage\" which begs the question: \"should this be seen as the start of a new cycle or a continuation of the last cycle after a period of covid related hibernation?The answer to this will give us clues as to how long this cycle lasts, future Fed activity, and on the inflationary consequences of the current strong rebound.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158339769,"gmtCreate":1625128218151,"gmtModify":1703736691193,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"airbnb good buy!","listText":"airbnb good buy!","text":"airbnb good buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/158339769","repostId":"2147817357","repostType":4,"repost":{"id":"2147817357","kind":"highlight","pubTimestamp":1625127904,"share":"https://ttm.financial/m/news/2147817357?lang=&edition=fundamental","pubTime":"2021-07-01 16:25","market":"us","language":"en","title":"2 Great Stocks You Can Buy on Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2147817357","media":"Motley Fool","summary":"The stock prices of Airbnb and Appian are down big from their 52-week highs, but both look like buys.","content":"<p>Part of being a long-term investor is learning how to weather volatility. Of course, no <a href=\"https://laohu8.com/S/AONE\">one</a> likes to see a stock in their portfolio suffer a price plummet, but those downturns can actually be buying opportunities if it's a company you believe in.</p>\n<p>For instance, the stock prices of <b>Airbnb</b> (NASDAQ:ABNB) and <b>Appian</b> (NASDAQ:APPN) are down 33% and 37%, respectively, from their 52-week highs. But both stocks still look like good long-term investments. Here's why these are two great stocks you can buy on sale.</p>\n<h2>1. Airbnb</h2>\n<p>Airbnb is disrupting travel and tourism, an industry that accounted for over 10% of global GDP in 2019. The company's platform connects potential guests and hosts, allowing travelers to browse rental properties and book stays in thousands of cities around the world.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/43b3d402eb52be309defa3ad792f13fd\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<p>Of course, traditional hotels already do that. So what makes Airbnb special? With a network of 4 million hosts, potential guests have access to a much wider range of unique and immersive accommodations. For instance, you could book a private cottage along the coast, a secluded cabin in the mountains, or a castle in the English countryside. You could even stay in a cave that's been converted into a cozy hideaway. Those types of experiences simply aren't possible with hotels.</p>\n<p>Last year, the travel industry was hit hard by the pandemic, and Airbnb's revenue dropped 30%. Even so, the company still fared better than rivals like <b>Marriott</b> and <b>Hilton</b>, which saw revenue plunge 50% and 54%, respectively. That underscores <a href=\"https://laohu8.com/S/AONE.U\">one</a> of Airbnb's key advantages: resilience.</p>\n<p>In fact, business appears to be rebounding already. Airbnb's revenue rose 5% to $887 million in the first quarter, and gross booking value surged 52% to $10.3 billion. Investors should look for those trends to accelerate as the pandemic fades.</p>\n<p>What's more, some fallout from the pandemic could actually create opportunities for Airbnb. For instance, remote work is already reshaping the travel industry, affording people the flexibility they didn't have in the office. In fact, CEO Brian Chesky recently noted: \"People can travel anytime, they are traveling to more places, and they are staying longer.\"</p>\n<p>To capitalize on those trends, Airbnb recently upgraded its platform. Guests can now search for stays with flexible dates and destinations, and new hosts&nbsp;can sign up more quickly. While these are small changes, both could bring new users to the platform, helping Airbnb capture more of its $3.4 trillion&nbsp;market opportunity.</p>\n<h2>2. Appian</h2>\n<p>Appian's low-code tools simplify software development, enabling clients to build enterprise-grade applications with a visual interface, using flowcharts instead of computer code. The Appian platform also integrates robotic process automation (RPA) and artificial intelligence (AI), allowing clients to automate tasks and complex workflows.</p>\n<p>For example, clients could use Appian's tools to extract data from a document (e.g. an invoice, application, or email), then automatically integrate that data into a custom application for further processing, eliminating the need for human involvement.</p>\n<p>Why does that matter? Custom software can play an important role in helping enterprises differentiate themselves, and Appian makes the development process more efficient. In fact, Appian believes its platform allows users to build applications 10 times faster and at half the cost&nbsp;of traditional solutions.</p>\n<p>That value proposition has been a key growth driver for Appian.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>2017</p></th>\n   <th><p>Q1 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$176.7 million</p></td>\n   <td width=\"156\"><p>$314.6 million</p></td>\n   <td width=\"156\"><p>19%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Appian SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Also noteworthy, Appian has achieved a cloud subscription renewal rate of 98%&nbsp;over the last three years, meaning it keeps the vast majority of its customers. Likewise, Appian outranked all rivals in the most recent <b>Gartner</b> Peer Insights report, indicating a greater degree of customer satisfaction. In both cases, Appian's good rapport with clients bodes well for the future.</p>\n<p>Going forward, management puts Appian's market opportunity at $37 billion, giving the company plenty of room to grow. And as more enterprises seek efficiency through low-code development and automation, Appian should benefit from increased demand. That's why investors should consider adding this stock to their portfolios.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Great Stocks You Can Buy on Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Great Stocks You Can Buy on Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/30/great-stocks-you-can-buy-on-sale-appian-airbnb/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Part of being a long-term investor is learning how to weather volatility. Of course, no one likes to see a stock in their portfolio suffer a price plummet, but those downturns can actually be buying ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/30/great-stocks-you-can-buy-on-sale-appian-airbnb/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APPN":"Appian Corp","ABNB":"爱彼迎"},"source_url":"https://www.fool.com/investing/2021/06/30/great-stocks-you-can-buy-on-sale-appian-airbnb/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147817357","content_text":"Part of being a long-term investor is learning how to weather volatility. Of course, no one likes to see a stock in their portfolio suffer a price plummet, but those downturns can actually be buying opportunities if it's a company you believe in.\nFor instance, the stock prices of Airbnb (NASDAQ:ABNB) and Appian (NASDAQ:APPN) are down 33% and 37%, respectively, from their 52-week highs. But both stocks still look like good long-term investments. Here's why these are two great stocks you can buy on sale.\n1. Airbnb\nAirbnb is disrupting travel and tourism, an industry that accounted for over 10% of global GDP in 2019. The company's platform connects potential guests and hosts, allowing travelers to browse rental properties and book stays in thousands of cities around the world.\nImage source: Getty Images.\nOf course, traditional hotels already do that. So what makes Airbnb special? With a network of 4 million hosts, potential guests have access to a much wider range of unique and immersive accommodations. For instance, you could book a private cottage along the coast, a secluded cabin in the mountains, or a castle in the English countryside. You could even stay in a cave that's been converted into a cozy hideaway. Those types of experiences simply aren't possible with hotels.\nLast year, the travel industry was hit hard by the pandemic, and Airbnb's revenue dropped 30%. Even so, the company still fared better than rivals like Marriott and Hilton, which saw revenue plunge 50% and 54%, respectively. That underscores one of Airbnb's key advantages: resilience.\nIn fact, business appears to be rebounding already. Airbnb's revenue rose 5% to $887 million in the first quarter, and gross booking value surged 52% to $10.3 billion. Investors should look for those trends to accelerate as the pandemic fades.\nWhat's more, some fallout from the pandemic could actually create opportunities for Airbnb. For instance, remote work is already reshaping the travel industry, affording people the flexibility they didn't have in the office. In fact, CEO Brian Chesky recently noted: \"People can travel anytime, they are traveling to more places, and they are staying longer.\"\nTo capitalize on those trends, Airbnb recently upgraded its platform. Guests can now search for stays with flexible dates and destinations, and new hosts can sign up more quickly. While these are small changes, both could bring new users to the platform, helping Airbnb capture more of its $3.4 trillion market opportunity.\n2. Appian\nAppian's low-code tools simplify software development, enabling clients to build enterprise-grade applications with a visual interface, using flowcharts instead of computer code. The Appian platform also integrates robotic process automation (RPA) and artificial intelligence (AI), allowing clients to automate tasks and complex workflows.\nFor example, clients could use Appian's tools to extract data from a document (e.g. an invoice, application, or email), then automatically integrate that data into a custom application for further processing, eliminating the need for human involvement.\nWhy does that matter? Custom software can play an important role in helping enterprises differentiate themselves, and Appian makes the development process more efficient. In fact, Appian believes its platform allows users to build applications 10 times faster and at half the cost of traditional solutions.\nThat value proposition has been a key growth driver for Appian.\n\n\n\nMetric\n2017\nQ1 2021 (TTM)\nCAGR\n\n\n\n\nRevenue\n$176.7 million\n$314.6 million\n19%\n\n\n\nData source: Appian SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nAlso noteworthy, Appian has achieved a cloud subscription renewal rate of 98% over the last three years, meaning it keeps the vast majority of its customers. Likewise, Appian outranked all rivals in the most recent Gartner Peer Insights report, indicating a greater degree of customer satisfaction. In both cases, Appian's good rapport with clients bodes well for the future.\nGoing forward, management puts Appian's market opportunity at $37 billion, giving the company plenty of room to grow. And as more enterprises seek efficiency through low-code development and automation, Appian should benefit from increased demand. That's why investors should consider adding this stock to their portfolios.","news_type":1},"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150783185,"gmtCreate":1624927880447,"gmtModify":1703848056960,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"going stronk please like and comment","listText":"going stronk please like and comment","text":"going stronk please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/150783185","repostId":"1182036516","repostType":4,"repost":{"id":"1182036516","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624892087,"share":"https://ttm.financial/m/news/1182036516?lang=&edition=fundamental","pubTime":"2021-06-28 22:54","market":"us","language":"en","title":"Nvidia shares rose more than 5% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1182036516","media":"Tiger Newspress","summary":"Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.\n\n","content":"<p>Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.</p>\n<p><img src=\"https://static.tigerbbs.com/05201fd147f1f824ea42bb1d0bcac789\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Three major chip makers have reportedly stepped up to say they support&nbsp;Nvidia‘s&nbsp;proposed acquisition of the U.K.-based chip-design house Arm.</p>\n<p>Last September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from&nbsp;SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.</p>\n<p>But the U.K.’s&nbsp;<i>Sunday Times</i>&nbsp;over the weekend&nbsp;reported&nbsp;that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based&nbsp;MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.</p>\n<p>Citi analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.</p>\n<p>“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”</p>\n<p>Malik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares rose more than 5% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares rose more than 5% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-28 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.</p>\n<p><img src=\"https://static.tigerbbs.com/05201fd147f1f824ea42bb1d0bcac789\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Three major chip makers have reportedly stepped up to say they support&nbsp;Nvidia‘s&nbsp;proposed acquisition of the U.K.-based chip-design house Arm.</p>\n<p>Last September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from&nbsp;SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.</p>\n<p>But the U.K.’s&nbsp;<i>Sunday Times</i>&nbsp;over the weekend&nbsp;reported&nbsp;that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based&nbsp;MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.</p>\n<p>Citi analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.</p>\n<p>“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”</p>\n<p>Malik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182036516","content_text":"Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.\n\nThree major chip makers have reportedly stepped up to say they support Nvidia‘s proposed acquisition of the U.K.-based chip-design house Arm.\nLast September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.\nBut the U.K.’s Sunday Times over the weekend reported that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.\nCiti analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.\n“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”\nMalik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120490958,"gmtCreate":1624330554874,"gmtModify":1703833692003,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"oh no","listText":"oh no","text":"oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120490958","repostId":"1123368698","repostType":4,"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164946542,"gmtCreate":1624168471886,"gmtModify":1703830046572,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"wow, excited for this news","listText":"wow, excited for this news","text":"wow, excited for this news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164946542","repostId":"2144779308","repostType":4,"repost":{"id":"2144779308","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1624022423,"share":"https://ttm.financial/m/news/2144779308?lang=&edition=fundamental","pubTime":"2021-06-18 21:20","market":"us","language":"en","title":"New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End","url":"https://stock-news.laohu8.com/highlight/detail?id=2144779308","media":"Investors","summary":"Atai Life Sciences, a backer of psychedelic-drug developers, will start trading Friday, making it the latest such company to hit a major exchange.","content":"<p><b>Atai Life Sciences</b>, a backer of psychedelic-drug developers, will start trading Friday, making it the latest such company to hit a major exchange as it tries to bring hallucinogens to the world of therapeutics.</p>\n<p>The Germany-based company, backed by billionaire investor and <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b> co-founder Peter Thiel, priced its IPO at $15, compared compared to an expected range of $13 and $15.</p>\n<p>The Atai IPO will generate gross proceeds of $225 million from the sale of 15 million shares. Underwriters also have an option to buy another 2.25 million shares.</p>\n<p>Last week, Atai said it planned to offer 14,286,000 shares in its IPO. The offering also included a 30-day option for the underwriters to buy up to 2,142,900 additional shares.</p>\n<p>Credit Suisse, Citigroup, Cowen, and Berenberg were book-running managers for the offering. Other book-running managers included Cantor, RBC Capital Markets and Canaccord Genuity, a big dealmaker in the cannabis industry that has shown up in psychedelics as well.</p>\n<h2>Psychedelic Drug Stocks</h2>\n<p>The Atai IPO follows that of <b>Compass Pathways</b>, which is researching a therapy regimen that uses a crystalline form of psilocybin. Atai is also a large shareholder in Compass.</p>\n<p><b>MindMed</b>, another psychedelics developer, listed on the Nasdaq in April. Others trade in Canada.</p>\n<p>MindMed rose 0.3% in premarket trading on the stock market today. Compass Pathways was quiet.</p>\n<p>More psychedelic drug companies over the past year have tried to reach investors via U.S. and Canadian exchanges. But investing in the space carries the same challenges as other nascent drug developers, where trials can burn through money and still come up short of approval.</p>\n<p>Sales, let alone profits, could be years away. Regulators, such as the FDA and DEA, can approve research on drugs, even though some, like LSD and psilocybin, are considered controlled substances. But executives in the industry have said regulatory approval, rather than state or local legalization, will define growth in the psychedelics industry.</p>\n<p>Spravato, a drug from&nbsp;<b>Johnson &amp; Johnson</b> that uses a derivative of ketamine, was approved in 2019 for treatment-resistant depression.</p>\n<h2>Atai IPO Details, Planned Trials</h2>\n<p>Atai was founded in 2018 by Christian Angermayer, a biotech investor. Angermayer also founded Apeiron Investment Group, which is Atai's biggest shareholder, according to the Atai IPO prospectus.</p>\n<p>In that filing, from April, Atai said it had raised $362.3 million as of that time. Atai reported a net loss last year of around $179 million.</p>\n<p>Atai invests in companies developing mental health treatments, often with a majority interest or an option to get <a href=\"https://laohu8.com/S/AONE\">one</a>. It oversees 10 therapeutic programs handled by such companies. Five of those involve some form of psychedelic compound, such as MDMA — also known as ecstasy or molly — ibogaine, R-ketamine and DMT, a substance found in ayahuasca.</p>\n<p>One of those companies, Atai said, Recognify Life Sciences, has initiated a Phase 2a trial in the United States. Atai said it expected to start a Phase 2 trial for another program this year, with three more next year.</p>\n<p>However, drug development is expensive and time-consuming. If funding falls through, those efforts could be derailed. Atai said it had cash of $97.2 million as of the end of last year.</p>\n<p>Atai also said that under its agreements with Recognify and DemeRx — another company it has invested in that is researching ibogaine — they could lose their majority interest in both companies if Atai misses certain milestone payments.</p>\n<p>These Are The 5 Best Stocks To Buy And Watch Now</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-06-18 21:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Atai Life Sciences</b>, a backer of psychedelic-drug developers, will start trading Friday, making it the latest such company to hit a major exchange as it tries to bring hallucinogens to the world of therapeutics.</p>\n<p>The Germany-based company, backed by billionaire investor and <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b> co-founder Peter Thiel, priced its IPO at $15, compared compared to an expected range of $13 and $15.</p>\n<p>The Atai IPO will generate gross proceeds of $225 million from the sale of 15 million shares. Underwriters also have an option to buy another 2.25 million shares.</p>\n<p>Last week, Atai said it planned to offer 14,286,000 shares in its IPO. The offering also included a 30-day option for the underwriters to buy up to 2,142,900 additional shares.</p>\n<p>Credit Suisse, Citigroup, Cowen, and Berenberg were book-running managers for the offering. Other book-running managers included Cantor, RBC Capital Markets and Canaccord Genuity, a big dealmaker in the cannabis industry that has shown up in psychedelics as well.</p>\n<h2>Psychedelic Drug Stocks</h2>\n<p>The Atai IPO follows that of <b>Compass Pathways</b>, which is researching a therapy regimen that uses a crystalline form of psilocybin. Atai is also a large shareholder in Compass.</p>\n<p><b>MindMed</b>, another psychedelics developer, listed on the Nasdaq in April. Others trade in Canada.</p>\n<p>MindMed rose 0.3% in premarket trading on the stock market today. Compass Pathways was quiet.</p>\n<p>More psychedelic drug companies over the past year have tried to reach investors via U.S. and Canadian exchanges. But investing in the space carries the same challenges as other nascent drug developers, where trials can burn through money and still come up short of approval.</p>\n<p>Sales, let alone profits, could be years away. Regulators, such as the FDA and DEA, can approve research on drugs, even though some, like LSD and psilocybin, are considered controlled substances. But executives in the industry have said regulatory approval, rather than state or local legalization, will define growth in the psychedelics industry.</p>\n<p>Spravato, a drug from&nbsp;<b>Johnson &amp; Johnson</b> that uses a derivative of ketamine, was approved in 2019 for treatment-resistant depression.</p>\n<h2>Atai IPO Details, Planned Trials</h2>\n<p>Atai was founded in 2018 by Christian Angermayer, a biotech investor. Angermayer also founded Apeiron Investment Group, which is Atai's biggest shareholder, according to the Atai IPO prospectus.</p>\n<p>In that filing, from April, Atai said it had raised $362.3 million as of that time. Atai reported a net loss last year of around $179 million.</p>\n<p>Atai invests in companies developing mental health treatments, often with a majority interest or an option to get <a href=\"https://laohu8.com/S/AONE\">one</a>. It oversees 10 therapeutic programs handled by such companies. Five of those involve some form of psychedelic compound, such as MDMA — also known as ecstasy or molly — ibogaine, R-ketamine and DMT, a substance found in ayahuasca.</p>\n<p>One of those companies, Atai said, Recognify Life Sciences, has initiated a Phase 2a trial in the United States. Atai said it expected to start a Phase 2 trial for another program this year, with three more next year.</p>\n<p>However, drug development is expensive and time-consuming. If funding falls through, those efforts could be derailed. Atai said it had cash of $97.2 million as of the end of last year.</p>\n<p>Atai also said that under its agreements with Recognify and DemeRx — another company it has invested in that is researching ibogaine — they could lose their majority interest in both companies if Atai misses certain milestone payments.</p>\n<p>These Are The 5 Best Stocks To Buy And Watch Now</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATAI":"ATAI Life Sciences B.V.*"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144779308","content_text":"Atai Life Sciences, a backer of psychedelic-drug developers, will start trading Friday, making it the latest such company to hit a major exchange as it tries to bring hallucinogens to the world of therapeutics.\nThe Germany-based company, backed by billionaire investor and PayPal co-founder Peter Thiel, priced its IPO at $15, compared compared to an expected range of $13 and $15.\nThe Atai IPO will generate gross proceeds of $225 million from the sale of 15 million shares. Underwriters also have an option to buy another 2.25 million shares.\nLast week, Atai said it planned to offer 14,286,000 shares in its IPO. The offering also included a 30-day option for the underwriters to buy up to 2,142,900 additional shares.\nCredit Suisse, Citigroup, Cowen, and Berenberg were book-running managers for the offering. Other book-running managers included Cantor, RBC Capital Markets and Canaccord Genuity, a big dealmaker in the cannabis industry that has shown up in psychedelics as well.\nPsychedelic Drug Stocks\nThe Atai IPO follows that of Compass Pathways, which is researching a therapy regimen that uses a crystalline form of psilocybin. Atai is also a large shareholder in Compass.\nMindMed, another psychedelics developer, listed on the Nasdaq in April. Others trade in Canada.\nMindMed rose 0.3% in premarket trading on the stock market today. Compass Pathways was quiet.\nMore psychedelic drug companies over the past year have tried to reach investors via U.S. and Canadian exchanges. But investing in the space carries the same challenges as other nascent drug developers, where trials can burn through money and still come up short of approval.\nSales, let alone profits, could be years away. Regulators, such as the FDA and DEA, can approve research on drugs, even though some, like LSD and psilocybin, are considered controlled substances. But executives in the industry have said regulatory approval, rather than state or local legalization, will define growth in the psychedelics industry.\nSpravato, a drug from Johnson & Johnson that uses a derivative of ketamine, was approved in 2019 for treatment-resistant depression.\nAtai IPO Details, Planned Trials\nAtai was founded in 2018 by Christian Angermayer, a biotech investor. Angermayer also founded Apeiron Investment Group, which is Atai's biggest shareholder, according to the Atai IPO prospectus.\nIn that filing, from April, Atai said it had raised $362.3 million as of that time. Atai reported a net loss last year of around $179 million.\nAtai invests in companies developing mental health treatments, often with a majority interest or an option to get one. It oversees 10 therapeutic programs handled by such companies. Five of those involve some form of psychedelic compound, such as MDMA — also known as ecstasy or molly — ibogaine, R-ketamine and DMT, a substance found in ayahuasca.\nOne of those companies, Atai said, Recognify Life Sciences, has initiated a Phase 2a trial in the United States. Atai said it expected to start a Phase 2 trial for another program this year, with three more next year.\nHowever, drug development is expensive and time-consuming. If funding falls through, those efforts could be derailed. Atai said it had cash of $97.2 million as of the end of last year.\nAtai also said that under its agreements with Recognify and DemeRx — another company it has invested in that is researching ibogaine — they could lose their majority interest in both companies if Atai misses certain milestone payments.\nThese Are The 5 Best Stocks To Buy And Watch Now","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163892034,"gmtCreate":1623866713028,"gmtModify":1703822024262,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"so truee","listText":"so truee","text":"so truee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163892034","repostId":"1160215752","repostType":4,"repost":{"id":"1160215752","kind":"news","pubTimestamp":1623854569,"share":"https://ttm.financial/m/news/1160215752?lang=&edition=fundamental","pubTime":"2021-06-16 22:42","market":"us","language":"en","title":"Stocks usually fall during Powell’s press conference and Cramer thinks it may happen again","url":"https://stock-news.laohu8.com/highlight/detail?id=1160215752","media":"cnbc","summary":"Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-deci","content":"<div>\n<p>Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks usually fall during Powell’s press conference and Cramer thinks it may happen again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks usually fall during Powell’s press conference and Cramer thinks it may happen again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 22:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1160215752","content_text":"Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a similar performance, and possibly even worse.\nBespoke Investment Group looked at the intraday data and found theS&P 500typically is higher going into the 2:30 p.m. ET press conference, but then, on average, turns lower when Powell’s briefing begins. After the turn lower, the benchmark ends Powell press conference days lower by 2 basis points, according to Bespoke. (1 basis point is 0.01%)\n“Powell taking the podium has been the equivalent of ‘last call’ at a bar,” the firm said in a note.\nThis time, the Fed chief is faced with one of the tougher tightrope walks in his tenure as markets expect him to address the bubbling inflationary pressures that he previously characterized as transitory. At the same time, many believe Powell could upset the market if he signals that the central bank will start tapering their ultra-easy monetary policy. Investors will parse through tiny shifts in sentiment during Powell’s delicate dance this afternoon.\nThe Fed’s statement on policy and forecasts will be released at 2 p.m. ET Wednesday and Powell will take the podium at 2:30 p.m.\nBillionaire investors Paul Tudor Jonestold CNBC on Mondaythat this is the most important press conference in Powell’s career, and if he’s not careful, it could lead to another taper tantrum that could cause a correction in stocks.\nCramer echoed the sentiment on Wednesday, saying Powell could trigger a sell-off in the stock market as reporters will likely grill him on inflation.\n“I think that a lot of the heckling, which is what I regard the questions of the press being, is going to be about oil and inflation and at some point if Powell breaks his resolve and says, ‘Yes, I’m looking at oil,’ the traders will come in at 2:43 and smash the market.” Cramer said. “Press has to give Powell a hard time. At one point Powell slips up, the market goes down big.”\nTo be sure, the market’s performance during Powell’s briefing has been less negative in the pandemic era. The average for the past year’s Fed days has seen the S&P 500 hit its highs of the day after the press conference begins, and while there has been a sharp reversal off those highs, by the end of the day, the S&P 500 has only been modestly below its pre-announcement levels, according to Bespoke.","news_type":1},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184411769,"gmtCreate":1623721368551,"gmtModify":1704209520009,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184411769","repostId":"1180739794","repostType":4,"repost":{"id":"1180739794","kind":"news","pubTimestamp":1623720576,"share":"https://ttm.financial/m/news/1180739794?lang=&edition=fundamental","pubTime":"2021-06-15 09:29","market":"us","language":"en","title":"This cannabis stock is a new Reddit favorite","url":"https://stock-news.laohu8.com/highlight/detail?id=1180739794","media":"CNN Business","summary":"New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen","content":"<p><b>New York (CNN Business)&nbsp;</b>-&nbsp;Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.</p>\n<p>As backers tout the growing number of states legalizing recreational and medical marijuana, some investors are holding out for the dream scenario of federal legalization — even though that might be a stretch in the near term.</p>\n<p>But are investors going a little crazy?Tilray&nbsp;(TLRY)&nbsp;is now up more than 130% this year. That's much higher than the gains for rivalsCanopy Growth&nbsp;(CGC)&nbsp;and&nbsp;Cronos&nbsp;(CRON), which have the backing of consumer products giantsConstellation Brands(STZ)andAltria(MO), respectively.</p>\n<p>Short-sellers are targeting Tilray. And Redditors have gleefully tried to squeeze the shorts — investors who borrow stocks and sell them with hopes of buying them back at a lower price.</p>\n<p>If a stock suddenly starts to rise, short-sellers have no choice but to buy it back or face prohibitively large losses. That's a big reason behind the recent spikes in&nbsp;AMC(AMC),GameStop(GME)&nbsp;and other stocks that the Reddit community has glommed onto this year.</p>\n<p>One Reddit user&nbsp;wrote in a post&nbsp;last week that Tilray \"is a movement,\" adding that the company has \"fantastic stats\" and is \"a worthy opponent to AMC\" as a meme stock.</p>\n<p>The short-sellers have seemingly taken control in this battle lately though. After a 6% pop in Tilray's stock last Wednesday, share prices have fallen for the past three trading days.</p>\n<p>But some backers aren't deterred by the recent pullback. One Redditor on the site's Tilray board&nbsp;wrote the following message&nbsp;to any would be short sellers: \"Weed Stocks to Bears: I'm not leaving.\"</p>\n<p>The post, which also mentioned cannabis stocksAurora(ACB)andSundial Growers(SNDL), showed a clip of Leonardo DiCaprio's inspirational speech to employes from \"The Wolf of Wall Street\" in which his Jordan Belfort character exclaimed he wasn't going anywhere.</p>\n<p>The Reddit community also seems to appreciate that Tilray CEO Irwin Simon is acknowledging their support. In an interview with CNBC last week, Simon said \"we love having them as part of our shareholder base\" in response to a question about the retail investor interest in the stock.</p>\n<p>One commenter referred to Simon last week as a \"diamond\" — the ultimate Reddit compliment.</p>\n<p>\"[He] wants to build a global green giant. This dude wants to take us to tendie town gentleman,\" the poster said, using the Reddit lingo \"tendie\" to describe trading profits.</p>\n<p>\"This company has a shot to literally rocket to the top as a fundamental and strong global brand,\" the Reddit user added.</p>\n<p>Still, Tilray's faithful may have a tough time convincing the Wall Street establishment that this is a stock worth owning.</p>\n<p>Analysts who cover the stock are lukewarm on its prospects. Only four have a buy rating on Tilray, compared with 13 holds and one sell. What's more, the consensus target price is about $19 — right around where the stock is currently trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This cannabis stock is a new Reddit favorite</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis cannabis stock is a new Reddit favorite\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 09:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.\nAs backers tout...</p>\n\n<a href=\"https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180739794","content_text":"New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.\nAs backers tout the growing number of states legalizing recreational and medical marijuana, some investors are holding out for the dream scenario of federal legalization — even though that might be a stretch in the near term.\nBut are investors going a little crazy?Tilray (TLRY) is now up more than 130% this year. That's much higher than the gains for rivalsCanopy Growth (CGC) and Cronos (CRON), which have the backing of consumer products giantsConstellation Brands(STZ)andAltria(MO), respectively.\nShort-sellers are targeting Tilray. And Redditors have gleefully tried to squeeze the shorts — investors who borrow stocks and sell them with hopes of buying them back at a lower price.\nIf a stock suddenly starts to rise, short-sellers have no choice but to buy it back or face prohibitively large losses. That's a big reason behind the recent spikes in AMC(AMC),GameStop(GME) and other stocks that the Reddit community has glommed onto this year.\nOne Reddit user wrote in a post last week that Tilray \"is a movement,\" adding that the company has \"fantastic stats\" and is \"a worthy opponent to AMC\" as a meme stock.\nThe short-sellers have seemingly taken control in this battle lately though. After a 6% pop in Tilray's stock last Wednesday, share prices have fallen for the past three trading days.\nBut some backers aren't deterred by the recent pullback. One Redditor on the site's Tilray board wrote the following message to any would be short sellers: \"Weed Stocks to Bears: I'm not leaving.\"\nThe post, which also mentioned cannabis stocksAurora(ACB)andSundial Growers(SNDL), showed a clip of Leonardo DiCaprio's inspirational speech to employes from \"The Wolf of Wall Street\" in which his Jordan Belfort character exclaimed he wasn't going anywhere.\nThe Reddit community also seems to appreciate that Tilray CEO Irwin Simon is acknowledging their support. In an interview with CNBC last week, Simon said \"we love having them as part of our shareholder base\" in response to a question about the retail investor interest in the stock.\nOne commenter referred to Simon last week as a \"diamond\" — the ultimate Reddit compliment.\n\"[He] wants to build a global green giant. This dude wants to take us to tendie town gentleman,\" the poster said, using the Reddit lingo \"tendie\" to describe trading profits.\n\"This company has a shot to literally rocket to the top as a fundamental and strong global brand,\" the Reddit user added.\nStill, Tilray's faithful may have a tough time convincing the Wall Street establishment that this is a stock worth owning.\nAnalysts who cover the stock are lukewarm on its prospects. Only four have a buy rating on Tilray, compared with 13 holds and one sell. What's more, the consensus target price is about $19 — right around where the stock is currently trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184985406,"gmtCreate":1623681044805,"gmtModify":1704208578921,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"nicee","listText":"nicee","text":"nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184985406","repostId":"2143780519","repostType":4,"repost":{"id":"2143780519","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1623679234,"share":"https://ttm.financial/m/news/2143780519?lang=&edition=fundamental","pubTime":"2021-06-14 22:00","market":"us","language":"en","title":"Novavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants","url":"https://stock-news.laohu8.com/highlight/detail?id=2143780519","media":"Investors","summary":"Novavax said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing.","content":"<p><b>Novavax</b> said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.</p>\n<p>The study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.</p>\n<p>\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.</p>\n<p>In morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.</p>\n<h2>NVAX Stock Yo-Yoes On Vaccine Test</h2>\n<p>Overall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.</p>\n<p>There were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.</p>\n<p>Further, the vaccine was 91% effective in people at high risk of severe disease.</p>\n<p>NVAX stock initially rose to its highest point in a month.</p>\n<h2>Protective Against Variants</h2>\n<p>Novavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.</p>\n<p>Another 10 were other variants. All of these occurred in the placebo group.</p>\n<p>Bullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson &amp; Johnson's vaccine was temporarily suspended due to blood clots.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-06-14 22:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Novavax</b> said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.</p>\n<p>The study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.</p>\n<p>\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.</p>\n<p>In morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.</p>\n<h2>NVAX Stock Yo-Yoes On Vaccine Test</h2>\n<p>Overall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.</p>\n<p>There were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.</p>\n<p>Further, the vaccine was 91% effective in people at high risk of severe disease.</p>\n<p>NVAX stock initially rose to its highest point in a month.</p>\n<h2>Protective Against Variants</h2>\n<p>Novavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.</p>\n<p>Another 10 were other variants. All of these occurred in the placebo group.</p>\n<p>Bullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson &amp; Johnson's vaccine was temporarily suspended due to blood clots.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143780519","content_text":"Novavax said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.\nThe study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.\n\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.\nIn morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.\nNVAX Stock Yo-Yoes On Vaccine Test\nOverall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.\nThere were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.\nFurther, the vaccine was 91% effective in people at high risk of severe disease.\nNVAX stock initially rose to its highest point in a month.\nProtective Against Variants\nNovavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.\nAnother 10 were other variants. All of these occurred in the placebo group.\nBullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson & Johnson's vaccine was temporarily suspended due to blood clots.","news_type":1},"isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183027967,"gmtCreate":1623295368659,"gmtModify":1704200304959,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183027967","repostId":"1117452441","repostType":4,"repost":{"id":"1117452441","kind":"news","pubTimestamp":1623294390,"share":"https://ttm.financial/m/news/1117452441?lang=&edition=fundamental","pubTime":"2021-06-10 11:06","market":"us","language":"en","title":"Grab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm","url":"https://stock-news.laohu8.com/highlight/detail?id=1117452441","media":"cnbc","summary":"SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for","content":"<div>\n<p>SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 11:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","BABA":"阿里巴巴"},"source_url":"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1117452441","content_text":"SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\nContrary to concerns thatregional heavyweights may \"gobble up\"smaller start-ups and stymie innovation, Vishal Harnal told CNBC that \"couldn't be further from the truth.\" Rather, he said, the initial public offerings of Grab and GoTo could boost the ecosystem and produce more billion-dollar start-ups.\nSingapore-based ride-hailing companyGrab announced in Aprilthat it would go public through a special purpose acquisition company merger valued at $39.6 billion —  the largest ever blank-check deal. Meanwhile, thenewly-merged Indonesia on-demand platform GoTo Groupconfirmed to CNBC that it would go public this year.\n\"While there will be (mergers and acquisitions), while these companies will acquire smaller start-ups, they're going to invest in far more companies than they acquire, and it's going to lead to a lot more billion-dollar companies — or unicorns — being born as a result of that,\" Harnal told \"Street Signs Asia\"Monday.\n\n They're going to invest in far more companies than they acquire, and it's going to lead to a lot more billion-dollar companies.Vishal HarnalMANAGING PARTNER, 500 STARTUPS\n\nThat's because the founders of successful companies will have newfound liquidity to invest in the ecosystem, either actively or as angel investors — those who invest in early stage businesses. Meanwhile, staff who have seen their employers grow from seed funding to IPO may be more inclined to build their own companies.\nHarnal likened the process to that which played out in China among its famous tech stocks known collectively as BAT –Baidu,Alibaba and Tencent.\nA passenger takes a ride on a Gojek motorcycle taxi in Jakarta on May 24, 2018.Bay Ismoyo | AFP | Getty Images\nAccording to 500 Startups research, out of the nearly 150 active and former unicorns created in China, 40% were invested by BAT companies. In total, BAT companies have invested in 915 tech companies since going public.\nIn contrast, there was less than half that number of mergers and acquisitions, with just 14 occurring in companies worth more than $1 billion.\n\"We saw this happening in China with BAT – Baidu, Alibaba, Tencent. Now in Southeast Asia, we've got the equivalent, GSG – Grab, Sea and GoTo,\" Harshal said, referencing the Singapore-based internet giantSea Group.\n\"The more money that companies like GSG spend in educating the ecosystem, in ensuring technology adoption, and investing in expanding the internet economy,\" he said. \"The more inroads it creates for newer start-ups to build companies and leverage on those companies that now exist.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189124488,"gmtCreate":1623248782044,"gmtModify":1704199350097,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"sick","listText":"sick","text":"sick","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/189124488","repostId":"2142321626","repostType":4,"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117735218,"gmtCreate":1623160335534,"gmtModify":1704197361534,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"liked","listText":"liked","text":"liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117735218","repostId":"1195023067","repostType":4,"repost":{"id":"1195023067","kind":"news","pubTimestamp":1623155236,"share":"https://ttm.financial/m/news/1195023067?lang=&edition=fundamental","pubTime":"2021-06-08 20:27","market":"us","language":"en","title":"Apple is encroaching on Facebook’s territory like never before with new social features","url":"https://stock-news.laohu8.com/highlight/detail?id=1195023067","media":"cnbc","summary":"KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you ","content":"<div>\n<p>KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple is encroaching on Facebook’s territory like never before with new social features</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple is encroaching on Facebook’s territory like never before with new social features\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 20:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1195023067","content_text":"KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall as part of Apple’s iOS 15 update for iPhones.\nThey will also set Apple up to compete more directly with Facebook, which has increased its complaints about Apple’s policies as the two companies start to overlap more.\n\nStarting this fall, thedecade-long spatbetweenAppleandFacebookwill start a new chapter. And this part of the story has Apple encroaching on Facebook's territory in ways it never has before.\nOn Monday, Apple revealed several new social features that will come to iPhones and iPadswith the launch of iOS 15this fall.\nSoon, iPhone users will be able to holdFaceTime video calls with Android and Windows users for the first time. They will also be able to use a new feature called SharePlay, which lets you hold a FaceTime call and watch a streaming movie, listen to music, or share your screen with your contacts. IMessage is getting a boost as well, with new features that make it easier to share web links, photos, Apple Music tracks and Apple News articles with your contacts.\nIn short, Apple is laying the groundwork for a suite of social features designed to let you do a lot of what you would normally do on Instagram and Facebook, only with more emphasis on privacy. Think of it as a watered-down social network without all the bloat and annoying stuff you find in other apps.\nIt's the kind of stuff that will drive Facebook CEO Mark Zuckerberg absolutely crazy.\nZuckerberg has already said heconsiders Apple a major competitor, largely because of apps like FaceTime and iMessage that come preinstalled on the more than 1 billion Apple gadgets in use around the world.\nOn top of that, Facebook late last year started ananti-Apple PR and advertising blitzover a new iOS privacy feature that limits how companies like Facebook can use your personal data to send you targeted ads. (Facebook makes most of its money from ads, and needs that targeting data for its ads to be effective.)\nIt's no coincidenceZuckerberg took a swipe at the 30% feeApple collects from many app makers on the iPhone just hours before Apple's big event on Monday.\nApple's new social features in iOS 15 are also coming well before Zuckerberg can complete Facebook's pivot to privacy,which he announced more than two years ago. In Zuckerberg's view, there will be two types of social sharing on the internet in the future: private communication, such as messaging in Facebook apps like WhatsApp and Messenger, and public communication, like posts on Instagram or the core Facebook service.\nApple's announcements on Monday proved you don't need Facebook for a lot of the stuff you already do on Facebook. Why log into Facebook or Instagram and give up personal data when you can just as easily share photos, messages, and videos right there in iOS 15?\nIf Zuckerberg was right and there will be a large swath of communication that takes place on a \"privacy-focused\" version of the internet, Apple has largely beaten Facebook to that future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113406494,"gmtCreate":1622630641618,"gmtModify":1704187663034,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"d","listText":"d","text":"d","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/113406494","repostId":"1182886492","repostType":4,"repost":{"id":"1182886492","kind":"news","pubTimestamp":1622604857,"share":"https://ttm.financial/m/news/1182886492?lang=&edition=fundamental","pubTime":"2021-06-02 11:34","market":"hk","language":"en","title":"30 Top Stock Picks That Billionaires Love","url":"https://stock-news.laohu8.com/highlight/detail?id=1182886492","media":"Nasdaq","summary":"It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful  to know what they've been up to.Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.Study","content":"<p>It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fruitful) to know what they've been up to.</p><p>Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.</p><p>Studying which stocks they're chasing with their capital (or whichstocks the billionaires are selling off, for that matter) can be an edifying exercise for retail investors.</p><p>After all, there's a reason the rich get richer.</p><p><b>Here are 30 of the most recent top stock picks from the billionaire class.</b>In each case, at least one billionaire – be it a person, hedge fund or advisory – has a substantial stake and/or added to its holdings. In most cases, these stocks are owned by multiple billionaire investors and billionaire investor firms. And while several of these investments are popular blue chips, others keep a much lower profile.</p><p>Either way, the smart money isn't kidding around when it comes to these stock picks.</p><p>Prices are as of May 28. Data is courtesy of S&amp;P Global Market Intelligence, WhaleWisdom.com&nbsp;and regulatory filings made with the Securities and Exchange Commission. Stocks are ranked in reverse order of their weight in the selected billionaire investor's equity portfolio.</p><p>Walmart</p><ul><li><b>Market value:</b>$400.0 billion</li><li><b>Billionaire investor:</b>Ray Dalio (Bridgewater Associates)</li><li><b>Percent of portfolio:</b>4.3%</li></ul><p>Ordinarily, we look for stocks that account for at least 5% of a billionaire investor's portfolio before including them on this list, but Bridgewater Associates' interest in<b>Walmart</b>(WMT, $142.03) is sort of a special case.</p><p>Legendary investor Ray Dalio's massive hedge fund – it has $223 billion in assets under management (AUM) – has nearly 11% of its portfolio sitting in an S&amp;P 500 index fund. Indeed, the SPDR S&amp;P 500 ETF (SPY), with its 0.0945% expense ratio, is Bridgewater's largest holding.</p><p>The fund's second-largest holding is<i>also</i>an ETF. The Vanguard Emerging Markets ETF (VWO) accounts for 5.1% of the hedge fund's total portfolio value.</p><p>So it's something of a feather in Walmart's cap that the world's largest retailer and Dow Jones Industrial Average component happens to be tops among Dalio's actual stock picks.</p><p>Indeed, in the first quarter of 2021, Bridgewater upped its WMT stake by 16%, or 512,347 shares. The total stake of 3.6 million shares, worth $487.8 million at the end of Q1, now accounts for 4.3% of Bridgewater's total portfolio value.</p><p>Note well that Dalio, whose net worth is estimated at $20.3 billion, according to Forbes, is a big fan of Dow stocks and ETFs. In addition to WMT at No. 3, Bridegwater's top 10 holdings include stakes in Procter &amp; Gamble (PG), Coca-Cola (KO) and Johnson &amp; Johnson (JNJ), as well as the SPDR Gold Trust ETF (GLD) and the iShares Core MSCI Emerging Markets ETF (IEMG).</p><p>Amazon.com</p><ul><li><b>Market value:</b>$1.6 trillion</li><li><b>Billionaire investor:</b>Stephen Mandel (Lone Pine Capital)</li><li><b>Percent of portfolio:</b>5.4%</li></ul><p>Hedge-fund legend Stephen Mandel stepped back from managing investments at Lone Pine Capital a couple years back, but he remains a managing director at the firm, and it still runs very much in his image.</p><p>That's probably a good thing, given that Mandel's investing acumen allowed him to accumulate a net worth of nearly $4 billion, per Forbes.</p><p>Lone Pine – based in the hedge-fund capital of the world, Greenwich, Connecticut – lists more than $27.5 billion in managed securities. Lately, it has been putting more cash to work in big-nametechnology stocks, and few get higher accolades from Wall Street analysts than<b>Amazon.com</b>(AMZN, $3,223.07).</p><p>Indeed, analysts say AMZN is one of thebest Nasdaq stocks you can buy, giving it a high conviction consensus recommendation of Strong Buy. That's due in no small part to the fact that they expect Amazon to generate average annual earnings per share growth of almost 35% over the next three to five years – this despite the fact that the e-commerce giant is already a $1.6 trillion company.</p><p>Lone Pine upped its bet on AMZN by 87%, or 224,618 shares, in the first quarter, bringing its total holdings to 481,744 shares. That stake, which was worth $1.5 billion at the end of Q1, accounts for 5.4% of Lone Pine's total portfolio value, making it fifth among the hedge fund's stock picks.</p><p>Danaher</p><ul><li><b>Market value:</b>$182.7 billion</li><li><b>Billionaire investor:</b>Tran Capital Management</li><li><b>Percent of portfolio:</b>5.4%</li></ul><p>Tran Capital Management, a hedge fund based in San Rafael, California, is incrementally more bullish on the life sciences industry.</p><p>Tran, with $1.1 billion in AUM, added 2,001 shares to its stake in<b>Danaher</b>(DHR, $256.14), which makes a variety of instruments and diagnostics equipment to support medical, industrial and commercial processes.</p><p>Tran now holds a total of 267,376 shares, which were worth $60.1 million at the end of Q1. The DHR stake is Tran's fourth-largest holding, accounting for 5.4% of its stock portfolio value. The hedge fund has been an investor in DHR since the first quarter of 2014, though even with the latest purchase, it still currently owns just 0.04% of the company's shares outstanding.</p><p>The Street is likewise bullish on this healthcare name, which stands to benefit from the pharmaceutical industry's ongoing efforts against the novel coronavirus. Indeed, analysts' consensus recommendation on DHR comes to Buy, according to S&amp;PGlobal MarketIntelligence.</p><p>\"We believe that Danaher is well positioned to help biopharma companies develop new medicines, including treatments and vaccines for COVID-19,\" writes Argus Research analyst David Toung, who rates DHR at Buy. \"We expect recent strong customer demand to be sustained over the remainder of 2021.\"</p><p>Abbott Laboratories</p><ul><li><b>Market value:</b>$207.3 billion</li><li><b>Billionaire investor:</b>Polen Capital Management</li><li><b>Percent of portfolio:</b>5.6%</li></ul><p>Polen Capital Management's top four stock picks are a who's who of hot-growth, mega-cap tech stocks: Facebook (FB), Microsoft (MSFT), Google-parent Alphabet's Class C shares (GOOG) and Adobe (ADBE).</p><p>So it's kind of neat to see that the hedge fund's fifth-largest position is an income investor's dream.</p><p><b>Abbott Laboratories</b>(ABT, $116.65) is as stalwart a divided payer as they come. It's a member of the S&amp;P Dividend Aristocrats, an index ofdividend stocks that have increased their payouts annually for at least 25 consecutive years.</p><p>ABT, which manufactures a wide variety of healthcare goods, such as branded generic drugs, medical devices and nutrition and diagnostic products, has hiked its dividend for 49 years and counting. The last increase came in December: a whopping 25% improvement to 45 cents per share.</p><p>Polen, a hedge fund based in Boca Raton, Florida, with AUM of more than $46 billion, has owned a stake in ABT since the third quarter of 2019. Most recently, it upped its position by 1%, or 220,118 shares. Polen's total of 20.7 million shares was worth $2.5 billion at the end of Q1, and accounted for 5.6% of its portfolio value.</p><p>Importantly, Polen owns 1.2% of Abbott Lab's shares outstanding, putting it among the company's 15 largest investors.</p><p>UnitedHealth Group</p><ul><li><b>Market value:</b>$388.7 billion</li><li><b>Billionaire investor:</b>Allen Investment Management</li><li><b>Percent of portfolio:</b>5.7%</li></ul><p><b>UnitedHealth Group</b>(UNH, $411.92) is a hedge-fund favorite, and Wall Street gives it high marks too.</p><p>As the largest health insurer by both market value and revenue – and a member of the Dow Industrials to boot – UNH is sort of a must-have stock for institutional investors seeking broad exposure to the healthcare sector.</p><p>Meanwhile, analysts' consensus recommendation on the name comes to Buy. Of the 27 analysts covering the stock tracked by S&amp;P Global Market Intelligence, 16 rate UNH at Strong Buy, six say Buy, three have it at Hold and one calls it a Sell.</p><p>\"With the increase in Covid-19 vaccinations, we expect medical utilization patterns to return to normal levels, while at the same time we anticipate higher utilizations resulting from missed medical visits and delayed electives,\" writes CFRA Research analyst Sel Hardy, who rates the stock at Strong Buy.</p><p>So it's only fitting that Allen Investment Management, a New York hedge fund with $9.3 billion in AUM, upped its stake in UNH by 2%, or 21,086 shares, during the first quarter.</p><p>At 5.7% of the portfolio, UNH is the fund's third-largest position, trailing only Allen stock picks Alphabet Class C shares and Facebook. The hedge fund's stake of 990,525 shares was worth $368.5 million at the end of the first quarter.</p><p>Gaming and Leisure Properties</p><ul><li><b>Market value:</b>$10.8 billion</li><li><b>Billionaire investor:</b>Gates Capital Management</li><li><b>Percent of portfolio:</b>6.0%</li></ul><p>Gates Capital Management is a fan of one of Wall Street pros' favorite Nasdaq stocks. The New York hedge fund with $3 billion in AUM upped its stake in<b>Gaming and Leisure Properties</b>(GLPI, $46.36) by 35%, or more than 1 million shares, during the first quarter.</p><p>Gates Capital now holds 3.9 million shares in thisreal estate investment trust (REIT)– a stake worth $165.6 million as of March 31.</p><p>Analysts like this casino real estate play thanks to both a snazzy dividend yield and attractive growth prospects coming out of the pandemic. The company, whose properties include the Belle of Baton Rouge and Argosy Casino Riverside in Missouri, collected 100% of its rents in 2020.</p><p>Mizuho Securities initiated coverage of Gaming and Leisure Properties at Buy in late March, citing its unique attributes in an industry set to benefit from a recovery in consumer spending and gaming revenue.</p><p>\"GLPI is the most diversified of the three Gaming REITs, with strong underlying tenant credit and structural lease enhancements, resulting in a lower-risk platform that we believe is under-appreciated by the market,\" writes Mizuho analyst Haendel St. Juste.</p><p>Analysts' consensus recommendation on the name stands at Strong Buy, according to S&amp;P Global Market Intelligence.</p><p>The bull case for GLPI makes it easy to understand why Gates Capital increased its exposure to a stock it first bought back in 2013. The hedge fund holds 1.7% of GLPI's shares outstanding, making it the REIT's 12th largest investor.</p><p>S&amp;P Global</p><ul><li><b>Market value:</b>$91.4 billion</li><li><b>Billionaire investor:</b>Chris Hohn (TCI Fund Management)</li><li><b>Percent of portfolio:</b>6.0%</li></ul><p>Activist investor Chris Hohn has made quite a name for himself with The Children's Investment Fund Management – more commonly known as TCI Fund Management. Indeed, the London-based investor has parlayed his many stock picks into a personal net worth of $5.9 billion, per Forbes.</p><p>TCI, with more than $34 billion in managed securities, made a handful of moves in Q1, and none was bigger in percentage terms than its doubling down (and then some) on<b>S&amp;P Global</b>(SPGI, $379.47).</p><p>Hohn increased the fund's stake in SPGI by 147% – by far its largest addition of the quarter in percentage terms – adding 3.5 million shares. TCI now owns 5.9 million shares in the company behind S&amp;P Global Ratings, S&amp;P Global Market Intelligence and S&amp;P Global Platts.</p><p>The stake, worth $2.1 billion at the end of Q1, accounts for 6.0% of TCI's portfolio value, and gives Hohn ownership of 2.4% of S&amp;P's shares outstanding. That makes TCI the company's sixth-largest shareholder.</p><p>Although most investors probably know S&amp;P for its majority stake in S&amp;P Dow Jones Indices – which maintains the benchmark S&amp;P 500 index and the blue-chip Dow Jones Industrial Average – it's also a central player in corporate and financial analytics, information and research.</p><p>Dedicated long-term income investors probably already know thatSPGI happens to be a Dividend Aristocrat. The company has increased its dividend annually for nearly half a century.</p><p>AbbVie</p><ul><li><b>Market value:</b>$199.9 billion</li><li><b>Billionaire investor:</b>Avidity Partners Management</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p><b>AbbVie</b>(ABBV, $113.20) was spun off from the above-mentioned Abbott Laboratories in 2013. It too, is a Dividend Aristocrat, having lifted its dividend annually for almost half a century.</p><p>Consumers best know the pharma firm for Humira, a blockbuster drug for rheumatoid arthritis that has been approved for numerous other ailments. AbbVie also makes cancer drug Imbruvica, as well as testosterone replacement therapy AndroGel.</p><p>Avidity Partners Management, a Dallas hedge fund with AUM of $6.2 billion, focuses primarily on stock picks in the healthcare sector, and it has been a fan of AbbVie since the fourth quarter of 2019. Most recently, it upped its stake in the pharma giant by 53%, or 721,200 shares. Avidity now holds a total of nearly 2.1 million shares in ABBV, worth $225 million at the end of Q1.</p><p>At 6.3% of its equity portfolio, AbbVie is Avidity's single largest position. That's up from 4.7% about three months ago.</p><p>The Street is a solid fan of ABBV, too. Analysts' consensus recommendation stands at Buy, with 11 Strong Buy ratings, six Buys and five Hold calls. One analyst has a Sell recommendation on the stock.</p><p>\"AbbVie is developing new growth drivers to help offset slowing sales of Humira, still its largest product by revenue,\" writes Argus Research analyst David Toung, who rates the stock at Buy. \"We expect continued strong growth from the oncology portfolio and newer immunology drugs in 2021.\"</p><p>Applied Materials</p><ul><li><b>Market value:</b>$126.2 billion</li><li><b>Billionaire investor:</b>Bristol Gate Capital Partners</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p>Bristol Gate Capital Partners, a Toronto hedge fund with AUM of $1.7 billion, initiated a position in<b>Applied Materials</b>(AMAT, $138.13) in the first quarter.</p><p>And what a commitment it was. The new purchase of 783,931 shares, worth $105 million at the end of Q1, vaulted the position to Bristol Gate's top holding, accounting for 6.3% of its portfolio.</p><p>Applied Materials, which provides manufacturing equipment and technology to the semiconductor industry, is an allied play on the global chip shortage. Indeed, relentless demand for semiconductors from a wide range of industries has helped AMAT stock jump about 60% for the year-to-date.</p><p>The Street is heavily bullish on the name, too. Analysts' consensus recommendation stands at Buy, according to S&amp;P Global Market Research. The high opinion stems in part from the Street's forecast for EPS to increase at an average annual rate of nearly 19% over the next three to five years.</p><p>\"We believe underlying secular drivers are robust, broad-based and multi-year in nature,\" writes B. Riley analyst Craig Ellis, who rates AMAT at Buy.</p><p>Johnson &amp; Johnson</p><ul><li><b>Market value:</b>$445.7 billion</li><li><b>Billionaire investor:</b>ACR Alpine Capital Research</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p>ACR Alpine Capital Research, a large advisory with $2.5 billion in AUM, has been a long-time fan of blue-chip<b>Johnson &amp; Johnson</b>(JNJ, $169.25). The St. Louis-based asset manager first invested in the Dow stock at the end of 2010, and it added incrementally to the position in Q1.</p><p>ACR upped its stake in the multifaceted pharma giant by 1%, or 8,790 shares, bringing its total holdings to 704,842 shares. The stake, worth $115.8 million at quarter's end, is at the tail end of the advisory's top 10 stock picks, taking up 6.3% of ACR's total portfolio value.</p><p>Analysts have a consensus recommendation of Buy on JNJ. Among the arguments in favor of the stock, bulls point to its strong pharmaceutical pipeline, as well as a rebound in demand for medical devices as patients undergo elective procedures put off during the pandemic.</p><p>\"We expect the recovery in elective procedures and patient visit volumes to accelerate as the pandemic is starting to get under control in the U.S., which should result in a strong recovery in Medical Devices sales and solid growth in Pharma revenues,\" writes CFRA Research analyst Sel Hardy, who rates shares at Buy.</p><p>Investors and analysts alike no doubt also appreciate the company's commitment to delivering income to investors. JNJ announced a 5% quarterly dividend increase in April 2021, to $1.06 per share from $1.01 per share. That marked this Dividend Aristocrat's 59th consecutive year of dividend increases.</p><p>Xilinx</p><ul><li><b>Market value:</b>$31.2 billion</li><li><b>Billionaire investor:</b>Canyon Capital Advisors</li><li><b>Percent of portfolio:</b>7.0%</li></ul><p>Canyon Capital Advisors, with AUM of $20.9 billion, has propelled founders Joshua Friedman and Mitchell Julis to Forbes' list of highest-earning hedge fund millionaires.</p><p>So it's of interest that the Los Angeles-based fund significantly pared back on its two largest stock picks in Q1 – while greatly increasing its bet on chipmaker<b>Xilinx</b>(XLNX, $127.00).</p><p>In October 2020, Advanced Micro Devices (AMD) and Xilinx announced a deal in which AMD would acquire the latter in an all-stock transaction valued at $35 billion.</p><p>Canyon first bought shares in Xilinx in the fourth quarter of 2020, at which point the stake accounted for 4.6% of the fund's portfolio value. Then in Q1, Canyon upped its XLNX holdings by 89%, or 672,829 shares.</p><p>The hedge fund's total stake of 1.4 million shares, worth $176.3 million at the end of Q1, now accounts for 7.0% of its portfolio value.</p><p>Canyon, with ownership of 0.58% of XLNX's shares outstanding, is a top-30 stockholder in the soon-to-be-acquired company. AMD and Xilinx expect their deal to close at the end of 2021.</p><p>Analysts' consensus recommendation on XLNX stands at Hold, pending the deal close. They do, however, rate AMD at Buy, and generally applaud the strategic rationale of merging the two chipmakers' complementary assets.</p><p>D.R. Horton</p><ul><li><b>Market value:</b>$34.4 billion</li><li><b>Billionaire investor:</b>George Soros (Soros Fund Management)</li><li><b>Percent of portfolio:</b>7.4%</li></ul><p>Legendary hedge-fund tycoon George Soros, with an estimated net worth of $8.6 billion, per Forbes, today spends his days running Soros Fund Management.</p><p>The New York-based family office – a sort of private hedge fund – has $5.3 billion in AUM, and one of its biggest stock picks is a bet on the severe shortage of new homes for sale.</p><p>Soros first took a stake in homebuilder<b>D.R. Horton</b>(DHI, $95.29) during the first quarter of 2019, and he apparently remains bullish on the outlook. After all, the billionaire increased his DHI stake by 19%, or 703,850 shares, in the first quarter.</p><p>Soros Fund Management's most recent investment makes DHI its second-largest holding, at 7.4% of the portfolio. The stake of 4.4 million shares – worth $392.8 million at the end of Q1 – equals 1.2% of the homebuilder's shares outstanding. As such, Soros Fund Management is D.R. Horton's 15th largest shareholder.</p><p>With a consensus recommendation of Buy, per S&amp;P Global Market Intelligence, the Street is also bullish on the name.</p><p>\"With inventory constraints growing across the industry and buyer demand still nearly insatiable, we think DHI remains in an extraordinarily strong position to gain further market share and leverage its sector-leading scale,\" writes Raymond James analyst Buck Horne, who rates shares at Outperform (the equivalent of Buy).</p><p>Microsoft</p><ul><li><b>Market value:</b>$1.9 trillion</li><li><b>Billionaire investor:</b>Chase Coleman III (Tiger Global Management)</li><li><b>Percent of portfolio:</b>7.4%</li></ul><p>Hedge-fund legend Chase Coleman III, with a net worth of $10.3 billion, according to Forbes, upped his bet on<b>Microsoft</b>(MSFT, $249.68) in the first quarter of 2021.</p><p>And he did so in a compelling fashion.</p><p>Coleman's Tiger Global Management ($79 billion AUM) increased its stake in MSFT by 15%, or 1.8 million shares, in the first three months of the year. The hedge fund now owns a total of 13.7 million shares, worth $3.2 billion at the end of Q1.</p><p>The MSFT stake, which accounts for 7.4% of Tiger Global's portfolio value, is second only to its bet on Chinese e-commerce company JD.com (JD), which is top among Coleman's stock picks at 9.9% of the portfolio.</p><p>Tiger Global first bought MSFT in the fourth quarter of 2016, and adding to the stake certainly makes sense. Wall Street analysts mostly adore this component of the Dow Jones Industrial Average.</p><p>After all, MSFT – the second-largest U.S. company by market value after Apple (AAPL) – lands among the pro's11 best Nasdaq stocks you can buy. Analysts' consensus recommendation on MSFT comes to Strong Buy, with 26 Strong Buy calls, 11 Buys and one Hold rating.</p><p>Tesla</p><ul><li><b>Market value:</b>$602.3&nbsp;billion</li><li><b>Billionaire investor:</b>Ark Invest</li><li><b>Percent of portfolio:</b>7.6%</li></ul><p>Ark Invest features prominently in the financial news these days, thanks to the strong performance of several of its actively managed exchange-traded funds.</p><p>Indeed, as Kiplinger has noted, 2020 was the year of Cathie Wood, CEO and founder of Ark Invest, who steered its then-five separate actively managed innovation-themed funds to the ranks ofthe best-performing equity ETFsof the year.</p><p>In addition to ETFs, Ark offers managed accounts and other products and services aimed at high net worth investors. Thanks to the various products and services it offers, the firm has amassed more than $55 billion in AUM.</p><p>So it says something when Ark's single-largest holding is<b>Tesla</b>(TSLA, $625.22) – especially since the firm is increasing its exposure to the electric vehicle maker at an accelerating pace.</p><p>Ark boosted its TSLA position by 39%, or 1.7 million shares, during the first quarter of 2021. The stake, which accounts for 7.6% of Ark Investment Management's equity portfolio, was worth nearly $4 billion at the end of Q1.</p><p>It's not hard to see why Wood likes TSLA so much. Her investment approach focuses on innovation, and Tesla, led by the mercurial Elon Musk, is nothing if not innovative.</p><p>Comcast</p><ul><li><b>Market value:</b>$263.4 billion</li><li><b>Billionaire investor:</b>Rothschild &amp; Company Wealth Management UK</li><li><b>Percent of portfolio:</b>9.0%</li></ul><p>Rothschild &amp; Company Wealth Management UK, a London-based hedge fund with $16.4 billion in AUM, is increasingly bullish on<b>Comcast</b>(CMCSA, $57.34).</p><p>Welcome to the club.</p><p>The nation's largest cable company regularly makes the list ofhedge funds' favorite stock picks. That's because its combination of content, broadband, pay TV, theme parks and movies is unparalleled by rivals, and gives thisblue-chip stocka huge strategic advantage.</p><p>CMCSA's diversification came in especially handy last year when the pandemic walloped theme parks, cinemas and spending on advertising.</p><p>\"While the pandemic has materially impacted Comcast, the company's steady cable division continues to provide vital connectivity for its large base of 23 million subscribers,\" writes Argus Research analyst Joseph Bonner (Buy).</p><p>Rothschild first bought shares in the cable operator in the first quarter of 2019, and most recently upped its bet by 2%, or 194,324 shares. The hedge fund's total holdings of 9.2 million shares, worth $500.2 million at the end of Q1, accounted for 9.0% of its portfolio. CMCSA is now Rothchild's sixth-largest position.</p><p>Analysts' consensus recommendation on the stock comes to Buy, per S&amp;P Global Market Intelligence, with 20 Strong Buy ratings, nine Buys, four Holds and one Strong Sell. The Street expects the company to deliver average annual EPS growth of nearly 16% over the next three to five years.</p><p>Aptiv</p><ul><li><b>Market value:</b>$40.7 billion</li><li><b>Billionaire investor:</b>Caxton Associates</li><li><b>Percent of portfolio:</b>9.4%</li></ul><p>Billionaire philanthropist Bruce Kovner, with an estimated net worth of $6.6 billion, retired from his management role at Caxton Associates a decade ago. But the hedge fund he founded continues to rake in the bucks with his global macroeconomic trading strategies.</p><p>Indeed, Caxton last year closed its flagship fund to new money after posting record 40% gains during the pandemic. And the firm shows no signs of slowing down.</p><p>Caxton, with AUM of $25.7 billion, has owned<b>Aptiv</b>(APTV, $150.42) since the first quarter of 2019, but it really went all in earlier this year.</p><p>Caxton upped its stake in APTV by 61%, or 285,618 shares. Indeed, the purchase made APTV the fund's top stock pick, accounting for 9.4% of the portfolio, up from 4.2% three months ago. Caxton's 747,843 shares were worth $103.1 million at the end of Q1.</p><p>Shares in Aptiv, which makes safety, connectivity and green technology for vehicles, have essentially doubled over the past 52 weeks, and analysts say they have more room to run.</p><p>\"Aptiv indeed is not only benefitting from accelerating industry adoption of vehicle electrification, advanced driver-assistance systems, and connected vehicle technologies, but also achieving dominant win rates in several of these areas based on its complete system knowledge, and software-based flexible architectures,\" writes Deutsche Bank analyst Emmanuel Rosner (Buy).</p><p>Adobe</p><ul><li><b>Market value:</b>$241.2 billion</li><li><b>Billionaire investor:</b>Atalan Capital Partners</li><li><b>Percent of portfolio:</b>9.6%</li></ul><p>Atalan Capital Partners, a New York hedge fund with AUM of $2 billion, boosted its stake in<b>Adobe</b>(ADBE, $504.58) in Q1, which vaulted the software company into the No. 2 spot among its stock picks.</p><p>Atalan increased its holdings by 38%, or 82,000 shares, in Q1, lifting its total stake to 295,000 shares worth $140.2 million as of March 31. The position accounts for 9.6% of the portfolio.</p><p>Atalan first picked up ADBE in the second quarter of 2020, which was not the best timing. Shares are up just about 16% since June 30 of last year, lagging the S&amp;P 500 by roughly 20 percentage points.</p><p>That's not to say ADBE stock won't continue to be a winner in the longer run. Analysts tend to be heavily bullish on the name, thanks to its dominance in its field. After all, Adobe is the undisputed leader in making software for designers and other creative types. Its software arsenal includes Photoshop, Premiere Pro for video editing and Dreamweaver for website design, among others.</p><p>\"As a result of its early-mover position and strategic M&amp;A transactions, Adobe has established itself as the unchallenged leader in Creative software,\" writes Stifel analyst Jeffrey Parker Lane (Buy). \"We view Adobe as one of the most compelling investment cases in our coverage areas.\"</p><p>The Street's consensus recommendation stands at Buy, with an annual EPS growth forecast of more than 15% over the next three to five years.</p><p>Thermo Fisher Scientific</p><ul><li><b>Market value:</b>$184.5 billion</li><li><b>Billionaire investor:</b>Cryder Capital Partners</li><li><b>Percent of portfolio:</b>9.7%</li></ul><p><b>Thermo Fisher Scientific</b>(TMO, $469.50), is sometimes called the \"Amazon of the healthcare industry\" because of its wide-ranging portfolio of life sciences products, analytics and laboratory instruments.</p><p>As such, it has been highly active in the fight against COVID-19, which in turn has raised its profile and investor interest. And although TMO has been a holding of Cryder Capital Partners since 2015, the hedge fund remains an incremental buyer.</p><p>London-based Cryder Capital, with $1 billion in AUM, lifted its stake in TMO by 2%, or 6,398 shares, during the first three months of the year. The hedge fund now holds a total of 298,587 shares, worth $136.3 million as of March 31. Despite a high weight of 9.7%, TMO is just seventh largest among the fund's stock picks.</p><p>Analysts' consensus recommendation stands at Strong Buy, according to S&amp;P Global Market Intelligence. Argus Research is just one research shop in the bull camp.</p><p>\"Thermo is seeing strong demand for COVID-19 testing solutions as well as for instruments and supplies used by developers of vaccines and other treatments,\" writes analyst David Toung (Buy). \"But the company is also investing its substantial cash flow in technology upgrades, capacity expansions and acquisitions.\"</p><p>With an average target price of $557.17, the Street gives TMO stock implied upside of about 18% in the next 12 months or so.</p><p>Visa</p><ul><li><b>Market value:</b>$484.8 billion</li><li><b>Billionaire investor:</b>Valley Forge Capital Management</li><li><b>Percent of portfolio:</b>10.2%</li></ul><p><b>Visa</b>(V, $227.30) routinely makes most lists of analysts', hedge funds' or billionaires' favorite stocks.<b>Berkshire Hathaway</b>(BRK.B)owns a stake worth more than $2 billion, although chairman and CEO Warren Buffett readily credits the holding to one of his stock-picking lieutenants.</p><p>And indeed, there is much to like about this Dow stock. Visa operates the world's largest payments network, and thus is well-positioned to benefit from the growth of cashless transactions and digital mobile payments.</p><p>The Street's consensus recommendation is a high-conviction Buy. Of the analysts covering the stock tracked by S&amp;P Global Market Intelligence, 21 call V a Strong Buy, 12 rate it at Buy, four say Hold and one calls it a Sell.</p><p>Valley Forge Capital Management, a hedge fund in Wayne, Pennsylvania, with $1.1 billion in AUM, is certainly a big believer. Visa accounts for 10.2% of its equity portfolio.</p><p>The fund increased its Visa stake by 88%, or 477,181 shares, in Q1. It now holds more than 1 million shares worth $215 million as of March 31. Mind you, Valley Forge Capital is hardly a novice in this stock. The fund has counted Visa among its stock picks since 2016.</p><p>Although the pandemic greatly curtailed spending in a number of Visa's categories – most notably travel and entertainment – those headwinds should now be in the past. Indeed, the gradual global reopening – and accelerating secular growth in cashless payments,&nbsp;helped by the perception that cash is \"dirty\" – make a solid bull case for Visa stock.</p><p>Intel</p><ul><li><b>Market value:</b>$230.7 billion</li><li><b>Billionaire investor:</b>Cavalry Management Group</li><li><b>Percent of portfolio:</b>10.4%</li></ul><p><b>Intel</b>(INTC, $57.12) has fallen far behind the competition on any number of fronts, which is why analysts and investors were so delighted when the chipmaker hired Pat Gelsinger, former CEO of VMWare (VMW), to take over in February.</p><p>Heck, some observers said it was the best decision the troubled company made in more than a decade. And, indeed, this Dow stock has been a disappointing performer. Shares are up just 3% over the past three years vs. a gain of 54% for the S&amp;P 500.</p><p>So props to Cavalry Management Group for making a bold bet on the semiconductor company earlier this year. The San Francisco hedge fund with $2.6 billion in AUM initiated a large enough position to instantly make Intel its top stock pick.</p><p>Cavalry Management bought 1.7 million shares during the first three months of 2021. With a value of $111.6 million at the end of Q1, INTC accounted for more than 10% of the hedge fund's investments.</p><p>Cavalry largely focuses on large-cap tech stocks, so Intel certainly fits well with its broader strategy. Other moves the fund made in Q1 included more than tripling its stake in Microsoft, and almost doubling its holdings in Ericsson (ERIC).</p><p>The Street is generally more cautious on INTC than Cavalry Management is. Analysts' consensus recommendation stands at Hold, per S&amp;P Global Market Intelligence.</p><p>PayPal Holdings</p><ul><li><b>Market value:</b>$305.5 billion</li><li><b>Billionaire investor:</b>Dorsey Asset Management</li><li><b>Percent of portfolio:</b>11.8%</li></ul><p>Digital mobile payments and the expansion of cashless transactions are one of the hottest areas of growth in financial tech. And although the sector offers no shortage of promising new names, old-timer<b>PayPal Holdings</b>(PYPL, $260.02) still gets plenty of analyst – and billionaire investor – love.</p><p>Explosive growth in mobile transactions, the monetization of its Venmo property and incremental revenue growth in its Xoom business all help make for a compelling bull case on PYPL, analysts say.</p><p>\"Simply put, PayPal should continue to benefit from the secular shift to e-commerce that should drive a roughly 20% revenue compound annual growth rate (CAGR), which, coupled with margin expansion and capital allocation (mergers &amp; acquisitions plus stock buybacks), should result in an earnings CAGR north of 20% over the next several years,\" writes Raymond James analyst John Davis, who rates the stock at Outperform (the equivalent of Buy).</p><p>Dorsey Asset Management, with $1.3 billion in AUM, embraces the bull case on PYPL in a big way. The Chicago-based hedge fund increased its stake in PayPal by 81%, or 209,025 shares, in Q1. Its total holdings of 465,266 shares, worth $113 million as of March 31, comprises 11.8% of its stock investments.</p><p>That's up from 7.9% of the portfolio three months ago. PYPL, which Dorsey has owned since the second quarter of 2018, is now its fifth-largest position.</p><p>Analysts' consensus recommendation on the stock stands at Buy, according to S&amp;P Global Market Intelligence.</p><p>Howard Hughes</p><ul><li><b>Market value:</b>$5.8 billion</li><li><b>Billionaire investor:</b>Bill Ackman (Pershing Square Capital)</li><li><b>Percent of portfolio:</b>12.1%</li></ul><p>No one doubts Bill Ackman's investing acumen. His Pershing Square Capital hedge fund has allowed the investor to amass a personal fortune of $3 billion, per Forbes.</p><p>And he's never been one to shy away from the media. So his increasing stake in<b>Howard Hughes Corp.</b>(HHC, $105.83) is far from a state secret. Indeed, Ackman has owned shares in the master-planned community developer since it was spun off from General Growth Properties in 2010.</p><p>Given Ackman's propensity for being anactivist investor, his latest purchase is eyebrow-raising news, nonetheless.</p><p>The hedge-fund billionaire increased his stake in HHC by 23%, or 2.6 million shares, in Q1. Pershing Square's stake of 13.5 million shares was worth $1.3 billion at the first quarter's end.</p><p>Most notably, Ackman now holds almost a quarter of HHC's shares outstanding. That makes the hedge fund the company's largest investor by a wide margin. Asset manager Vanguard, at No. 2, owns just 10.8% of HHC.</p><p>Meanwhile, HHC, at 12.1% of its portfolio, is now Pershing Square Capital's sixth-largest position.</p><p>For those keeping score at home, HHC stock has doubled over the past 52 weeks vs. a gain of about 38% for the S&amp;P 500. For the year-to-date, it's up by more than a third. That compares with the broader market's gain of about 12% so far this year.</p><p>Only three analysts cover HHC, according to S&amp;P Global Market Intelligence. One rates it at Strong Buy, while the other two say Buy.</p><p>Lowe's</p><ul><li><b>Market value:</b>$137.7 billion</li><li><b>Billionaire investor:</b>Two Creeks Capital Management</li><li><b>Percent of portfolio:</b>12.2%</li></ul><p>Two Creeks Capital Management, a New York hedge fund with AUM of $2.8 billion, made a big addition to its stake in<b>Lowe's</b>(LOW, $194.83) in the first quarter – a move most analysts would regard as wise.</p><p>The nation's second-largest home improvement retailer after Home Depot (HD) benefited greatly from the work-from-home/stuck-at-home reality of pandemic life. Analysts say many of the do-it-yourself habits consumers adopted during COVID times are here to stay. Lowe's is also being aided by the ultra-tight housing market.</p><p>The Street gives LOW a consensus recommendation of Buy. Argus Research, which counts itself in the Buy camp, says Lowe's has several strong tailwinds behind it.</p><p>\"We believe that the major drivers of post-pandemic sales growth remain the same,\" writes Argus Research analyst Christopher Graja. \"There has been significant underinvestment in housing. About 70% of U.S. homes are more than 25 years old and likely in need of upgrades and repairs. Millennials are starting families.\"</p><p>Income investors know the power of Lowe's dividend over the longer haul. The Dividend Aristocrat has paid a cash distribution every quarter since going public in 1961, and that dividend has increased annually for almost 60 years.</p><p>The bullish investment thesis led Two Creeks to up its stake in this stock pick by 14%, or 132,811 shares, in Q1. The hedge fund's total stake of 1.1 million LOW shares, worth $200 million at the end of Q1, accounts for 12.2% of its portfolio, representing its third-largest holding.</p><p>Alphabet</p><ul><li><b>Market value:</b>$1.6 trillion</li><li><b>Billionaire investor:</b>Metropolis Capital</li><li><b>Percent of portfolio:</b>13.3%</li></ul><p>It should come as no surprise that hedge funds are big believers in Google parent<b>Alphabet</b>(GOOGL, $2,356,85). Metropolis Capital, a U.K.-based investor with $1.4 billion in AUM, is just one of about 225 hedge funds upping its stake in the internet giant in Q1.</p><p>Metropolis thinks highly enough of the search leader that it increased its stake by 22%, or 13,679 shares. The firm now holds a total of 74,868 shares worth $154.4 million, or 13.3% of its total portfolio, as of March 31.</p><p>Alphabet happens to be in good company at this hedge fund. GOOGL is Metropolis' second-largest stock pick after Berkshire Hathaway (BRK.B).</p><p>If nothing else, Alphabet's pandemic performance in totality bolstered the case that GOOGL is not a one-trick pony. Its numerous other endeavors likewise shore up the case. For example, Alphabet is a key player in cloud-based services, and home to Nest Labs and self-driving car startup Waymo. Artificial intelligence, machine learning and virtual reality are other areas of heavy investment.</p><p>\"We continue to favor Google as a core large-cap growth holding given the strong digital advertising backdrop, continued strength from Cloud, ongoing share repurchases (with the newly authorized $50 billion program) and a reasonable valuation,\" writes Canaccord Genuity analyst Maria Ripps (Buy).</p><p>Analysts' consensus recommendation on the name stands at Strong Buy. Of the 45 analysts issuing opinions on the stock tracked by S&amp;P Global Market Intelligence, 32 rate it at Strong Buy, 12 say Buy and one has it at Hold.</p><p>Walt Disney</p><ul><li><b>Market value:</b>$324.6 billion</li><li><b>Billionaire investor:</b>Kirkoswald Asset Management</li><li><b>Percent of portfolio:</b>16.5%</li></ul><p>Coronavirus took a huge bite out of some of<b>Walt Disney's</b>(DIS, $178.65) most important businesses: namely, its theme parks and studios. But after encouraging quarterly results, analysts say business is set to bounce back in a big way.</p><p>Disneyland and other California amusement parks have reopened with restrictions. And admissions at Florida's Disney World continue to climb.</p><p>\"With mask mandates lifted and capacity constraints loosened further, we would not be surprised to see a step change in attendance in the near future,\" writes Deutsche Bank analyst Bryan Kraft (Buy).</p><p>But that's nothing compared to what DIS has on its hands in thestreaming mediawars.</p><p>Disney+ is a smashing success. The streaming platform, which launched in November 2019, has already amassed almost 100 million subscribers – a staggering rate of growth. Consider that Disney+ now has about half as many subscribers as Netflix (NFLX) – but Netflix had a roughly 12-year head start.</p><p>Kirkoswald Asset Management, a New York hedge fund with AUM of $4 billion, decided to get in on DIS asa recovery stock pickin Q1. It initiated a stake of 5,200 shares, worth almost $1 million, during the first three months of the year.</p><p>The new stake immediately made DIS its second-largest position among $5.8 million in managed securities.</p><p>Most of the Street would approve of Kirkoswald's investment. Analysts have a consensus Buy recommendation on this Dow stock.</p><p>Berkshire Hathaway</p><ul><li><b>Market value:</b>$661.0 billion</li><li><b>Billionaire investor:</b>Southeast Asset Advisors</li><li><b>Percent of portfolio:</b>16.8%</li></ul><p>If you can't beat 'em, join 'em.</p><p>It's hard to compete with Warren Buffett when it comes toasset allocation. As CEO and chairman of<b>Berkshire Hathaway</b>(BRK.B, $289.44), he's arguably the greatest long-term investor of all time.</p><p>So it's little wonder that so many hedge funds, large advisories and other billion-dollar-plus pools of money throw in their lots with the Oracle of Omaha.</p><p>Southeast Asset Advisors, an investment manager and hedge fund based in Thomasville, Georgia, with $1.6 billion in AUM, has been a BRK.B shareholder since 2008. Indeed, BRK.B, at 16.8% of its portfolio, is the fund's top holding.</p><p>And it's only getting bigger.</p><p>Southeast increased its stake in BRK.B by 2%, or 7,747 shares, in Q1. It now holds 365,149 shares worth $93.3 million. Only Alphabet Class C shares (GOOG) come close to the firm's BRK.B stake, accounting for 11.7% of the portfolio.</p><p>BRK.B has been an outstanding performer both in 2021 and over the past 52 weeks. The stock is up 25% for the year-to-date, essentially doubling the S&amp;P 500's gains. And over the past year? BRK.B returned 57% vs. a price increase of less than 40% for the broad-market gauge.</p><p>Only four analysts cover BRK.B stock, per S&amp;P Global Market Intelligence. Their consensus recommendation comes to Buy.</p><p>Alibaba</p><ul><li><b>Market value:</b>$580.4 billion</li><li><b>Billionaire investor:</b>Conifer Management</li><li><b>Percent of portfolio:</b>20.7%</li></ul><p>Conifer Management, a New York hedge fund with $7.7 billion in AUM, has more than a fifth of its portfolio invested in Chinese e-commerce giant<b>Alibaba</b>(BABA, $213.96).</p><p>Indeed, after upping its stake by 147%, or 884,845 shares, in Q1, BABA is Conifer's top holding. Its total stake of 1.5 million shares was worth $336.7 million at the end of the first quarter.</p><p>Conifer initiated its stake in BABA only in the final quarter of last year. To the hedge fund's credit, this stock pick is a highly defensible investment idea.</p><p>Alibaba is sometimes called the Amazon of China. There are important differences between the two, but they do share the enviable trait of being undisputed titans ine-commerce.</p><p>And like Amazon, Alibaba has never shied away from investing heavily to both build out its existing businesses and enter new ones. As a result, BABA finds itself spreading beyond its core e-commerce business into cloud computing, digital payments and more.</p><p>It also helps that BABA and investors can now move past a $2.75 billion fine imposed by Chinese regulators for violating anti-monopoly laws.</p><p>Some analysts worry about decelerating revenue in the company's cloud services business, but the majority of the Street sees recent share-price weakness as a buying opportunity.</p><p>The consensus recommendation of 49 analysts tracked by S&amp;P Global Market Intelligence comes to Strong Buy on BABA stock.</p><p>Mastercard</p><ul><li><b>Market value:</b>$357.4 billion</li><li><b>Billionaire investor:</b>Valley Forge Capital Management</li><li><b>Percent of portfolio:</b>22.6%</li></ul><p>If Valley Forge Capital Management likes Visa – as noted above – it absolutely adores competitor<b>Mastercard</b>(MA, $360.58).</p><p>The Wayne, Pennsylvania-based hedge fund with $1.1 billion in AUM almost doubled its stake in this stock pick in the first quarter. And with more than a fifth of its portfolio tied up in the payments processor, Mastercard is Valley Forge's top holding.</p><p>The hedge fund bought another 665,544 shares, representing a 98% increase, in Q1, bringing its total holdings to 1.3 million shares. The position was worth $477.9 million as of March 31.</p><p>Valley Forge, which owns 0.14% of MA's shares outstanding, has been an investor in the company since 2016. It's a bet that appears to have done quite well. Mastercard stock's five-year total return – price appreciation plus dividends – comes to 30.8%, according to Morningstar data. That beats its sector by 5.7 percentage points and leads the broader market by 13.4 percentage points.</p><p>Like Visa, Mastercard has relentless growth in digital mobile payments and other cashless transactions at its back.</p><p>\"Mastercard is a key beneficiary of the long-term secular shift toward electronic forms of payments, and that new technology is helping accelerate the shift,\" writes William Blair analyst Robert Napoli (Outperform)</p><p>And, just like Visa, MA has a lot of fans on the Street. Analysts' consensus recommendation stands at Buy.</p><p>Facebook</p><ul><li><b>Market value:</b>$932.1 billion</li><li><b>Billionaire investor:</b>Altarock Partners</li><li><b>Percent of portfolio:</b>24.4%</li></ul><p>There's a strong bull case to be made for<b>Facebook</b>(FB, $328.73), the social media giant that forms a digital-ad duopoly with Google. Just ask Altarock Partners.</p><p>This hedge fund, based in Beverly, Massachusetts, with AUM of $3.1 billion, has almost a quarter of its portfolio socked away in Facebook stock. After buying another 465,800 shares, a 27% increase, in Q1, the hedge fund is sitting on 2.2 million shares worth $641.4 million as of March 31.</p><p>That makes FB Altarock's second-largest holding.</p><p>And just who is at No. 1?</p><p>None other than Google parent Alphabet, which commands 25.1% of Altarock's investment portfolio.</p><p>The hedge fund first bought FB in the fourth quarter of last year, so it's building up its position on the stock pick pretty rapidly. And well it should, if analysts are right about this name.</p><p>The Street's consensus recommendation on FB stands at Strong Buy, as analysts forecast the company to deliver truly impressive profit growth for some time.</p><p>\"We believe Facebook's share gains during the pandemic and new initiatives in e-commerce can drive many years of above-market growth,\" writes Stifel analyst John Egbert (Buy). \"We are comfortable with the potential outcomes of antitrust inquiries and believe FB shares offer investors a rare combination of growth and value relative to its peers.\"</p><p>Seagen</p><ul><li><b>Market value:</b>$28.2 billion</li><li><b>Billionaire investor:</b>Felix and Julian Baker (Baker Bros. Advisors)</li><li><b>Percent of portfolio:</b>29.7%</li></ul><p><b>Seagen</b>(SGEN, $155.35), a biotechnology firm specializing in oncology treatments, couldn't get a bigger vote of confidence than being the top holding of Baker Bros. Advisors.</p><p>This New York-based hedge fund with $35.8 billion in AUM is led by billionaire biotech investors Julian and Felix Baker. The brothers may keep a low profile, but they're plenty famous in the world ofbiotech stocks. A series of successful investments have allowed the Bakers to build an estimated combined fortune of about $4 billion, according to Forbes.</p><p>And judging by their latest regulatory filings, the brothers have great expectations for Seagen, too. The stock pick accounts for nearly 30% of the total value of the Baker Bros.' holdings, up from 28.5% three months ago.</p><p>The increase stems in part from Baker Bros. buying another 347,745 shares in SGEN in the first quarter of 2021. The fund's total holdings of 47.6 million shares were worth more than $7 billion at the end of Q1.</p><p>The stake gives Baker Bros. ownership of 26.3% of SGEN's shares outstanding, which makes it the biotech company's largest shareholder by a wide margin. The second-largest investor – Capital Research and Management – holds only 8.6% of SGEN's shares outstanding.</p><p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p><p>TRENDING TOPICS</p><p>TRENDING ARTICLES</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>30 Top Stock Picks That Billionaires Love</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n30 Top Stock Picks That Billionaires Love\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 11:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01><strong>Nasdaq</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be ...</p>\n\n<a href=\"https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182886492","content_text":"It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fruitful) to know what they've been up to.Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.Studying which stocks they're chasing with their capital (or whichstocks the billionaires are selling off, for that matter) can be an edifying exercise for retail investors.After all, there's a reason the rich get richer.Here are 30 of the most recent top stock picks from the billionaire class.In each case, at least one billionaire – be it a person, hedge fund or advisory – has a substantial stake and/or added to its holdings. In most cases, these stocks are owned by multiple billionaire investors and billionaire investor firms. And while several of these investments are popular blue chips, others keep a much lower profile.Either way, the smart money isn't kidding around when it comes to these stock picks.Prices are as of May 28. Data is courtesy of S&P Global Market Intelligence, WhaleWisdom.com and regulatory filings made with the Securities and Exchange Commission. Stocks are ranked in reverse order of their weight in the selected billionaire investor's equity portfolio.WalmartMarket value:$400.0 billionBillionaire investor:Ray Dalio (Bridgewater Associates)Percent of portfolio:4.3%Ordinarily, we look for stocks that account for at least 5% of a billionaire investor's portfolio before including them on this list, but Bridgewater Associates' interest inWalmart(WMT, $142.03) is sort of a special case.Legendary investor Ray Dalio's massive hedge fund – it has $223 billion in assets under management (AUM) – has nearly 11% of its portfolio sitting in an S&P 500 index fund. Indeed, the SPDR S&P 500 ETF (SPY), with its 0.0945% expense ratio, is Bridgewater's largest holding.The fund's second-largest holding isalsoan ETF. The Vanguard Emerging Markets ETF (VWO) accounts for 5.1% of the hedge fund's total portfolio value.So it's something of a feather in Walmart's cap that the world's largest retailer and Dow Jones Industrial Average component happens to be tops among Dalio's actual stock picks.Indeed, in the first quarter of 2021, Bridgewater upped its WMT stake by 16%, or 512,347 shares. The total stake of 3.6 million shares, worth $487.8 million at the end of Q1, now accounts for 4.3% of Bridgewater's total portfolio value.Note well that Dalio, whose net worth is estimated at $20.3 billion, according to Forbes, is a big fan of Dow stocks and ETFs. In addition to WMT at No. 3, Bridegwater's top 10 holdings include stakes in Procter & Gamble (PG), Coca-Cola (KO) and Johnson & Johnson (JNJ), as well as the SPDR Gold Trust ETF (GLD) and the iShares Core MSCI Emerging Markets ETF (IEMG).Amazon.comMarket value:$1.6 trillionBillionaire investor:Stephen Mandel (Lone Pine Capital)Percent of portfolio:5.4%Hedge-fund legend Stephen Mandel stepped back from managing investments at Lone Pine Capital a couple years back, but he remains a managing director at the firm, and it still runs very much in his image.That's probably a good thing, given that Mandel's investing acumen allowed him to accumulate a net worth of nearly $4 billion, per Forbes.Lone Pine – based in the hedge-fund capital of the world, Greenwich, Connecticut – lists more than $27.5 billion in managed securities. Lately, it has been putting more cash to work in big-nametechnology stocks, and few get higher accolades from Wall Street analysts thanAmazon.com(AMZN, $3,223.07).Indeed, analysts say AMZN is one of thebest Nasdaq stocks you can buy, giving it a high conviction consensus recommendation of Strong Buy. That's due in no small part to the fact that they expect Amazon to generate average annual earnings per share growth of almost 35% over the next three to five years – this despite the fact that the e-commerce giant is already a $1.6 trillion company.Lone Pine upped its bet on AMZN by 87%, or 224,618 shares, in the first quarter, bringing its total holdings to 481,744 shares. That stake, which was worth $1.5 billion at the end of Q1, accounts for 5.4% of Lone Pine's total portfolio value, making it fifth among the hedge fund's stock picks.DanaherMarket value:$182.7 billionBillionaire investor:Tran Capital ManagementPercent of portfolio:5.4%Tran Capital Management, a hedge fund based in San Rafael, California, is incrementally more bullish on the life sciences industry.Tran, with $1.1 billion in AUM, added 2,001 shares to its stake inDanaher(DHR, $256.14), which makes a variety of instruments and diagnostics equipment to support medical, industrial and commercial processes.Tran now holds a total of 267,376 shares, which were worth $60.1 million at the end of Q1. The DHR stake is Tran's fourth-largest holding, accounting for 5.4% of its stock portfolio value. The hedge fund has been an investor in DHR since the first quarter of 2014, though even with the latest purchase, it still currently owns just 0.04% of the company's shares outstanding.The Street is likewise bullish on this healthcare name, which stands to benefit from the pharmaceutical industry's ongoing efforts against the novel coronavirus. Indeed, analysts' consensus recommendation on DHR comes to Buy, according to S&PGlobal MarketIntelligence.\"We believe that Danaher is well positioned to help biopharma companies develop new medicines, including treatments and vaccines for COVID-19,\" writes Argus Research analyst David Toung, who rates DHR at Buy. \"We expect recent strong customer demand to be sustained over the remainder of 2021.\"Abbott LaboratoriesMarket value:$207.3 billionBillionaire investor:Polen Capital ManagementPercent of portfolio:5.6%Polen Capital Management's top four stock picks are a who's who of hot-growth, mega-cap tech stocks: Facebook (FB), Microsoft (MSFT), Google-parent Alphabet's Class C shares (GOOG) and Adobe (ADBE).So it's kind of neat to see that the hedge fund's fifth-largest position is an income investor's dream.Abbott Laboratories(ABT, $116.65) is as stalwart a divided payer as they come. It's a member of the S&P Dividend Aristocrats, an index ofdividend stocks that have increased their payouts annually for at least 25 consecutive years.ABT, which manufactures a wide variety of healthcare goods, such as branded generic drugs, medical devices and nutrition and diagnostic products, has hiked its dividend for 49 years and counting. The last increase came in December: a whopping 25% improvement to 45 cents per share.Polen, a hedge fund based in Boca Raton, Florida, with AUM of more than $46 billion, has owned a stake in ABT since the third quarter of 2019. Most recently, it upped its position by 1%, or 220,118 shares. Polen's total of 20.7 million shares was worth $2.5 billion at the end of Q1, and accounted for 5.6% of its portfolio value.Importantly, Polen owns 1.2% of Abbott Lab's shares outstanding, putting it among the company's 15 largest investors.UnitedHealth GroupMarket value:$388.7 billionBillionaire investor:Allen Investment ManagementPercent of portfolio:5.7%UnitedHealth Group(UNH, $411.92) is a hedge-fund favorite, and Wall Street gives it high marks too.As the largest health insurer by both market value and revenue – and a member of the Dow Industrials to boot – UNH is sort of a must-have stock for institutional investors seeking broad exposure to the healthcare sector.Meanwhile, analysts' consensus recommendation on the name comes to Buy. Of the 27 analysts covering the stock tracked by S&P Global Market Intelligence, 16 rate UNH at Strong Buy, six say Buy, three have it at Hold and one calls it a Sell.\"With the increase in Covid-19 vaccinations, we expect medical utilization patterns to return to normal levels, while at the same time we anticipate higher utilizations resulting from missed medical visits and delayed electives,\" writes CFRA Research analyst Sel Hardy, who rates the stock at Strong Buy.So it's only fitting that Allen Investment Management, a New York hedge fund with $9.3 billion in AUM, upped its stake in UNH by 2%, or 21,086 shares, during the first quarter.At 5.7% of the portfolio, UNH is the fund's third-largest position, trailing only Allen stock picks Alphabet Class C shares and Facebook. The hedge fund's stake of 990,525 shares was worth $368.5 million at the end of the first quarter.Gaming and Leisure PropertiesMarket value:$10.8 billionBillionaire investor:Gates Capital ManagementPercent of portfolio:6.0%Gates Capital Management is a fan of one of Wall Street pros' favorite Nasdaq stocks. The New York hedge fund with $3 billion in AUM upped its stake inGaming and Leisure Properties(GLPI, $46.36) by 35%, or more than 1 million shares, during the first quarter.Gates Capital now holds 3.9 million shares in thisreal estate investment trust (REIT)– a stake worth $165.6 million as of March 31.Analysts like this casino real estate play thanks to both a snazzy dividend yield and attractive growth prospects coming out of the pandemic. The company, whose properties include the Belle of Baton Rouge and Argosy Casino Riverside in Missouri, collected 100% of its rents in 2020.Mizuho Securities initiated coverage of Gaming and Leisure Properties at Buy in late March, citing its unique attributes in an industry set to benefit from a recovery in consumer spending and gaming revenue.\"GLPI is the most diversified of the three Gaming REITs, with strong underlying tenant credit and structural lease enhancements, resulting in a lower-risk platform that we believe is under-appreciated by the market,\" writes Mizuho analyst Haendel St. Juste.Analysts' consensus recommendation on the name stands at Strong Buy, according to S&P Global Market Intelligence.The bull case for GLPI makes it easy to understand why Gates Capital increased its exposure to a stock it first bought back in 2013. The hedge fund holds 1.7% of GLPI's shares outstanding, making it the REIT's 12th largest investor.S&P GlobalMarket value:$91.4 billionBillionaire investor:Chris Hohn (TCI Fund Management)Percent of portfolio:6.0%Activist investor Chris Hohn has made quite a name for himself with The Children's Investment Fund Management – more commonly known as TCI Fund Management. Indeed, the London-based investor has parlayed his many stock picks into a personal net worth of $5.9 billion, per Forbes.TCI, with more than $34 billion in managed securities, made a handful of moves in Q1, and none was bigger in percentage terms than its doubling down (and then some) onS&P Global(SPGI, $379.47).Hohn increased the fund's stake in SPGI by 147% – by far its largest addition of the quarter in percentage terms – adding 3.5 million shares. TCI now owns 5.9 million shares in the company behind S&P Global Ratings, S&P Global Market Intelligence and S&P Global Platts.The stake, worth $2.1 billion at the end of Q1, accounts for 6.0% of TCI's portfolio value, and gives Hohn ownership of 2.4% of S&P's shares outstanding. That makes TCI the company's sixth-largest shareholder.Although most investors probably know S&P for its majority stake in S&P Dow Jones Indices – which maintains the benchmark S&P 500 index and the blue-chip Dow Jones Industrial Average – it's also a central player in corporate and financial analytics, information and research.Dedicated long-term income investors probably already know thatSPGI happens to be a Dividend Aristocrat. The company has increased its dividend annually for nearly half a century.AbbVieMarket value:$199.9 billionBillionaire investor:Avidity Partners ManagementPercent of portfolio:6.3%AbbVie(ABBV, $113.20) was spun off from the above-mentioned Abbott Laboratories in 2013. It too, is a Dividend Aristocrat, having lifted its dividend annually for almost half a century.Consumers best know the pharma firm for Humira, a blockbuster drug for rheumatoid arthritis that has been approved for numerous other ailments. AbbVie also makes cancer drug Imbruvica, as well as testosterone replacement therapy AndroGel.Avidity Partners Management, a Dallas hedge fund with AUM of $6.2 billion, focuses primarily on stock picks in the healthcare sector, and it has been a fan of AbbVie since the fourth quarter of 2019. Most recently, it upped its stake in the pharma giant by 53%, or 721,200 shares. Avidity now holds a total of nearly 2.1 million shares in ABBV, worth $225 million at the end of Q1.At 6.3% of its equity portfolio, AbbVie is Avidity's single largest position. That's up from 4.7% about three months ago.The Street is a solid fan of ABBV, too. Analysts' consensus recommendation stands at Buy, with 11 Strong Buy ratings, six Buys and five Hold calls. One analyst has a Sell recommendation on the stock.\"AbbVie is developing new growth drivers to help offset slowing sales of Humira, still its largest product by revenue,\" writes Argus Research analyst David Toung, who rates the stock at Buy. \"We expect continued strong growth from the oncology portfolio and newer immunology drugs in 2021.\"Applied MaterialsMarket value:$126.2 billionBillionaire investor:Bristol Gate Capital PartnersPercent of portfolio:6.3%Bristol Gate Capital Partners, a Toronto hedge fund with AUM of $1.7 billion, initiated a position inApplied Materials(AMAT, $138.13) in the first quarter.And what a commitment it was. The new purchase of 783,931 shares, worth $105 million at the end of Q1, vaulted the position to Bristol Gate's top holding, accounting for 6.3% of its portfolio.Applied Materials, which provides manufacturing equipment and technology to the semiconductor industry, is an allied play on the global chip shortage. Indeed, relentless demand for semiconductors from a wide range of industries has helped AMAT stock jump about 60% for the year-to-date.The Street is heavily bullish on the name, too. Analysts' consensus recommendation stands at Buy, according to S&P Global Market Research. The high opinion stems in part from the Street's forecast for EPS to increase at an average annual rate of nearly 19% over the next three to five years.\"We believe underlying secular drivers are robust, broad-based and multi-year in nature,\" writes B. Riley analyst Craig Ellis, who rates AMAT at Buy.Johnson & JohnsonMarket value:$445.7 billionBillionaire investor:ACR Alpine Capital ResearchPercent of portfolio:6.3%ACR Alpine Capital Research, a large advisory with $2.5 billion in AUM, has been a long-time fan of blue-chipJohnson & Johnson(JNJ, $169.25). The St. Louis-based asset manager first invested in the Dow stock at the end of 2010, and it added incrementally to the position in Q1.ACR upped its stake in the multifaceted pharma giant by 1%, or 8,790 shares, bringing its total holdings to 704,842 shares. The stake, worth $115.8 million at quarter's end, is at the tail end of the advisory's top 10 stock picks, taking up 6.3% of ACR's total portfolio value.Analysts have a consensus recommendation of Buy on JNJ. Among the arguments in favor of the stock, bulls point to its strong pharmaceutical pipeline, as well as a rebound in demand for medical devices as patients undergo elective procedures put off during the pandemic.\"We expect the recovery in elective procedures and patient visit volumes to accelerate as the pandemic is starting to get under control in the U.S., which should result in a strong recovery in Medical Devices sales and solid growth in Pharma revenues,\" writes CFRA Research analyst Sel Hardy, who rates shares at Buy.Investors and analysts alike no doubt also appreciate the company's commitment to delivering income to investors. JNJ announced a 5% quarterly dividend increase in April 2021, to $1.06 per share from $1.01 per share. That marked this Dividend Aristocrat's 59th consecutive year of dividend increases.XilinxMarket value:$31.2 billionBillionaire investor:Canyon Capital AdvisorsPercent of portfolio:7.0%Canyon Capital Advisors, with AUM of $20.9 billion, has propelled founders Joshua Friedman and Mitchell Julis to Forbes' list of highest-earning hedge fund millionaires.So it's of interest that the Los Angeles-based fund significantly pared back on its two largest stock picks in Q1 – while greatly increasing its bet on chipmakerXilinx(XLNX, $127.00).In October 2020, Advanced Micro Devices (AMD) and Xilinx announced a deal in which AMD would acquire the latter in an all-stock transaction valued at $35 billion.Canyon first bought shares in Xilinx in the fourth quarter of 2020, at which point the stake accounted for 4.6% of the fund's portfolio value. Then in Q1, Canyon upped its XLNX holdings by 89%, or 672,829 shares.The hedge fund's total stake of 1.4 million shares, worth $176.3 million at the end of Q1, now accounts for 7.0% of its portfolio value.Canyon, with ownership of 0.58% of XLNX's shares outstanding, is a top-30 stockholder in the soon-to-be-acquired company. AMD and Xilinx expect their deal to close at the end of 2021.Analysts' consensus recommendation on XLNX stands at Hold, pending the deal close. They do, however, rate AMD at Buy, and generally applaud the strategic rationale of merging the two chipmakers' complementary assets.D.R. HortonMarket value:$34.4 billionBillionaire investor:George Soros (Soros Fund Management)Percent of portfolio:7.4%Legendary hedge-fund tycoon George Soros, with an estimated net worth of $8.6 billion, per Forbes, today spends his days running Soros Fund Management.The New York-based family office – a sort of private hedge fund – has $5.3 billion in AUM, and one of its biggest stock picks is a bet on the severe shortage of new homes for sale.Soros first took a stake in homebuilderD.R. Horton(DHI, $95.29) during the first quarter of 2019, and he apparently remains bullish on the outlook. After all, the billionaire increased his DHI stake by 19%, or 703,850 shares, in the first quarter.Soros Fund Management's most recent investment makes DHI its second-largest holding, at 7.4% of the portfolio. The stake of 4.4 million shares – worth $392.8 million at the end of Q1 – equals 1.2% of the homebuilder's shares outstanding. As such, Soros Fund Management is D.R. Horton's 15th largest shareholder.With a consensus recommendation of Buy, per S&P Global Market Intelligence, the Street is also bullish on the name.\"With inventory constraints growing across the industry and buyer demand still nearly insatiable, we think DHI remains in an extraordinarily strong position to gain further market share and leverage its sector-leading scale,\" writes Raymond James analyst Buck Horne, who rates shares at Outperform (the equivalent of Buy).MicrosoftMarket value:$1.9 trillionBillionaire investor:Chase Coleman III (Tiger Global Management)Percent of portfolio:7.4%Hedge-fund legend Chase Coleman III, with a net worth of $10.3 billion, according to Forbes, upped his bet onMicrosoft(MSFT, $249.68) in the first quarter of 2021.And he did so in a compelling fashion.Coleman's Tiger Global Management ($79 billion AUM) increased its stake in MSFT by 15%, or 1.8 million shares, in the first three months of the year. The hedge fund now owns a total of 13.7 million shares, worth $3.2 billion at the end of Q1.The MSFT stake, which accounts for 7.4% of Tiger Global's portfolio value, is second only to its bet on Chinese e-commerce company JD.com (JD), which is top among Coleman's stock picks at 9.9% of the portfolio.Tiger Global first bought MSFT in the fourth quarter of 2016, and adding to the stake certainly makes sense. Wall Street analysts mostly adore this component of the Dow Jones Industrial Average.After all, MSFT – the second-largest U.S. company by market value after Apple (AAPL) – lands among the pro's11 best Nasdaq stocks you can buy. Analysts' consensus recommendation on MSFT comes to Strong Buy, with 26 Strong Buy calls, 11 Buys and one Hold rating.TeslaMarket value:$602.3 billionBillionaire investor:Ark InvestPercent of portfolio:7.6%Ark Invest features prominently in the financial news these days, thanks to the strong performance of several of its actively managed exchange-traded funds.Indeed, as Kiplinger has noted, 2020 was the year of Cathie Wood, CEO and founder of Ark Invest, who steered its then-five separate actively managed innovation-themed funds to the ranks ofthe best-performing equity ETFsof the year.In addition to ETFs, Ark offers managed accounts and other products and services aimed at high net worth investors. Thanks to the various products and services it offers, the firm has amassed more than $55 billion in AUM.So it says something when Ark's single-largest holding isTesla(TSLA, $625.22) – especially since the firm is increasing its exposure to the electric vehicle maker at an accelerating pace.Ark boosted its TSLA position by 39%, or 1.7 million shares, during the first quarter of 2021. The stake, which accounts for 7.6% of Ark Investment Management's equity portfolio, was worth nearly $4 billion at the end of Q1.It's not hard to see why Wood likes TSLA so much. Her investment approach focuses on innovation, and Tesla, led by the mercurial Elon Musk, is nothing if not innovative.ComcastMarket value:$263.4 billionBillionaire investor:Rothschild & Company Wealth Management UKPercent of portfolio:9.0%Rothschild & Company Wealth Management UK, a London-based hedge fund with $16.4 billion in AUM, is increasingly bullish onComcast(CMCSA, $57.34).Welcome to the club.The nation's largest cable company regularly makes the list ofhedge funds' favorite stock picks. That's because its combination of content, broadband, pay TV, theme parks and movies is unparalleled by rivals, and gives thisblue-chip stocka huge strategic advantage.CMCSA's diversification came in especially handy last year when the pandemic walloped theme parks, cinemas and spending on advertising.\"While the pandemic has materially impacted Comcast, the company's steady cable division continues to provide vital connectivity for its large base of 23 million subscribers,\" writes Argus Research analyst Joseph Bonner (Buy).Rothschild first bought shares in the cable operator in the first quarter of 2019, and most recently upped its bet by 2%, or 194,324 shares. The hedge fund's total holdings of 9.2 million shares, worth $500.2 million at the end of Q1, accounted for 9.0% of its portfolio. CMCSA is now Rothchild's sixth-largest position.Analysts' consensus recommendation on the stock comes to Buy, per S&P Global Market Intelligence, with 20 Strong Buy ratings, nine Buys, four Holds and one Strong Sell. The Street expects the company to deliver average annual EPS growth of nearly 16% over the next three to five years.AptivMarket value:$40.7 billionBillionaire investor:Caxton AssociatesPercent of portfolio:9.4%Billionaire philanthropist Bruce Kovner, with an estimated net worth of $6.6 billion, retired from his management role at Caxton Associates a decade ago. But the hedge fund he founded continues to rake in the bucks with his global macroeconomic trading strategies.Indeed, Caxton last year closed its flagship fund to new money after posting record 40% gains during the pandemic. And the firm shows no signs of slowing down.Caxton, with AUM of $25.7 billion, has ownedAptiv(APTV, $150.42) since the first quarter of 2019, but it really went all in earlier this year.Caxton upped its stake in APTV by 61%, or 285,618 shares. Indeed, the purchase made APTV the fund's top stock pick, accounting for 9.4% of the portfolio, up from 4.2% three months ago. Caxton's 747,843 shares were worth $103.1 million at the end of Q1.Shares in Aptiv, which makes safety, connectivity and green technology for vehicles, have essentially doubled over the past 52 weeks, and analysts say they have more room to run.\"Aptiv indeed is not only benefitting from accelerating industry adoption of vehicle electrification, advanced driver-assistance systems, and connected vehicle technologies, but also achieving dominant win rates in several of these areas based on its complete system knowledge, and software-based flexible architectures,\" writes Deutsche Bank analyst Emmanuel Rosner (Buy).AdobeMarket value:$241.2 billionBillionaire investor:Atalan Capital PartnersPercent of portfolio:9.6%Atalan Capital Partners, a New York hedge fund with AUM of $2 billion, boosted its stake inAdobe(ADBE, $504.58) in Q1, which vaulted the software company into the No. 2 spot among its stock picks.Atalan increased its holdings by 38%, or 82,000 shares, in Q1, lifting its total stake to 295,000 shares worth $140.2 million as of March 31. The position accounts for 9.6% of the portfolio.Atalan first picked up ADBE in the second quarter of 2020, which was not the best timing. Shares are up just about 16% since June 30 of last year, lagging the S&P 500 by roughly 20 percentage points.That's not to say ADBE stock won't continue to be a winner in the longer run. Analysts tend to be heavily bullish on the name, thanks to its dominance in its field. After all, Adobe is the undisputed leader in making software for designers and other creative types. Its software arsenal includes Photoshop, Premiere Pro for video editing and Dreamweaver for website design, among others.\"As a result of its early-mover position and strategic M&A transactions, Adobe has established itself as the unchallenged leader in Creative software,\" writes Stifel analyst Jeffrey Parker Lane (Buy). \"We view Adobe as one of the most compelling investment cases in our coverage areas.\"The Street's consensus recommendation stands at Buy, with an annual EPS growth forecast of more than 15% over the next three to five years.Thermo Fisher ScientificMarket value:$184.5 billionBillionaire investor:Cryder Capital PartnersPercent of portfolio:9.7%Thermo Fisher Scientific(TMO, $469.50), is sometimes called the \"Amazon of the healthcare industry\" because of its wide-ranging portfolio of life sciences products, analytics and laboratory instruments.As such, it has been highly active in the fight against COVID-19, which in turn has raised its profile and investor interest. And although TMO has been a holding of Cryder Capital Partners since 2015, the hedge fund remains an incremental buyer.London-based Cryder Capital, with $1 billion in AUM, lifted its stake in TMO by 2%, or 6,398 shares, during the first three months of the year. The hedge fund now holds a total of 298,587 shares, worth $136.3 million as of March 31. Despite a high weight of 9.7%, TMO is just seventh largest among the fund's stock picks.Analysts' consensus recommendation stands at Strong Buy, according to S&P Global Market Intelligence. Argus Research is just one research shop in the bull camp.\"Thermo is seeing strong demand for COVID-19 testing solutions as well as for instruments and supplies used by developers of vaccines and other treatments,\" writes analyst David Toung (Buy). \"But the company is also investing its substantial cash flow in technology upgrades, capacity expansions and acquisitions.\"With an average target price of $557.17, the Street gives TMO stock implied upside of about 18% in the next 12 months or so.VisaMarket value:$484.8 billionBillionaire investor:Valley Forge Capital ManagementPercent of portfolio:10.2%Visa(V, $227.30) routinely makes most lists of analysts', hedge funds' or billionaires' favorite stocks.Berkshire Hathaway(BRK.B)owns a stake worth more than $2 billion, although chairman and CEO Warren Buffett readily credits the holding to one of his stock-picking lieutenants.And indeed, there is much to like about this Dow stock. Visa operates the world's largest payments network, and thus is well-positioned to benefit from the growth of cashless transactions and digital mobile payments.The Street's consensus recommendation is a high-conviction Buy. Of the analysts covering the stock tracked by S&P Global Market Intelligence, 21 call V a Strong Buy, 12 rate it at Buy, four say Hold and one calls it a Sell.Valley Forge Capital Management, a hedge fund in Wayne, Pennsylvania, with $1.1 billion in AUM, is certainly a big believer. Visa accounts for 10.2% of its equity portfolio.The fund increased its Visa stake by 88%, or 477,181 shares, in Q1. It now holds more than 1 million shares worth $215 million as of March 31. Mind you, Valley Forge Capital is hardly a novice in this stock. The fund has counted Visa among its stock picks since 2016.Although the pandemic greatly curtailed spending in a number of Visa's categories – most notably travel and entertainment – those headwinds should now be in the past. Indeed, the gradual global reopening – and accelerating secular growth in cashless payments, helped by the perception that cash is \"dirty\" – make a solid bull case for Visa stock.IntelMarket value:$230.7 billionBillionaire investor:Cavalry Management GroupPercent of portfolio:10.4%Intel(INTC, $57.12) has fallen far behind the competition on any number of fronts, which is why analysts and investors were so delighted when the chipmaker hired Pat Gelsinger, former CEO of VMWare (VMW), to take over in February.Heck, some observers said it was the best decision the troubled company made in more than a decade. And, indeed, this Dow stock has been a disappointing performer. Shares are up just 3% over the past three years vs. a gain of 54% for the S&P 500.So props to Cavalry Management Group for making a bold bet on the semiconductor company earlier this year. The San Francisco hedge fund with $2.6 billion in AUM initiated a large enough position to instantly make Intel its top stock pick.Cavalry Management bought 1.7 million shares during the first three months of 2021. With a value of $111.6 million at the end of Q1, INTC accounted for more than 10% of the hedge fund's investments.Cavalry largely focuses on large-cap tech stocks, so Intel certainly fits well with its broader strategy. Other moves the fund made in Q1 included more than tripling its stake in Microsoft, and almost doubling its holdings in Ericsson (ERIC).The Street is generally more cautious on INTC than Cavalry Management is. Analysts' consensus recommendation stands at Hold, per S&P Global Market Intelligence.PayPal HoldingsMarket value:$305.5 billionBillionaire investor:Dorsey Asset ManagementPercent of portfolio:11.8%Digital mobile payments and the expansion of cashless transactions are one of the hottest areas of growth in financial tech. And although the sector offers no shortage of promising new names, old-timerPayPal Holdings(PYPL, $260.02) still gets plenty of analyst – and billionaire investor – love.Explosive growth in mobile transactions, the monetization of its Venmo property and incremental revenue growth in its Xoom business all help make for a compelling bull case on PYPL, analysts say.\"Simply put, PayPal should continue to benefit from the secular shift to e-commerce that should drive a roughly 20% revenue compound annual growth rate (CAGR), which, coupled with margin expansion and capital allocation (mergers & acquisitions plus stock buybacks), should result in an earnings CAGR north of 20% over the next several years,\" writes Raymond James analyst John Davis, who rates the stock at Outperform (the equivalent of Buy).Dorsey Asset Management, with $1.3 billion in AUM, embraces the bull case on PYPL in a big way. The Chicago-based hedge fund increased its stake in PayPal by 81%, or 209,025 shares, in Q1. Its total holdings of 465,266 shares, worth $113 million as of March 31, comprises 11.8% of its stock investments.That's up from 7.9% of the portfolio three months ago. PYPL, which Dorsey has owned since the second quarter of 2018, is now its fifth-largest position.Analysts' consensus recommendation on the stock stands at Buy, according to S&P Global Market Intelligence.Howard HughesMarket value:$5.8 billionBillionaire investor:Bill Ackman (Pershing Square Capital)Percent of portfolio:12.1%No one doubts Bill Ackman's investing acumen. His Pershing Square Capital hedge fund has allowed the investor to amass a personal fortune of $3 billion, per Forbes.And he's never been one to shy away from the media. So his increasing stake inHoward Hughes Corp.(HHC, $105.83) is far from a state secret. Indeed, Ackman has owned shares in the master-planned community developer since it was spun off from General Growth Properties in 2010.Given Ackman's propensity for being anactivist investor, his latest purchase is eyebrow-raising news, nonetheless.The hedge-fund billionaire increased his stake in HHC by 23%, or 2.6 million shares, in Q1. Pershing Square's stake of 13.5 million shares was worth $1.3 billion at the first quarter's end.Most notably, Ackman now holds almost a quarter of HHC's shares outstanding. That makes the hedge fund the company's largest investor by a wide margin. Asset manager Vanguard, at No. 2, owns just 10.8% of HHC.Meanwhile, HHC, at 12.1% of its portfolio, is now Pershing Square Capital's sixth-largest position.For those keeping score at home, HHC stock has doubled over the past 52 weeks vs. a gain of about 38% for the S&P 500. For the year-to-date, it's up by more than a third. That compares with the broader market's gain of about 12% so far this year.Only three analysts cover HHC, according to S&P Global Market Intelligence. One rates it at Strong Buy, while the other two say Buy.Lowe'sMarket value:$137.7 billionBillionaire investor:Two Creeks Capital ManagementPercent of portfolio:12.2%Two Creeks Capital Management, a New York hedge fund with AUM of $2.8 billion, made a big addition to its stake inLowe's(LOW, $194.83) in the first quarter – a move most analysts would regard as wise.The nation's second-largest home improvement retailer after Home Depot (HD) benefited greatly from the work-from-home/stuck-at-home reality of pandemic life. Analysts say many of the do-it-yourself habits consumers adopted during COVID times are here to stay. Lowe's is also being aided by the ultra-tight housing market.The Street gives LOW a consensus recommendation of Buy. Argus Research, which counts itself in the Buy camp, says Lowe's has several strong tailwinds behind it.\"We believe that the major drivers of post-pandemic sales growth remain the same,\" writes Argus Research analyst Christopher Graja. \"There has been significant underinvestment in housing. About 70% of U.S. homes are more than 25 years old and likely in need of upgrades and repairs. Millennials are starting families.\"Income investors know the power of Lowe's dividend over the longer haul. The Dividend Aristocrat has paid a cash distribution every quarter since going public in 1961, and that dividend has increased annually for almost 60 years.The bullish investment thesis led Two Creeks to up its stake in this stock pick by 14%, or 132,811 shares, in Q1. The hedge fund's total stake of 1.1 million LOW shares, worth $200 million at the end of Q1, accounts for 12.2% of its portfolio, representing its third-largest holding.AlphabetMarket value:$1.6 trillionBillionaire investor:Metropolis CapitalPercent of portfolio:13.3%It should come as no surprise that hedge funds are big believers in Google parentAlphabet(GOOGL, $2,356,85). Metropolis Capital, a U.K.-based investor with $1.4 billion in AUM, is just one of about 225 hedge funds upping its stake in the internet giant in Q1.Metropolis thinks highly enough of the search leader that it increased its stake by 22%, or 13,679 shares. The firm now holds a total of 74,868 shares worth $154.4 million, or 13.3% of its total portfolio, as of March 31.Alphabet happens to be in good company at this hedge fund. GOOGL is Metropolis' second-largest stock pick after Berkshire Hathaway (BRK.B).If nothing else, Alphabet's pandemic performance in totality bolstered the case that GOOGL is not a one-trick pony. Its numerous other endeavors likewise shore up the case. For example, Alphabet is a key player in cloud-based services, and home to Nest Labs and self-driving car startup Waymo. Artificial intelligence, machine learning and virtual reality are other areas of heavy investment.\"We continue to favor Google as a core large-cap growth holding given the strong digital advertising backdrop, continued strength from Cloud, ongoing share repurchases (with the newly authorized $50 billion program) and a reasonable valuation,\" writes Canaccord Genuity analyst Maria Ripps (Buy).Analysts' consensus recommendation on the name stands at Strong Buy. Of the 45 analysts issuing opinions on the stock tracked by S&P Global Market Intelligence, 32 rate it at Strong Buy, 12 say Buy and one has it at Hold.Walt DisneyMarket value:$324.6 billionBillionaire investor:Kirkoswald Asset ManagementPercent of portfolio:16.5%Coronavirus took a huge bite out of some ofWalt Disney's(DIS, $178.65) most important businesses: namely, its theme parks and studios. But after encouraging quarterly results, analysts say business is set to bounce back in a big way.Disneyland and other California amusement parks have reopened with restrictions. And admissions at Florida's Disney World continue to climb.\"With mask mandates lifted and capacity constraints loosened further, we would not be surprised to see a step change in attendance in the near future,\" writes Deutsche Bank analyst Bryan Kraft (Buy).But that's nothing compared to what DIS has on its hands in thestreaming mediawars.Disney+ is a smashing success. The streaming platform, which launched in November 2019, has already amassed almost 100 million subscribers – a staggering rate of growth. Consider that Disney+ now has about half as many subscribers as Netflix (NFLX) – but Netflix had a roughly 12-year head start.Kirkoswald Asset Management, a New York hedge fund with AUM of $4 billion, decided to get in on DIS asa recovery stock pickin Q1. It initiated a stake of 5,200 shares, worth almost $1 million, during the first three months of the year.The new stake immediately made DIS its second-largest position among $5.8 million in managed securities.Most of the Street would approve of Kirkoswald's investment. Analysts have a consensus Buy recommendation on this Dow stock.Berkshire HathawayMarket value:$661.0 billionBillionaire investor:Southeast Asset AdvisorsPercent of portfolio:16.8%If you can't beat 'em, join 'em.It's hard to compete with Warren Buffett when it comes toasset allocation. As CEO and chairman ofBerkshire Hathaway(BRK.B, $289.44), he's arguably the greatest long-term investor of all time.So it's little wonder that so many hedge funds, large advisories and other billion-dollar-plus pools of money throw in their lots with the Oracle of Omaha.Southeast Asset Advisors, an investment manager and hedge fund based in Thomasville, Georgia, with $1.6 billion in AUM, has been a BRK.B shareholder since 2008. Indeed, BRK.B, at 16.8% of its portfolio, is the fund's top holding.And it's only getting bigger.Southeast increased its stake in BRK.B by 2%, or 7,747 shares, in Q1. It now holds 365,149 shares worth $93.3 million. Only Alphabet Class C shares (GOOG) come close to the firm's BRK.B stake, accounting for 11.7% of the portfolio.BRK.B has been an outstanding performer both in 2021 and over the past 52 weeks. The stock is up 25% for the year-to-date, essentially doubling the S&P 500's gains. And over the past year? BRK.B returned 57% vs. a price increase of less than 40% for the broad-market gauge.Only four analysts cover BRK.B stock, per S&P Global Market Intelligence. Their consensus recommendation comes to Buy.AlibabaMarket value:$580.4 billionBillionaire investor:Conifer ManagementPercent of portfolio:20.7%Conifer Management, a New York hedge fund with $7.7 billion in AUM, has more than a fifth of its portfolio invested in Chinese e-commerce giantAlibaba(BABA, $213.96).Indeed, after upping its stake by 147%, or 884,845 shares, in Q1, BABA is Conifer's top holding. Its total stake of 1.5 million shares was worth $336.7 million at the end of the first quarter.Conifer initiated its stake in BABA only in the final quarter of last year. To the hedge fund's credit, this stock pick is a highly defensible investment idea.Alibaba is sometimes called the Amazon of China. There are important differences between the two, but they do share the enviable trait of being undisputed titans ine-commerce.And like Amazon, Alibaba has never shied away from investing heavily to both build out its existing businesses and enter new ones. As a result, BABA finds itself spreading beyond its core e-commerce business into cloud computing, digital payments and more.It also helps that BABA and investors can now move past a $2.75 billion fine imposed by Chinese regulators for violating anti-monopoly laws.Some analysts worry about decelerating revenue in the company's cloud services business, but the majority of the Street sees recent share-price weakness as a buying opportunity.The consensus recommendation of 49 analysts tracked by S&P Global Market Intelligence comes to Strong Buy on BABA stock.MastercardMarket value:$357.4 billionBillionaire investor:Valley Forge Capital ManagementPercent of portfolio:22.6%If Valley Forge Capital Management likes Visa – as noted above – it absolutely adores competitorMastercard(MA, $360.58).The Wayne, Pennsylvania-based hedge fund with $1.1 billion in AUM almost doubled its stake in this stock pick in the first quarter. And with more than a fifth of its portfolio tied up in the payments processor, Mastercard is Valley Forge's top holding.The hedge fund bought another 665,544 shares, representing a 98% increase, in Q1, bringing its total holdings to 1.3 million shares. The position was worth $477.9 million as of March 31.Valley Forge, which owns 0.14% of MA's shares outstanding, has been an investor in the company since 2016. It's a bet that appears to have done quite well. Mastercard stock's five-year total return – price appreciation plus dividends – comes to 30.8%, according to Morningstar data. That beats its sector by 5.7 percentage points and leads the broader market by 13.4 percentage points.Like Visa, Mastercard has relentless growth in digital mobile payments and other cashless transactions at its back.\"Mastercard is a key beneficiary of the long-term secular shift toward electronic forms of payments, and that new technology is helping accelerate the shift,\" writes William Blair analyst Robert Napoli (Outperform)And, just like Visa, MA has a lot of fans on the Street. Analysts' consensus recommendation stands at Buy.FacebookMarket value:$932.1 billionBillionaire investor:Altarock PartnersPercent of portfolio:24.4%There's a strong bull case to be made forFacebook(FB, $328.73), the social media giant that forms a digital-ad duopoly with Google. Just ask Altarock Partners.This hedge fund, based in Beverly, Massachusetts, with AUM of $3.1 billion, has almost a quarter of its portfolio socked away in Facebook stock. After buying another 465,800 shares, a 27% increase, in Q1, the hedge fund is sitting on 2.2 million shares worth $641.4 million as of March 31.That makes FB Altarock's second-largest holding.And just who is at No. 1?None other than Google parent Alphabet, which commands 25.1% of Altarock's investment portfolio.The hedge fund first bought FB in the fourth quarter of last year, so it's building up its position on the stock pick pretty rapidly. And well it should, if analysts are right about this name.The Street's consensus recommendation on FB stands at Strong Buy, as analysts forecast the company to deliver truly impressive profit growth for some time.\"We believe Facebook's share gains during the pandemic and new initiatives in e-commerce can drive many years of above-market growth,\" writes Stifel analyst John Egbert (Buy). \"We are comfortable with the potential outcomes of antitrust inquiries and believe FB shares offer investors a rare combination of growth and value relative to its peers.\"SeagenMarket value:$28.2 billionBillionaire investor:Felix and Julian Baker (Baker Bros. Advisors)Percent of portfolio:29.7%Seagen(SGEN, $155.35), a biotechnology firm specializing in oncology treatments, couldn't get a bigger vote of confidence than being the top holding of Baker Bros. Advisors.This New York-based hedge fund with $35.8 billion in AUM is led by billionaire biotech investors Julian and Felix Baker. The brothers may keep a low profile, but they're plenty famous in the world ofbiotech stocks. A series of successful investments have allowed the Bakers to build an estimated combined fortune of about $4 billion, according to Forbes.And judging by their latest regulatory filings, the brothers have great expectations for Seagen, too. The stock pick accounts for nearly 30% of the total value of the Baker Bros.' holdings, up from 28.5% three months ago.The increase stems in part from Baker Bros. buying another 347,745 shares in SGEN in the first quarter of 2021. The fund's total holdings of 47.6 million shares were worth more than $7 billion at the end of Q1.The stake gives Baker Bros. ownership of 26.3% of SGEN's shares outstanding, which makes it the biotech company's largest shareholder by a wide margin. The second-largest investor – Capital Research and Management – holds only 8.6% of SGEN's shares outstanding.The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.TRENDING TOPICSTRENDING ARTICLES","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135785454,"gmtCreate":1622185012478,"gmtModify":1704181076911,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"d","listText":"d","text":"d","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/135785454","repostId":"2138179881","repostType":4,"repost":{"id":"2138179881","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622145658,"share":"https://ttm.financial/m/news/2138179881?lang=&edition=fundamental","pubTime":"2021-05-28 04:00","market":"us","language":"en","title":"Wall Street ekes out gain as weekly jobless claims fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2138179881","media":"Reuters","summary":"Boeing climbs on rival Airbus' strong forecastNvidia beats forecast but shares dipKaplan says labor ","content":"<ul><li>Boeing climbs on rival Airbus' strong forecast</li><li>Nvidia beats forecast but shares dip</li><li>Kaplan says labor market tighter than realized</li></ul><p>NEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.</p><p>The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.</p><p>The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .</p><p>Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.</p><p>Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.</p><p>\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.</p><p>\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"</p><p>Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&amp;P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite&nbsp;dropped 1.62 points, or 0.01%, to 13,736.38.</p><p>Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&amp;P.</p><p>U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.</p><p>Boeing supplier General Electric    jumped and the two were the biggest boost to the S&amp;P industrials   , the best performing sector on the day.</p><p>Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.</p><p>Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.</p><p>Strategists expect the S&amp;P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.</p><p>Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.</p><p>(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ekes out gain as weekly jobless claims fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ekes out gain as weekly jobless claims fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-28 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Boeing climbs on rival Airbus' strong forecast</li><li>Nvidia beats forecast but shares dip</li><li>Kaplan says labor market tighter than realized</li></ul><p>NEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.</p><p>The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.</p><p>The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .</p><p>Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.</p><p>Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.</p><p>\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.</p><p>\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"</p><p>Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&amp;P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite&nbsp;dropped 1.62 points, or 0.01%, to 13,736.38.</p><p>Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&amp;P.</p><p>U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.</p><p>Boeing supplier General Electric    jumped and the two were the biggest boost to the S&amp;P industrials   , the best performing sector on the day.</p><p>Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.</p><p>Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.</p><p>Strategists expect the S&amp;P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.</p><p>Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.</p><p>(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PSQ":"纳指反向ETF",".IXIC":"NASDAQ Composite","QLD":"纳指两倍做多ETF","DXD":"道指两倍做空ETF","BA":"波音","DDM":"道指两倍做多ETF","DOG":"道指反向ETF","SQQQ":"纳指三倍做空ETF","TQQQ":"纳指三倍做多ETF",".SPX":"S&P 500 Index","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","SDOW":"道指三倍做空ETF-ProShares",".DJI":"道琼斯","QQQ":"纳指100ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138179881","content_text":"Boeing climbs on rival Airbus' strong forecastNvidia beats forecast but shares dipKaplan says labor market tighter than realizedNEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite dropped 1.62 points, or 0.01%, to 13,736.38.Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&P.U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.Boeing supplier General Electric    jumped and the two were the biggest boost to the S&P industrials   , the best performing sector on the day.Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.Strategists expect the S&P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135780413,"gmtCreate":1622184402132,"gmtModify":1704181068499,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"g","listText":"g","text":"g","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135780413","repostId":"1148985369","repostType":4,"isVote":1,"tweetType":1,"viewCount":271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":135785454,"gmtCreate":1622185012478,"gmtModify":1704181076911,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"d","listText":"d","text":"d","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/135785454","repostId":"2138179881","repostType":4,"repost":{"id":"2138179881","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622145658,"share":"https://ttm.financial/m/news/2138179881?lang=&edition=fundamental","pubTime":"2021-05-28 04:00","market":"us","language":"en","title":"Wall Street ekes out gain as weekly jobless claims fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2138179881","media":"Reuters","summary":"Boeing climbs on rival Airbus' strong forecastNvidia beats forecast but shares dipKaplan says labor ","content":"<ul><li>Boeing climbs on rival Airbus' strong forecast</li><li>Nvidia beats forecast but shares dip</li><li>Kaplan says labor market tighter than realized</li></ul><p>NEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.</p><p>The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.</p><p>The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .</p><p>Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.</p><p>Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.</p><p>\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.</p><p>\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"</p><p>Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&amp;P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite&nbsp;dropped 1.62 points, or 0.01%, to 13,736.38.</p><p>Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&amp;P.</p><p>U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.</p><p>Boeing supplier General Electric    jumped and the two were the biggest boost to the S&amp;P industrials   , the best performing sector on the day.</p><p>Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.</p><p>Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.</p><p>Strategists expect the S&amp;P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.</p><p>Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.</p><p>(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ekes out gain as weekly jobless claims fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ekes out gain as weekly jobless claims fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-28 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Boeing climbs on rival Airbus' strong forecast</li><li>Nvidia beats forecast but shares dip</li><li>Kaplan says labor market tighter than realized</li></ul><p>NEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.</p><p>The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.</p><p>The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .</p><p>Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.</p><p>Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.</p><p>\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.</p><p>\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"</p><p>Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&amp;P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite&nbsp;dropped 1.62 points, or 0.01%, to 13,736.38.</p><p>Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&amp;P.</p><p>U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.</p><p>Boeing supplier General Electric    jumped and the two were the biggest boost to the S&amp;P industrials   , the best performing sector on the day.</p><p>Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.</p><p>Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.</p><p>Strategists expect the S&amp;P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.</p><p>Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.</p><p>(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PSQ":"纳指反向ETF",".IXIC":"NASDAQ Composite","QLD":"纳指两倍做多ETF","DXD":"道指两倍做空ETF","BA":"波音","DDM":"道指两倍做多ETF","DOG":"道指反向ETF","SQQQ":"纳指三倍做空ETF","TQQQ":"纳指三倍做多ETF",".SPX":"S&P 500 Index","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","SDOW":"道指三倍做空ETF-ProShares",".DJI":"道琼斯","QQQ":"纳指100ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138179881","content_text":"Boeing climbs on rival Airbus' strong forecastNvidia beats forecast but shares dipKaplan says labor market tighter than realizedNEW YORK, May 27 (Reuters) - U.S. stocks advanced slightly on Thursday, as data showing improvement in the labor market helped bolster expectations in the economic recovery and spurred a minor rotation towards stocks seen as more likely to benefit from the rebound.The number of Americans filing new unemployment claims dropped more than expected last week to a 14-month low of 406,000 as pandemic restrictions continue to be lifted, while a separate report showed business spending on equipment picked up speed.The data helped lift U.S. Treasury yields, with the benchmark 10-year note    reaching a high of 1.625% and denting the attractiveness of higher-growth names in areas such as technology    while helping those seen as more likely to benefit from an improving economy such as financials    and small caps   .Still, the 10-year yield remained within the range it has been in for several days, which served to keep inflation concerns in check and limited the rotation within sectors.Investors have been closely watching economic data and comments from Federal Reserve officials for signs of runaway inflation and the possibility the central bank may begin to pull back on its massive stimulus measures.\"When you look at the jobless claims that actually shows we're continuing to make progress, if we get a strong jobs report in the next release that's going to provide some support, until then there's uncertainty so I don't think there's a lot of momentum either way,\" said Brad McMillan, chief investment officer for Commonwealth Financial Network, in Waltham, Mass.\"We've had the Fed come out and say we're going to continue to support things but now we're starting to be a little bit nervous, that's obviously a headwind.\"Unofficially, the Dow Jones Industrial Average    rose 136.72 points, or 0.4%, to 34,459.77, the S&P 500    gained 4.81 points, or 0.11%, to 4,200.8 and the Nasdaq Composite dropped 1.62 points, or 0.01%, to 13,736.38.Weighed down by weakness in tech shares, the Nasdaq underperformed the Dow and S&P.U.S. planemaker Boeing    climbed after its European rival Airbus    outlined an almost two-fold increase in production, citing a strong recovery in aviation from the COVID-19 pandemic.Boeing supplier General Electric    jumped and the two were the biggest boost to the S&P industrials   , the best performing sector on the day.Investors will now look to the personal consumption expenditure report due on Friday as it is the central bank's preferred inflation measure for its 2% long-term target.Fed officials have repeatedly maintained in recent days that the central bank is not ready to adjust its monetary support, although some have suggested they are open to begin discussing the reduction of its bond-buying plan. On Thursday, Federal Reserve Bank of Dallas President Robert Kaplan said the labor market is tighter than many realize.Strategists expect the S&P 500 to end the year at about 4,300, according to a Reuters poll. The benchmark index is currently less than 1% away from its record high of 4,238.04 points.Nvidia Corp    forecast second-quarter revenue above analysts' estimates, but shares fell as the chipmaker could not say for certain how much of its recent revenue rise was driven by the volatile cryptocurrency-mining market.(Reporting by Chuck Mikolajczak; Additional reporting by Sinéad Carew in New York; Editing by Lisa Shumaker)","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189124488,"gmtCreate":1623248782044,"gmtModify":1704199350097,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"sick","listText":"sick","text":"sick","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/189124488","repostId":"2142321626","repostType":4,"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113406494,"gmtCreate":1622630641618,"gmtModify":1704187663034,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"d","listText":"d","text":"d","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/113406494","repostId":"1182886492","repostType":4,"repost":{"id":"1182886492","kind":"news","pubTimestamp":1622604857,"share":"https://ttm.financial/m/news/1182886492?lang=&edition=fundamental","pubTime":"2021-06-02 11:34","market":"hk","language":"en","title":"30 Top Stock Picks That Billionaires Love","url":"https://stock-news.laohu8.com/highlight/detail?id=1182886492","media":"Nasdaq","summary":"It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful  to know what they've been up to.Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.Study","content":"<p>It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fruitful) to know what they've been up to.</p><p>Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.</p><p>Studying which stocks they're chasing with their capital (or whichstocks the billionaires are selling off, for that matter) can be an edifying exercise for retail investors.</p><p>After all, there's a reason the rich get richer.</p><p><b>Here are 30 of the most recent top stock picks from the billionaire class.</b>In each case, at least one billionaire – be it a person, hedge fund or advisory – has a substantial stake and/or added to its holdings. In most cases, these stocks are owned by multiple billionaire investors and billionaire investor firms. And while several of these investments are popular blue chips, others keep a much lower profile.</p><p>Either way, the smart money isn't kidding around when it comes to these stock picks.</p><p>Prices are as of May 28. Data is courtesy of S&amp;P Global Market Intelligence, WhaleWisdom.com&nbsp;and regulatory filings made with the Securities and Exchange Commission. Stocks are ranked in reverse order of their weight in the selected billionaire investor's equity portfolio.</p><p>Walmart</p><ul><li><b>Market value:</b>$400.0 billion</li><li><b>Billionaire investor:</b>Ray Dalio (Bridgewater Associates)</li><li><b>Percent of portfolio:</b>4.3%</li></ul><p>Ordinarily, we look for stocks that account for at least 5% of a billionaire investor's portfolio before including them on this list, but Bridgewater Associates' interest in<b>Walmart</b>(WMT, $142.03) is sort of a special case.</p><p>Legendary investor Ray Dalio's massive hedge fund – it has $223 billion in assets under management (AUM) – has nearly 11% of its portfolio sitting in an S&amp;P 500 index fund. Indeed, the SPDR S&amp;P 500 ETF (SPY), with its 0.0945% expense ratio, is Bridgewater's largest holding.</p><p>The fund's second-largest holding is<i>also</i>an ETF. The Vanguard Emerging Markets ETF (VWO) accounts for 5.1% of the hedge fund's total portfolio value.</p><p>So it's something of a feather in Walmart's cap that the world's largest retailer and Dow Jones Industrial Average component happens to be tops among Dalio's actual stock picks.</p><p>Indeed, in the first quarter of 2021, Bridgewater upped its WMT stake by 16%, or 512,347 shares. The total stake of 3.6 million shares, worth $487.8 million at the end of Q1, now accounts for 4.3% of Bridgewater's total portfolio value.</p><p>Note well that Dalio, whose net worth is estimated at $20.3 billion, according to Forbes, is a big fan of Dow stocks and ETFs. In addition to WMT at No. 3, Bridegwater's top 10 holdings include stakes in Procter &amp; Gamble (PG), Coca-Cola (KO) and Johnson &amp; Johnson (JNJ), as well as the SPDR Gold Trust ETF (GLD) and the iShares Core MSCI Emerging Markets ETF (IEMG).</p><p>Amazon.com</p><ul><li><b>Market value:</b>$1.6 trillion</li><li><b>Billionaire investor:</b>Stephen Mandel (Lone Pine Capital)</li><li><b>Percent of portfolio:</b>5.4%</li></ul><p>Hedge-fund legend Stephen Mandel stepped back from managing investments at Lone Pine Capital a couple years back, but he remains a managing director at the firm, and it still runs very much in his image.</p><p>That's probably a good thing, given that Mandel's investing acumen allowed him to accumulate a net worth of nearly $4 billion, per Forbes.</p><p>Lone Pine – based in the hedge-fund capital of the world, Greenwich, Connecticut – lists more than $27.5 billion in managed securities. Lately, it has been putting more cash to work in big-nametechnology stocks, and few get higher accolades from Wall Street analysts than<b>Amazon.com</b>(AMZN, $3,223.07).</p><p>Indeed, analysts say AMZN is one of thebest Nasdaq stocks you can buy, giving it a high conviction consensus recommendation of Strong Buy. That's due in no small part to the fact that they expect Amazon to generate average annual earnings per share growth of almost 35% over the next three to five years – this despite the fact that the e-commerce giant is already a $1.6 trillion company.</p><p>Lone Pine upped its bet on AMZN by 87%, or 224,618 shares, in the first quarter, bringing its total holdings to 481,744 shares. That stake, which was worth $1.5 billion at the end of Q1, accounts for 5.4% of Lone Pine's total portfolio value, making it fifth among the hedge fund's stock picks.</p><p>Danaher</p><ul><li><b>Market value:</b>$182.7 billion</li><li><b>Billionaire investor:</b>Tran Capital Management</li><li><b>Percent of portfolio:</b>5.4%</li></ul><p>Tran Capital Management, a hedge fund based in San Rafael, California, is incrementally more bullish on the life sciences industry.</p><p>Tran, with $1.1 billion in AUM, added 2,001 shares to its stake in<b>Danaher</b>(DHR, $256.14), which makes a variety of instruments and diagnostics equipment to support medical, industrial and commercial processes.</p><p>Tran now holds a total of 267,376 shares, which were worth $60.1 million at the end of Q1. The DHR stake is Tran's fourth-largest holding, accounting for 5.4% of its stock portfolio value. The hedge fund has been an investor in DHR since the first quarter of 2014, though even with the latest purchase, it still currently owns just 0.04% of the company's shares outstanding.</p><p>The Street is likewise bullish on this healthcare name, which stands to benefit from the pharmaceutical industry's ongoing efforts against the novel coronavirus. Indeed, analysts' consensus recommendation on DHR comes to Buy, according to S&amp;PGlobal MarketIntelligence.</p><p>\"We believe that Danaher is well positioned to help biopharma companies develop new medicines, including treatments and vaccines for COVID-19,\" writes Argus Research analyst David Toung, who rates DHR at Buy. \"We expect recent strong customer demand to be sustained over the remainder of 2021.\"</p><p>Abbott Laboratories</p><ul><li><b>Market value:</b>$207.3 billion</li><li><b>Billionaire investor:</b>Polen Capital Management</li><li><b>Percent of portfolio:</b>5.6%</li></ul><p>Polen Capital Management's top four stock picks are a who's who of hot-growth, mega-cap tech stocks: Facebook (FB), Microsoft (MSFT), Google-parent Alphabet's Class C shares (GOOG) and Adobe (ADBE).</p><p>So it's kind of neat to see that the hedge fund's fifth-largest position is an income investor's dream.</p><p><b>Abbott Laboratories</b>(ABT, $116.65) is as stalwart a divided payer as they come. It's a member of the S&amp;P Dividend Aristocrats, an index ofdividend stocks that have increased their payouts annually for at least 25 consecutive years.</p><p>ABT, which manufactures a wide variety of healthcare goods, such as branded generic drugs, medical devices and nutrition and diagnostic products, has hiked its dividend for 49 years and counting. The last increase came in December: a whopping 25% improvement to 45 cents per share.</p><p>Polen, a hedge fund based in Boca Raton, Florida, with AUM of more than $46 billion, has owned a stake in ABT since the third quarter of 2019. Most recently, it upped its position by 1%, or 220,118 shares. Polen's total of 20.7 million shares was worth $2.5 billion at the end of Q1, and accounted for 5.6% of its portfolio value.</p><p>Importantly, Polen owns 1.2% of Abbott Lab's shares outstanding, putting it among the company's 15 largest investors.</p><p>UnitedHealth Group</p><ul><li><b>Market value:</b>$388.7 billion</li><li><b>Billionaire investor:</b>Allen Investment Management</li><li><b>Percent of portfolio:</b>5.7%</li></ul><p><b>UnitedHealth Group</b>(UNH, $411.92) is a hedge-fund favorite, and Wall Street gives it high marks too.</p><p>As the largest health insurer by both market value and revenue – and a member of the Dow Industrials to boot – UNH is sort of a must-have stock for institutional investors seeking broad exposure to the healthcare sector.</p><p>Meanwhile, analysts' consensus recommendation on the name comes to Buy. Of the 27 analysts covering the stock tracked by S&amp;P Global Market Intelligence, 16 rate UNH at Strong Buy, six say Buy, three have it at Hold and one calls it a Sell.</p><p>\"With the increase in Covid-19 vaccinations, we expect medical utilization patterns to return to normal levels, while at the same time we anticipate higher utilizations resulting from missed medical visits and delayed electives,\" writes CFRA Research analyst Sel Hardy, who rates the stock at Strong Buy.</p><p>So it's only fitting that Allen Investment Management, a New York hedge fund with $9.3 billion in AUM, upped its stake in UNH by 2%, or 21,086 shares, during the first quarter.</p><p>At 5.7% of the portfolio, UNH is the fund's third-largest position, trailing only Allen stock picks Alphabet Class C shares and Facebook. The hedge fund's stake of 990,525 shares was worth $368.5 million at the end of the first quarter.</p><p>Gaming and Leisure Properties</p><ul><li><b>Market value:</b>$10.8 billion</li><li><b>Billionaire investor:</b>Gates Capital Management</li><li><b>Percent of portfolio:</b>6.0%</li></ul><p>Gates Capital Management is a fan of one of Wall Street pros' favorite Nasdaq stocks. The New York hedge fund with $3 billion in AUM upped its stake in<b>Gaming and Leisure Properties</b>(GLPI, $46.36) by 35%, or more than 1 million shares, during the first quarter.</p><p>Gates Capital now holds 3.9 million shares in thisreal estate investment trust (REIT)– a stake worth $165.6 million as of March 31.</p><p>Analysts like this casino real estate play thanks to both a snazzy dividend yield and attractive growth prospects coming out of the pandemic. The company, whose properties include the Belle of Baton Rouge and Argosy Casino Riverside in Missouri, collected 100% of its rents in 2020.</p><p>Mizuho Securities initiated coverage of Gaming and Leisure Properties at Buy in late March, citing its unique attributes in an industry set to benefit from a recovery in consumer spending and gaming revenue.</p><p>\"GLPI is the most diversified of the three Gaming REITs, with strong underlying tenant credit and structural lease enhancements, resulting in a lower-risk platform that we believe is under-appreciated by the market,\" writes Mizuho analyst Haendel St. Juste.</p><p>Analysts' consensus recommendation on the name stands at Strong Buy, according to S&amp;P Global Market Intelligence.</p><p>The bull case for GLPI makes it easy to understand why Gates Capital increased its exposure to a stock it first bought back in 2013. The hedge fund holds 1.7% of GLPI's shares outstanding, making it the REIT's 12th largest investor.</p><p>S&amp;P Global</p><ul><li><b>Market value:</b>$91.4 billion</li><li><b>Billionaire investor:</b>Chris Hohn (TCI Fund Management)</li><li><b>Percent of portfolio:</b>6.0%</li></ul><p>Activist investor Chris Hohn has made quite a name for himself with The Children's Investment Fund Management – more commonly known as TCI Fund Management. Indeed, the London-based investor has parlayed his many stock picks into a personal net worth of $5.9 billion, per Forbes.</p><p>TCI, with more than $34 billion in managed securities, made a handful of moves in Q1, and none was bigger in percentage terms than its doubling down (and then some) on<b>S&amp;P Global</b>(SPGI, $379.47).</p><p>Hohn increased the fund's stake in SPGI by 147% – by far its largest addition of the quarter in percentage terms – adding 3.5 million shares. TCI now owns 5.9 million shares in the company behind S&amp;P Global Ratings, S&amp;P Global Market Intelligence and S&amp;P Global Platts.</p><p>The stake, worth $2.1 billion at the end of Q1, accounts for 6.0% of TCI's portfolio value, and gives Hohn ownership of 2.4% of S&amp;P's shares outstanding. That makes TCI the company's sixth-largest shareholder.</p><p>Although most investors probably know S&amp;P for its majority stake in S&amp;P Dow Jones Indices – which maintains the benchmark S&amp;P 500 index and the blue-chip Dow Jones Industrial Average – it's also a central player in corporate and financial analytics, information and research.</p><p>Dedicated long-term income investors probably already know thatSPGI happens to be a Dividend Aristocrat. The company has increased its dividend annually for nearly half a century.</p><p>AbbVie</p><ul><li><b>Market value:</b>$199.9 billion</li><li><b>Billionaire investor:</b>Avidity Partners Management</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p><b>AbbVie</b>(ABBV, $113.20) was spun off from the above-mentioned Abbott Laboratories in 2013. It too, is a Dividend Aristocrat, having lifted its dividend annually for almost half a century.</p><p>Consumers best know the pharma firm for Humira, a blockbuster drug for rheumatoid arthritis that has been approved for numerous other ailments. AbbVie also makes cancer drug Imbruvica, as well as testosterone replacement therapy AndroGel.</p><p>Avidity Partners Management, a Dallas hedge fund with AUM of $6.2 billion, focuses primarily on stock picks in the healthcare sector, and it has been a fan of AbbVie since the fourth quarter of 2019. Most recently, it upped its stake in the pharma giant by 53%, or 721,200 shares. Avidity now holds a total of nearly 2.1 million shares in ABBV, worth $225 million at the end of Q1.</p><p>At 6.3% of its equity portfolio, AbbVie is Avidity's single largest position. That's up from 4.7% about three months ago.</p><p>The Street is a solid fan of ABBV, too. Analysts' consensus recommendation stands at Buy, with 11 Strong Buy ratings, six Buys and five Hold calls. One analyst has a Sell recommendation on the stock.</p><p>\"AbbVie is developing new growth drivers to help offset slowing sales of Humira, still its largest product by revenue,\" writes Argus Research analyst David Toung, who rates the stock at Buy. \"We expect continued strong growth from the oncology portfolio and newer immunology drugs in 2021.\"</p><p>Applied Materials</p><ul><li><b>Market value:</b>$126.2 billion</li><li><b>Billionaire investor:</b>Bristol Gate Capital Partners</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p>Bristol Gate Capital Partners, a Toronto hedge fund with AUM of $1.7 billion, initiated a position in<b>Applied Materials</b>(AMAT, $138.13) in the first quarter.</p><p>And what a commitment it was. The new purchase of 783,931 shares, worth $105 million at the end of Q1, vaulted the position to Bristol Gate's top holding, accounting for 6.3% of its portfolio.</p><p>Applied Materials, which provides manufacturing equipment and technology to the semiconductor industry, is an allied play on the global chip shortage. Indeed, relentless demand for semiconductors from a wide range of industries has helped AMAT stock jump about 60% for the year-to-date.</p><p>The Street is heavily bullish on the name, too. Analysts' consensus recommendation stands at Buy, according to S&amp;P Global Market Research. The high opinion stems in part from the Street's forecast for EPS to increase at an average annual rate of nearly 19% over the next three to five years.</p><p>\"We believe underlying secular drivers are robust, broad-based and multi-year in nature,\" writes B. Riley analyst Craig Ellis, who rates AMAT at Buy.</p><p>Johnson &amp; Johnson</p><ul><li><b>Market value:</b>$445.7 billion</li><li><b>Billionaire investor:</b>ACR Alpine Capital Research</li><li><b>Percent of portfolio:</b>6.3%</li></ul><p>ACR Alpine Capital Research, a large advisory with $2.5 billion in AUM, has been a long-time fan of blue-chip<b>Johnson &amp; Johnson</b>(JNJ, $169.25). The St. Louis-based asset manager first invested in the Dow stock at the end of 2010, and it added incrementally to the position in Q1.</p><p>ACR upped its stake in the multifaceted pharma giant by 1%, or 8,790 shares, bringing its total holdings to 704,842 shares. The stake, worth $115.8 million at quarter's end, is at the tail end of the advisory's top 10 stock picks, taking up 6.3% of ACR's total portfolio value.</p><p>Analysts have a consensus recommendation of Buy on JNJ. Among the arguments in favor of the stock, bulls point to its strong pharmaceutical pipeline, as well as a rebound in demand for medical devices as patients undergo elective procedures put off during the pandemic.</p><p>\"We expect the recovery in elective procedures and patient visit volumes to accelerate as the pandemic is starting to get under control in the U.S., which should result in a strong recovery in Medical Devices sales and solid growth in Pharma revenues,\" writes CFRA Research analyst Sel Hardy, who rates shares at Buy.</p><p>Investors and analysts alike no doubt also appreciate the company's commitment to delivering income to investors. JNJ announced a 5% quarterly dividend increase in April 2021, to $1.06 per share from $1.01 per share. That marked this Dividend Aristocrat's 59th consecutive year of dividend increases.</p><p>Xilinx</p><ul><li><b>Market value:</b>$31.2 billion</li><li><b>Billionaire investor:</b>Canyon Capital Advisors</li><li><b>Percent of portfolio:</b>7.0%</li></ul><p>Canyon Capital Advisors, with AUM of $20.9 billion, has propelled founders Joshua Friedman and Mitchell Julis to Forbes' list of highest-earning hedge fund millionaires.</p><p>So it's of interest that the Los Angeles-based fund significantly pared back on its two largest stock picks in Q1 – while greatly increasing its bet on chipmaker<b>Xilinx</b>(XLNX, $127.00).</p><p>In October 2020, Advanced Micro Devices (AMD) and Xilinx announced a deal in which AMD would acquire the latter in an all-stock transaction valued at $35 billion.</p><p>Canyon first bought shares in Xilinx in the fourth quarter of 2020, at which point the stake accounted for 4.6% of the fund's portfolio value. Then in Q1, Canyon upped its XLNX holdings by 89%, or 672,829 shares.</p><p>The hedge fund's total stake of 1.4 million shares, worth $176.3 million at the end of Q1, now accounts for 7.0% of its portfolio value.</p><p>Canyon, with ownership of 0.58% of XLNX's shares outstanding, is a top-30 stockholder in the soon-to-be-acquired company. AMD and Xilinx expect their deal to close at the end of 2021.</p><p>Analysts' consensus recommendation on XLNX stands at Hold, pending the deal close. They do, however, rate AMD at Buy, and generally applaud the strategic rationale of merging the two chipmakers' complementary assets.</p><p>D.R. Horton</p><ul><li><b>Market value:</b>$34.4 billion</li><li><b>Billionaire investor:</b>George Soros (Soros Fund Management)</li><li><b>Percent of portfolio:</b>7.4%</li></ul><p>Legendary hedge-fund tycoon George Soros, with an estimated net worth of $8.6 billion, per Forbes, today spends his days running Soros Fund Management.</p><p>The New York-based family office – a sort of private hedge fund – has $5.3 billion in AUM, and one of its biggest stock picks is a bet on the severe shortage of new homes for sale.</p><p>Soros first took a stake in homebuilder<b>D.R. Horton</b>(DHI, $95.29) during the first quarter of 2019, and he apparently remains bullish on the outlook. After all, the billionaire increased his DHI stake by 19%, or 703,850 shares, in the first quarter.</p><p>Soros Fund Management's most recent investment makes DHI its second-largest holding, at 7.4% of the portfolio. The stake of 4.4 million shares – worth $392.8 million at the end of Q1 – equals 1.2% of the homebuilder's shares outstanding. As such, Soros Fund Management is D.R. Horton's 15th largest shareholder.</p><p>With a consensus recommendation of Buy, per S&amp;P Global Market Intelligence, the Street is also bullish on the name.</p><p>\"With inventory constraints growing across the industry and buyer demand still nearly insatiable, we think DHI remains in an extraordinarily strong position to gain further market share and leverage its sector-leading scale,\" writes Raymond James analyst Buck Horne, who rates shares at Outperform (the equivalent of Buy).</p><p>Microsoft</p><ul><li><b>Market value:</b>$1.9 trillion</li><li><b>Billionaire investor:</b>Chase Coleman III (Tiger Global Management)</li><li><b>Percent of portfolio:</b>7.4%</li></ul><p>Hedge-fund legend Chase Coleman III, with a net worth of $10.3 billion, according to Forbes, upped his bet on<b>Microsoft</b>(MSFT, $249.68) in the first quarter of 2021.</p><p>And he did so in a compelling fashion.</p><p>Coleman's Tiger Global Management ($79 billion AUM) increased its stake in MSFT by 15%, or 1.8 million shares, in the first three months of the year. The hedge fund now owns a total of 13.7 million shares, worth $3.2 billion at the end of Q1.</p><p>The MSFT stake, which accounts for 7.4% of Tiger Global's portfolio value, is second only to its bet on Chinese e-commerce company JD.com (JD), which is top among Coleman's stock picks at 9.9% of the portfolio.</p><p>Tiger Global first bought MSFT in the fourth quarter of 2016, and adding to the stake certainly makes sense. Wall Street analysts mostly adore this component of the Dow Jones Industrial Average.</p><p>After all, MSFT – the second-largest U.S. company by market value after Apple (AAPL) – lands among the pro's11 best Nasdaq stocks you can buy. Analysts' consensus recommendation on MSFT comes to Strong Buy, with 26 Strong Buy calls, 11 Buys and one Hold rating.</p><p>Tesla</p><ul><li><b>Market value:</b>$602.3&nbsp;billion</li><li><b>Billionaire investor:</b>Ark Invest</li><li><b>Percent of portfolio:</b>7.6%</li></ul><p>Ark Invest features prominently in the financial news these days, thanks to the strong performance of several of its actively managed exchange-traded funds.</p><p>Indeed, as Kiplinger has noted, 2020 was the year of Cathie Wood, CEO and founder of Ark Invest, who steered its then-five separate actively managed innovation-themed funds to the ranks ofthe best-performing equity ETFsof the year.</p><p>In addition to ETFs, Ark offers managed accounts and other products and services aimed at high net worth investors. Thanks to the various products and services it offers, the firm has amassed more than $55 billion in AUM.</p><p>So it says something when Ark's single-largest holding is<b>Tesla</b>(TSLA, $625.22) – especially since the firm is increasing its exposure to the electric vehicle maker at an accelerating pace.</p><p>Ark boosted its TSLA position by 39%, or 1.7 million shares, during the first quarter of 2021. The stake, which accounts for 7.6% of Ark Investment Management's equity portfolio, was worth nearly $4 billion at the end of Q1.</p><p>It's not hard to see why Wood likes TSLA so much. Her investment approach focuses on innovation, and Tesla, led by the mercurial Elon Musk, is nothing if not innovative.</p><p>Comcast</p><ul><li><b>Market value:</b>$263.4 billion</li><li><b>Billionaire investor:</b>Rothschild &amp; Company Wealth Management UK</li><li><b>Percent of portfolio:</b>9.0%</li></ul><p>Rothschild &amp; Company Wealth Management UK, a London-based hedge fund with $16.4 billion in AUM, is increasingly bullish on<b>Comcast</b>(CMCSA, $57.34).</p><p>Welcome to the club.</p><p>The nation's largest cable company regularly makes the list ofhedge funds' favorite stock picks. That's because its combination of content, broadband, pay TV, theme parks and movies is unparalleled by rivals, and gives thisblue-chip stocka huge strategic advantage.</p><p>CMCSA's diversification came in especially handy last year when the pandemic walloped theme parks, cinemas and spending on advertising.</p><p>\"While the pandemic has materially impacted Comcast, the company's steady cable division continues to provide vital connectivity for its large base of 23 million subscribers,\" writes Argus Research analyst Joseph Bonner (Buy).</p><p>Rothschild first bought shares in the cable operator in the first quarter of 2019, and most recently upped its bet by 2%, or 194,324 shares. The hedge fund's total holdings of 9.2 million shares, worth $500.2 million at the end of Q1, accounted for 9.0% of its portfolio. CMCSA is now Rothchild's sixth-largest position.</p><p>Analysts' consensus recommendation on the stock comes to Buy, per S&amp;P Global Market Intelligence, with 20 Strong Buy ratings, nine Buys, four Holds and one Strong Sell. The Street expects the company to deliver average annual EPS growth of nearly 16% over the next three to five years.</p><p>Aptiv</p><ul><li><b>Market value:</b>$40.7 billion</li><li><b>Billionaire investor:</b>Caxton Associates</li><li><b>Percent of portfolio:</b>9.4%</li></ul><p>Billionaire philanthropist Bruce Kovner, with an estimated net worth of $6.6 billion, retired from his management role at Caxton Associates a decade ago. But the hedge fund he founded continues to rake in the bucks with his global macroeconomic trading strategies.</p><p>Indeed, Caxton last year closed its flagship fund to new money after posting record 40% gains during the pandemic. And the firm shows no signs of slowing down.</p><p>Caxton, with AUM of $25.7 billion, has owned<b>Aptiv</b>(APTV, $150.42) since the first quarter of 2019, but it really went all in earlier this year.</p><p>Caxton upped its stake in APTV by 61%, or 285,618 shares. Indeed, the purchase made APTV the fund's top stock pick, accounting for 9.4% of the portfolio, up from 4.2% three months ago. Caxton's 747,843 shares were worth $103.1 million at the end of Q1.</p><p>Shares in Aptiv, which makes safety, connectivity and green technology for vehicles, have essentially doubled over the past 52 weeks, and analysts say they have more room to run.</p><p>\"Aptiv indeed is not only benefitting from accelerating industry adoption of vehicle electrification, advanced driver-assistance systems, and connected vehicle technologies, but also achieving dominant win rates in several of these areas based on its complete system knowledge, and software-based flexible architectures,\" writes Deutsche Bank analyst Emmanuel Rosner (Buy).</p><p>Adobe</p><ul><li><b>Market value:</b>$241.2 billion</li><li><b>Billionaire investor:</b>Atalan Capital Partners</li><li><b>Percent of portfolio:</b>9.6%</li></ul><p>Atalan Capital Partners, a New York hedge fund with AUM of $2 billion, boosted its stake in<b>Adobe</b>(ADBE, $504.58) in Q1, which vaulted the software company into the No. 2 spot among its stock picks.</p><p>Atalan increased its holdings by 38%, or 82,000 shares, in Q1, lifting its total stake to 295,000 shares worth $140.2 million as of March 31. The position accounts for 9.6% of the portfolio.</p><p>Atalan first picked up ADBE in the second quarter of 2020, which was not the best timing. Shares are up just about 16% since June 30 of last year, lagging the S&amp;P 500 by roughly 20 percentage points.</p><p>That's not to say ADBE stock won't continue to be a winner in the longer run. Analysts tend to be heavily bullish on the name, thanks to its dominance in its field. After all, Adobe is the undisputed leader in making software for designers and other creative types. Its software arsenal includes Photoshop, Premiere Pro for video editing and Dreamweaver for website design, among others.</p><p>\"As a result of its early-mover position and strategic M&amp;A transactions, Adobe has established itself as the unchallenged leader in Creative software,\" writes Stifel analyst Jeffrey Parker Lane (Buy). \"We view Adobe as one of the most compelling investment cases in our coverage areas.\"</p><p>The Street's consensus recommendation stands at Buy, with an annual EPS growth forecast of more than 15% over the next three to five years.</p><p>Thermo Fisher Scientific</p><ul><li><b>Market value:</b>$184.5 billion</li><li><b>Billionaire investor:</b>Cryder Capital Partners</li><li><b>Percent of portfolio:</b>9.7%</li></ul><p><b>Thermo Fisher Scientific</b>(TMO, $469.50), is sometimes called the \"Amazon of the healthcare industry\" because of its wide-ranging portfolio of life sciences products, analytics and laboratory instruments.</p><p>As such, it has been highly active in the fight against COVID-19, which in turn has raised its profile and investor interest. And although TMO has been a holding of Cryder Capital Partners since 2015, the hedge fund remains an incremental buyer.</p><p>London-based Cryder Capital, with $1 billion in AUM, lifted its stake in TMO by 2%, or 6,398 shares, during the first three months of the year. The hedge fund now holds a total of 298,587 shares, worth $136.3 million as of March 31. Despite a high weight of 9.7%, TMO is just seventh largest among the fund's stock picks.</p><p>Analysts' consensus recommendation stands at Strong Buy, according to S&amp;P Global Market Intelligence. Argus Research is just one research shop in the bull camp.</p><p>\"Thermo is seeing strong demand for COVID-19 testing solutions as well as for instruments and supplies used by developers of vaccines and other treatments,\" writes analyst David Toung (Buy). \"But the company is also investing its substantial cash flow in technology upgrades, capacity expansions and acquisitions.\"</p><p>With an average target price of $557.17, the Street gives TMO stock implied upside of about 18% in the next 12 months or so.</p><p>Visa</p><ul><li><b>Market value:</b>$484.8 billion</li><li><b>Billionaire investor:</b>Valley Forge Capital Management</li><li><b>Percent of portfolio:</b>10.2%</li></ul><p><b>Visa</b>(V, $227.30) routinely makes most lists of analysts', hedge funds' or billionaires' favorite stocks.<b>Berkshire Hathaway</b>(BRK.B)owns a stake worth more than $2 billion, although chairman and CEO Warren Buffett readily credits the holding to one of his stock-picking lieutenants.</p><p>And indeed, there is much to like about this Dow stock. Visa operates the world's largest payments network, and thus is well-positioned to benefit from the growth of cashless transactions and digital mobile payments.</p><p>The Street's consensus recommendation is a high-conviction Buy. Of the analysts covering the stock tracked by S&amp;P Global Market Intelligence, 21 call V a Strong Buy, 12 rate it at Buy, four say Hold and one calls it a Sell.</p><p>Valley Forge Capital Management, a hedge fund in Wayne, Pennsylvania, with $1.1 billion in AUM, is certainly a big believer. Visa accounts for 10.2% of its equity portfolio.</p><p>The fund increased its Visa stake by 88%, or 477,181 shares, in Q1. It now holds more than 1 million shares worth $215 million as of March 31. Mind you, Valley Forge Capital is hardly a novice in this stock. The fund has counted Visa among its stock picks since 2016.</p><p>Although the pandemic greatly curtailed spending in a number of Visa's categories – most notably travel and entertainment – those headwinds should now be in the past. Indeed, the gradual global reopening – and accelerating secular growth in cashless payments,&nbsp;helped by the perception that cash is \"dirty\" – make a solid bull case for Visa stock.</p><p>Intel</p><ul><li><b>Market value:</b>$230.7 billion</li><li><b>Billionaire investor:</b>Cavalry Management Group</li><li><b>Percent of portfolio:</b>10.4%</li></ul><p><b>Intel</b>(INTC, $57.12) has fallen far behind the competition on any number of fronts, which is why analysts and investors were so delighted when the chipmaker hired Pat Gelsinger, former CEO of VMWare (VMW), to take over in February.</p><p>Heck, some observers said it was the best decision the troubled company made in more than a decade. And, indeed, this Dow stock has been a disappointing performer. Shares are up just 3% over the past three years vs. a gain of 54% for the S&amp;P 500.</p><p>So props to Cavalry Management Group for making a bold bet on the semiconductor company earlier this year. The San Francisco hedge fund with $2.6 billion in AUM initiated a large enough position to instantly make Intel its top stock pick.</p><p>Cavalry Management bought 1.7 million shares during the first three months of 2021. With a value of $111.6 million at the end of Q1, INTC accounted for more than 10% of the hedge fund's investments.</p><p>Cavalry largely focuses on large-cap tech stocks, so Intel certainly fits well with its broader strategy. Other moves the fund made in Q1 included more than tripling its stake in Microsoft, and almost doubling its holdings in Ericsson (ERIC).</p><p>The Street is generally more cautious on INTC than Cavalry Management is. Analysts' consensus recommendation stands at Hold, per S&amp;P Global Market Intelligence.</p><p>PayPal Holdings</p><ul><li><b>Market value:</b>$305.5 billion</li><li><b>Billionaire investor:</b>Dorsey Asset Management</li><li><b>Percent of portfolio:</b>11.8%</li></ul><p>Digital mobile payments and the expansion of cashless transactions are one of the hottest areas of growth in financial tech. And although the sector offers no shortage of promising new names, old-timer<b>PayPal Holdings</b>(PYPL, $260.02) still gets plenty of analyst – and billionaire investor – love.</p><p>Explosive growth in mobile transactions, the monetization of its Venmo property and incremental revenue growth in its Xoom business all help make for a compelling bull case on PYPL, analysts say.</p><p>\"Simply put, PayPal should continue to benefit from the secular shift to e-commerce that should drive a roughly 20% revenue compound annual growth rate (CAGR), which, coupled with margin expansion and capital allocation (mergers &amp; acquisitions plus stock buybacks), should result in an earnings CAGR north of 20% over the next several years,\" writes Raymond James analyst John Davis, who rates the stock at Outperform (the equivalent of Buy).</p><p>Dorsey Asset Management, with $1.3 billion in AUM, embraces the bull case on PYPL in a big way. The Chicago-based hedge fund increased its stake in PayPal by 81%, or 209,025 shares, in Q1. Its total holdings of 465,266 shares, worth $113 million as of March 31, comprises 11.8% of its stock investments.</p><p>That's up from 7.9% of the portfolio three months ago. PYPL, which Dorsey has owned since the second quarter of 2018, is now its fifth-largest position.</p><p>Analysts' consensus recommendation on the stock stands at Buy, according to S&amp;P Global Market Intelligence.</p><p>Howard Hughes</p><ul><li><b>Market value:</b>$5.8 billion</li><li><b>Billionaire investor:</b>Bill Ackman (Pershing Square Capital)</li><li><b>Percent of portfolio:</b>12.1%</li></ul><p>No one doubts Bill Ackman's investing acumen. His Pershing Square Capital hedge fund has allowed the investor to amass a personal fortune of $3 billion, per Forbes.</p><p>And he's never been one to shy away from the media. So his increasing stake in<b>Howard Hughes Corp.</b>(HHC, $105.83) is far from a state secret. Indeed, Ackman has owned shares in the master-planned community developer since it was spun off from General Growth Properties in 2010.</p><p>Given Ackman's propensity for being anactivist investor, his latest purchase is eyebrow-raising news, nonetheless.</p><p>The hedge-fund billionaire increased his stake in HHC by 23%, or 2.6 million shares, in Q1. Pershing Square's stake of 13.5 million shares was worth $1.3 billion at the first quarter's end.</p><p>Most notably, Ackman now holds almost a quarter of HHC's shares outstanding. That makes the hedge fund the company's largest investor by a wide margin. Asset manager Vanguard, at No. 2, owns just 10.8% of HHC.</p><p>Meanwhile, HHC, at 12.1% of its portfolio, is now Pershing Square Capital's sixth-largest position.</p><p>For those keeping score at home, HHC stock has doubled over the past 52 weeks vs. a gain of about 38% for the S&amp;P 500. For the year-to-date, it's up by more than a third. That compares with the broader market's gain of about 12% so far this year.</p><p>Only three analysts cover HHC, according to S&amp;P Global Market Intelligence. One rates it at Strong Buy, while the other two say Buy.</p><p>Lowe's</p><ul><li><b>Market value:</b>$137.7 billion</li><li><b>Billionaire investor:</b>Two Creeks Capital Management</li><li><b>Percent of portfolio:</b>12.2%</li></ul><p>Two Creeks Capital Management, a New York hedge fund with AUM of $2.8 billion, made a big addition to its stake in<b>Lowe's</b>(LOW, $194.83) in the first quarter – a move most analysts would regard as wise.</p><p>The nation's second-largest home improvement retailer after Home Depot (HD) benefited greatly from the work-from-home/stuck-at-home reality of pandemic life. Analysts say many of the do-it-yourself habits consumers adopted during COVID times are here to stay. Lowe's is also being aided by the ultra-tight housing market.</p><p>The Street gives LOW a consensus recommendation of Buy. Argus Research, which counts itself in the Buy camp, says Lowe's has several strong tailwinds behind it.</p><p>\"We believe that the major drivers of post-pandemic sales growth remain the same,\" writes Argus Research analyst Christopher Graja. \"There has been significant underinvestment in housing. About 70% of U.S. homes are more than 25 years old and likely in need of upgrades and repairs. Millennials are starting families.\"</p><p>Income investors know the power of Lowe's dividend over the longer haul. The Dividend Aristocrat has paid a cash distribution every quarter since going public in 1961, and that dividend has increased annually for almost 60 years.</p><p>The bullish investment thesis led Two Creeks to up its stake in this stock pick by 14%, or 132,811 shares, in Q1. The hedge fund's total stake of 1.1 million LOW shares, worth $200 million at the end of Q1, accounts for 12.2% of its portfolio, representing its third-largest holding.</p><p>Alphabet</p><ul><li><b>Market value:</b>$1.6 trillion</li><li><b>Billionaire investor:</b>Metropolis Capital</li><li><b>Percent of portfolio:</b>13.3%</li></ul><p>It should come as no surprise that hedge funds are big believers in Google parent<b>Alphabet</b>(GOOGL, $2,356,85). Metropolis Capital, a U.K.-based investor with $1.4 billion in AUM, is just one of about 225 hedge funds upping its stake in the internet giant in Q1.</p><p>Metropolis thinks highly enough of the search leader that it increased its stake by 22%, or 13,679 shares. The firm now holds a total of 74,868 shares worth $154.4 million, or 13.3% of its total portfolio, as of March 31.</p><p>Alphabet happens to be in good company at this hedge fund. GOOGL is Metropolis' second-largest stock pick after Berkshire Hathaway (BRK.B).</p><p>If nothing else, Alphabet's pandemic performance in totality bolstered the case that GOOGL is not a one-trick pony. Its numerous other endeavors likewise shore up the case. For example, Alphabet is a key player in cloud-based services, and home to Nest Labs and self-driving car startup Waymo. Artificial intelligence, machine learning and virtual reality are other areas of heavy investment.</p><p>\"We continue to favor Google as a core large-cap growth holding given the strong digital advertising backdrop, continued strength from Cloud, ongoing share repurchases (with the newly authorized $50 billion program) and a reasonable valuation,\" writes Canaccord Genuity analyst Maria Ripps (Buy).</p><p>Analysts' consensus recommendation on the name stands at Strong Buy. Of the 45 analysts issuing opinions on the stock tracked by S&amp;P Global Market Intelligence, 32 rate it at Strong Buy, 12 say Buy and one has it at Hold.</p><p>Walt Disney</p><ul><li><b>Market value:</b>$324.6 billion</li><li><b>Billionaire investor:</b>Kirkoswald Asset Management</li><li><b>Percent of portfolio:</b>16.5%</li></ul><p>Coronavirus took a huge bite out of some of<b>Walt Disney's</b>(DIS, $178.65) most important businesses: namely, its theme parks and studios. But after encouraging quarterly results, analysts say business is set to bounce back in a big way.</p><p>Disneyland and other California amusement parks have reopened with restrictions. And admissions at Florida's Disney World continue to climb.</p><p>\"With mask mandates lifted and capacity constraints loosened further, we would not be surprised to see a step change in attendance in the near future,\" writes Deutsche Bank analyst Bryan Kraft (Buy).</p><p>But that's nothing compared to what DIS has on its hands in thestreaming mediawars.</p><p>Disney+ is a smashing success. The streaming platform, which launched in November 2019, has already amassed almost 100 million subscribers – a staggering rate of growth. Consider that Disney+ now has about half as many subscribers as Netflix (NFLX) – but Netflix had a roughly 12-year head start.</p><p>Kirkoswald Asset Management, a New York hedge fund with AUM of $4 billion, decided to get in on DIS asa recovery stock pickin Q1. It initiated a stake of 5,200 shares, worth almost $1 million, during the first three months of the year.</p><p>The new stake immediately made DIS its second-largest position among $5.8 million in managed securities.</p><p>Most of the Street would approve of Kirkoswald's investment. Analysts have a consensus Buy recommendation on this Dow stock.</p><p>Berkshire Hathaway</p><ul><li><b>Market value:</b>$661.0 billion</li><li><b>Billionaire investor:</b>Southeast Asset Advisors</li><li><b>Percent of portfolio:</b>16.8%</li></ul><p>If you can't beat 'em, join 'em.</p><p>It's hard to compete with Warren Buffett when it comes toasset allocation. As CEO and chairman of<b>Berkshire Hathaway</b>(BRK.B, $289.44), he's arguably the greatest long-term investor of all time.</p><p>So it's little wonder that so many hedge funds, large advisories and other billion-dollar-plus pools of money throw in their lots with the Oracle of Omaha.</p><p>Southeast Asset Advisors, an investment manager and hedge fund based in Thomasville, Georgia, with $1.6 billion in AUM, has been a BRK.B shareholder since 2008. Indeed, BRK.B, at 16.8% of its portfolio, is the fund's top holding.</p><p>And it's only getting bigger.</p><p>Southeast increased its stake in BRK.B by 2%, or 7,747 shares, in Q1. It now holds 365,149 shares worth $93.3 million. Only Alphabet Class C shares (GOOG) come close to the firm's BRK.B stake, accounting for 11.7% of the portfolio.</p><p>BRK.B has been an outstanding performer both in 2021 and over the past 52 weeks. The stock is up 25% for the year-to-date, essentially doubling the S&amp;P 500's gains. And over the past year? BRK.B returned 57% vs. a price increase of less than 40% for the broad-market gauge.</p><p>Only four analysts cover BRK.B stock, per S&amp;P Global Market Intelligence. Their consensus recommendation comes to Buy.</p><p>Alibaba</p><ul><li><b>Market value:</b>$580.4 billion</li><li><b>Billionaire investor:</b>Conifer Management</li><li><b>Percent of portfolio:</b>20.7%</li></ul><p>Conifer Management, a New York hedge fund with $7.7 billion in AUM, has more than a fifth of its portfolio invested in Chinese e-commerce giant<b>Alibaba</b>(BABA, $213.96).</p><p>Indeed, after upping its stake by 147%, or 884,845 shares, in Q1, BABA is Conifer's top holding. Its total stake of 1.5 million shares was worth $336.7 million at the end of the first quarter.</p><p>Conifer initiated its stake in BABA only in the final quarter of last year. To the hedge fund's credit, this stock pick is a highly defensible investment idea.</p><p>Alibaba is sometimes called the Amazon of China. There are important differences between the two, but they do share the enviable trait of being undisputed titans ine-commerce.</p><p>And like Amazon, Alibaba has never shied away from investing heavily to both build out its existing businesses and enter new ones. As a result, BABA finds itself spreading beyond its core e-commerce business into cloud computing, digital payments and more.</p><p>It also helps that BABA and investors can now move past a $2.75 billion fine imposed by Chinese regulators for violating anti-monopoly laws.</p><p>Some analysts worry about decelerating revenue in the company's cloud services business, but the majority of the Street sees recent share-price weakness as a buying opportunity.</p><p>The consensus recommendation of 49 analysts tracked by S&amp;P Global Market Intelligence comes to Strong Buy on BABA stock.</p><p>Mastercard</p><ul><li><b>Market value:</b>$357.4 billion</li><li><b>Billionaire investor:</b>Valley Forge Capital Management</li><li><b>Percent of portfolio:</b>22.6%</li></ul><p>If Valley Forge Capital Management likes Visa – as noted above – it absolutely adores competitor<b>Mastercard</b>(MA, $360.58).</p><p>The Wayne, Pennsylvania-based hedge fund with $1.1 billion in AUM almost doubled its stake in this stock pick in the first quarter. And with more than a fifth of its portfolio tied up in the payments processor, Mastercard is Valley Forge's top holding.</p><p>The hedge fund bought another 665,544 shares, representing a 98% increase, in Q1, bringing its total holdings to 1.3 million shares. The position was worth $477.9 million as of March 31.</p><p>Valley Forge, which owns 0.14% of MA's shares outstanding, has been an investor in the company since 2016. It's a bet that appears to have done quite well. Mastercard stock's five-year total return – price appreciation plus dividends – comes to 30.8%, according to Morningstar data. That beats its sector by 5.7 percentage points and leads the broader market by 13.4 percentage points.</p><p>Like Visa, Mastercard has relentless growth in digital mobile payments and other cashless transactions at its back.</p><p>\"Mastercard is a key beneficiary of the long-term secular shift toward electronic forms of payments, and that new technology is helping accelerate the shift,\" writes William Blair analyst Robert Napoli (Outperform)</p><p>And, just like Visa, MA has a lot of fans on the Street. Analysts' consensus recommendation stands at Buy.</p><p>Facebook</p><ul><li><b>Market value:</b>$932.1 billion</li><li><b>Billionaire investor:</b>Altarock Partners</li><li><b>Percent of portfolio:</b>24.4%</li></ul><p>There's a strong bull case to be made for<b>Facebook</b>(FB, $328.73), the social media giant that forms a digital-ad duopoly with Google. Just ask Altarock Partners.</p><p>This hedge fund, based in Beverly, Massachusetts, with AUM of $3.1 billion, has almost a quarter of its portfolio socked away in Facebook stock. After buying another 465,800 shares, a 27% increase, in Q1, the hedge fund is sitting on 2.2 million shares worth $641.4 million as of March 31.</p><p>That makes FB Altarock's second-largest holding.</p><p>And just who is at No. 1?</p><p>None other than Google parent Alphabet, which commands 25.1% of Altarock's investment portfolio.</p><p>The hedge fund first bought FB in the fourth quarter of last year, so it's building up its position on the stock pick pretty rapidly. And well it should, if analysts are right about this name.</p><p>The Street's consensus recommendation on FB stands at Strong Buy, as analysts forecast the company to deliver truly impressive profit growth for some time.</p><p>\"We believe Facebook's share gains during the pandemic and new initiatives in e-commerce can drive many years of above-market growth,\" writes Stifel analyst John Egbert (Buy). \"We are comfortable with the potential outcomes of antitrust inquiries and believe FB shares offer investors a rare combination of growth and value relative to its peers.\"</p><p>Seagen</p><ul><li><b>Market value:</b>$28.2 billion</li><li><b>Billionaire investor:</b>Felix and Julian Baker (Baker Bros. Advisors)</li><li><b>Percent of portfolio:</b>29.7%</li></ul><p><b>Seagen</b>(SGEN, $155.35), a biotechnology firm specializing in oncology treatments, couldn't get a bigger vote of confidence than being the top holding of Baker Bros. Advisors.</p><p>This New York-based hedge fund with $35.8 billion in AUM is led by billionaire biotech investors Julian and Felix Baker. The brothers may keep a low profile, but they're plenty famous in the world ofbiotech stocks. A series of successful investments have allowed the Bakers to build an estimated combined fortune of about $4 billion, according to Forbes.</p><p>And judging by their latest regulatory filings, the brothers have great expectations for Seagen, too. The stock pick accounts for nearly 30% of the total value of the Baker Bros.' holdings, up from 28.5% three months ago.</p><p>The increase stems in part from Baker Bros. buying another 347,745 shares in SGEN in the first quarter of 2021. The fund's total holdings of 47.6 million shares were worth more than $7 billion at the end of Q1.</p><p>The stake gives Baker Bros. ownership of 26.3% of SGEN's shares outstanding, which makes it the biotech company's largest shareholder by a wide margin. The second-largest investor – Capital Research and Management – holds only 8.6% of SGEN's shares outstanding.</p><p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p><p>TRENDING TOPICS</p><p>TRENDING ARTICLES</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>30 Top Stock Picks That Billionaires Love</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n30 Top Stock Picks That Billionaires Love\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 11:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01><strong>Nasdaq</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be ...</p>\n\n<a href=\"https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/30-top-stock-picks-that-billionaires-love-2021-06-01","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182886492","content_text":"It's always interesting to see what billionaire investors are doing with their money. Sure, you can't match their gains simply by copying every single one of their stock picks, but it can still be helpful (and fruitful) to know what they've been up to.Consider that the billionaires, hedge funds and big-time advisories listed below have a great deal at stake. And their resources for research, as well as their intimate connections to insiders and others, can give them unique insight into their stock picks.Studying which stocks they're chasing with their capital (or whichstocks the billionaires are selling off, for that matter) can be an edifying exercise for retail investors.After all, there's a reason the rich get richer.Here are 30 of the most recent top stock picks from the billionaire class.In each case, at least one billionaire – be it a person, hedge fund or advisory – has a substantial stake and/or added to its holdings. In most cases, these stocks are owned by multiple billionaire investors and billionaire investor firms. And while several of these investments are popular blue chips, others keep a much lower profile.Either way, the smart money isn't kidding around when it comes to these stock picks.Prices are as of May 28. Data is courtesy of S&P Global Market Intelligence, WhaleWisdom.com and regulatory filings made with the Securities and Exchange Commission. Stocks are ranked in reverse order of their weight in the selected billionaire investor's equity portfolio.WalmartMarket value:$400.0 billionBillionaire investor:Ray Dalio (Bridgewater Associates)Percent of portfolio:4.3%Ordinarily, we look for stocks that account for at least 5% of a billionaire investor's portfolio before including them on this list, but Bridgewater Associates' interest inWalmart(WMT, $142.03) is sort of a special case.Legendary investor Ray Dalio's massive hedge fund – it has $223 billion in assets under management (AUM) – has nearly 11% of its portfolio sitting in an S&P 500 index fund. Indeed, the SPDR S&P 500 ETF (SPY), with its 0.0945% expense ratio, is Bridgewater's largest holding.The fund's second-largest holding isalsoan ETF. The Vanguard Emerging Markets ETF (VWO) accounts for 5.1% of the hedge fund's total portfolio value.So it's something of a feather in Walmart's cap that the world's largest retailer and Dow Jones Industrial Average component happens to be tops among Dalio's actual stock picks.Indeed, in the first quarter of 2021, Bridgewater upped its WMT stake by 16%, or 512,347 shares. The total stake of 3.6 million shares, worth $487.8 million at the end of Q1, now accounts for 4.3% of Bridgewater's total portfolio value.Note well that Dalio, whose net worth is estimated at $20.3 billion, according to Forbes, is a big fan of Dow stocks and ETFs. In addition to WMT at No. 3, Bridegwater's top 10 holdings include stakes in Procter & Gamble (PG), Coca-Cola (KO) and Johnson & Johnson (JNJ), as well as the SPDR Gold Trust ETF (GLD) and the iShares Core MSCI Emerging Markets ETF (IEMG).Amazon.comMarket value:$1.6 trillionBillionaire investor:Stephen Mandel (Lone Pine Capital)Percent of portfolio:5.4%Hedge-fund legend Stephen Mandel stepped back from managing investments at Lone Pine Capital a couple years back, but he remains a managing director at the firm, and it still runs very much in his image.That's probably a good thing, given that Mandel's investing acumen allowed him to accumulate a net worth of nearly $4 billion, per Forbes.Lone Pine – based in the hedge-fund capital of the world, Greenwich, Connecticut – lists more than $27.5 billion in managed securities. Lately, it has been putting more cash to work in big-nametechnology stocks, and few get higher accolades from Wall Street analysts thanAmazon.com(AMZN, $3,223.07).Indeed, analysts say AMZN is one of thebest Nasdaq stocks you can buy, giving it a high conviction consensus recommendation of Strong Buy. That's due in no small part to the fact that they expect Amazon to generate average annual earnings per share growth of almost 35% over the next three to five years – this despite the fact that the e-commerce giant is already a $1.6 trillion company.Lone Pine upped its bet on AMZN by 87%, or 224,618 shares, in the first quarter, bringing its total holdings to 481,744 shares. That stake, which was worth $1.5 billion at the end of Q1, accounts for 5.4% of Lone Pine's total portfolio value, making it fifth among the hedge fund's stock picks.DanaherMarket value:$182.7 billionBillionaire investor:Tran Capital ManagementPercent of portfolio:5.4%Tran Capital Management, a hedge fund based in San Rafael, California, is incrementally more bullish on the life sciences industry.Tran, with $1.1 billion in AUM, added 2,001 shares to its stake inDanaher(DHR, $256.14), which makes a variety of instruments and diagnostics equipment to support medical, industrial and commercial processes.Tran now holds a total of 267,376 shares, which were worth $60.1 million at the end of Q1. The DHR stake is Tran's fourth-largest holding, accounting for 5.4% of its stock portfolio value. The hedge fund has been an investor in DHR since the first quarter of 2014, though even with the latest purchase, it still currently owns just 0.04% of the company's shares outstanding.The Street is likewise bullish on this healthcare name, which stands to benefit from the pharmaceutical industry's ongoing efforts against the novel coronavirus. Indeed, analysts' consensus recommendation on DHR comes to Buy, according to S&PGlobal MarketIntelligence.\"We believe that Danaher is well positioned to help biopharma companies develop new medicines, including treatments and vaccines for COVID-19,\" writes Argus Research analyst David Toung, who rates DHR at Buy. \"We expect recent strong customer demand to be sustained over the remainder of 2021.\"Abbott LaboratoriesMarket value:$207.3 billionBillionaire investor:Polen Capital ManagementPercent of portfolio:5.6%Polen Capital Management's top four stock picks are a who's who of hot-growth, mega-cap tech stocks: Facebook (FB), Microsoft (MSFT), Google-parent Alphabet's Class C shares (GOOG) and Adobe (ADBE).So it's kind of neat to see that the hedge fund's fifth-largest position is an income investor's dream.Abbott Laboratories(ABT, $116.65) is as stalwart a divided payer as they come. It's a member of the S&P Dividend Aristocrats, an index ofdividend stocks that have increased their payouts annually for at least 25 consecutive years.ABT, which manufactures a wide variety of healthcare goods, such as branded generic drugs, medical devices and nutrition and diagnostic products, has hiked its dividend for 49 years and counting. The last increase came in December: a whopping 25% improvement to 45 cents per share.Polen, a hedge fund based in Boca Raton, Florida, with AUM of more than $46 billion, has owned a stake in ABT since the third quarter of 2019. Most recently, it upped its position by 1%, or 220,118 shares. Polen's total of 20.7 million shares was worth $2.5 billion at the end of Q1, and accounted for 5.6% of its portfolio value.Importantly, Polen owns 1.2% of Abbott Lab's shares outstanding, putting it among the company's 15 largest investors.UnitedHealth GroupMarket value:$388.7 billionBillionaire investor:Allen Investment ManagementPercent of portfolio:5.7%UnitedHealth Group(UNH, $411.92) is a hedge-fund favorite, and Wall Street gives it high marks too.As the largest health insurer by both market value and revenue – and a member of the Dow Industrials to boot – UNH is sort of a must-have stock for institutional investors seeking broad exposure to the healthcare sector.Meanwhile, analysts' consensus recommendation on the name comes to Buy. Of the 27 analysts covering the stock tracked by S&P Global Market Intelligence, 16 rate UNH at Strong Buy, six say Buy, three have it at Hold and one calls it a Sell.\"With the increase in Covid-19 vaccinations, we expect medical utilization patterns to return to normal levels, while at the same time we anticipate higher utilizations resulting from missed medical visits and delayed electives,\" writes CFRA Research analyst Sel Hardy, who rates the stock at Strong Buy.So it's only fitting that Allen Investment Management, a New York hedge fund with $9.3 billion in AUM, upped its stake in UNH by 2%, or 21,086 shares, during the first quarter.At 5.7% of the portfolio, UNH is the fund's third-largest position, trailing only Allen stock picks Alphabet Class C shares and Facebook. The hedge fund's stake of 990,525 shares was worth $368.5 million at the end of the first quarter.Gaming and Leisure PropertiesMarket value:$10.8 billionBillionaire investor:Gates Capital ManagementPercent of portfolio:6.0%Gates Capital Management is a fan of one of Wall Street pros' favorite Nasdaq stocks. The New York hedge fund with $3 billion in AUM upped its stake inGaming and Leisure Properties(GLPI, $46.36) by 35%, or more than 1 million shares, during the first quarter.Gates Capital now holds 3.9 million shares in thisreal estate investment trust (REIT)– a stake worth $165.6 million as of March 31.Analysts like this casino real estate play thanks to both a snazzy dividend yield and attractive growth prospects coming out of the pandemic. The company, whose properties include the Belle of Baton Rouge and Argosy Casino Riverside in Missouri, collected 100% of its rents in 2020.Mizuho Securities initiated coverage of Gaming and Leisure Properties at Buy in late March, citing its unique attributes in an industry set to benefit from a recovery in consumer spending and gaming revenue.\"GLPI is the most diversified of the three Gaming REITs, with strong underlying tenant credit and structural lease enhancements, resulting in a lower-risk platform that we believe is under-appreciated by the market,\" writes Mizuho analyst Haendel St. Juste.Analysts' consensus recommendation on the name stands at Strong Buy, according to S&P Global Market Intelligence.The bull case for GLPI makes it easy to understand why Gates Capital increased its exposure to a stock it first bought back in 2013. The hedge fund holds 1.7% of GLPI's shares outstanding, making it the REIT's 12th largest investor.S&P GlobalMarket value:$91.4 billionBillionaire investor:Chris Hohn (TCI Fund Management)Percent of portfolio:6.0%Activist investor Chris Hohn has made quite a name for himself with The Children's Investment Fund Management – more commonly known as TCI Fund Management. Indeed, the London-based investor has parlayed his many stock picks into a personal net worth of $5.9 billion, per Forbes.TCI, with more than $34 billion in managed securities, made a handful of moves in Q1, and none was bigger in percentage terms than its doubling down (and then some) onS&P Global(SPGI, $379.47).Hohn increased the fund's stake in SPGI by 147% – by far its largest addition of the quarter in percentage terms – adding 3.5 million shares. TCI now owns 5.9 million shares in the company behind S&P Global Ratings, S&P Global Market Intelligence and S&P Global Platts.The stake, worth $2.1 billion at the end of Q1, accounts for 6.0% of TCI's portfolio value, and gives Hohn ownership of 2.4% of S&P's shares outstanding. That makes TCI the company's sixth-largest shareholder.Although most investors probably know S&P for its majority stake in S&P Dow Jones Indices – which maintains the benchmark S&P 500 index and the blue-chip Dow Jones Industrial Average – it's also a central player in corporate and financial analytics, information and research.Dedicated long-term income investors probably already know thatSPGI happens to be a Dividend Aristocrat. The company has increased its dividend annually for nearly half a century.AbbVieMarket value:$199.9 billionBillionaire investor:Avidity Partners ManagementPercent of portfolio:6.3%AbbVie(ABBV, $113.20) was spun off from the above-mentioned Abbott Laboratories in 2013. It too, is a Dividend Aristocrat, having lifted its dividend annually for almost half a century.Consumers best know the pharma firm for Humira, a blockbuster drug for rheumatoid arthritis that has been approved for numerous other ailments. AbbVie also makes cancer drug Imbruvica, as well as testosterone replacement therapy AndroGel.Avidity Partners Management, a Dallas hedge fund with AUM of $6.2 billion, focuses primarily on stock picks in the healthcare sector, and it has been a fan of AbbVie since the fourth quarter of 2019. Most recently, it upped its stake in the pharma giant by 53%, or 721,200 shares. Avidity now holds a total of nearly 2.1 million shares in ABBV, worth $225 million at the end of Q1.At 6.3% of its equity portfolio, AbbVie is Avidity's single largest position. That's up from 4.7% about three months ago.The Street is a solid fan of ABBV, too. Analysts' consensus recommendation stands at Buy, with 11 Strong Buy ratings, six Buys and five Hold calls. One analyst has a Sell recommendation on the stock.\"AbbVie is developing new growth drivers to help offset slowing sales of Humira, still its largest product by revenue,\" writes Argus Research analyst David Toung, who rates the stock at Buy. \"We expect continued strong growth from the oncology portfolio and newer immunology drugs in 2021.\"Applied MaterialsMarket value:$126.2 billionBillionaire investor:Bristol Gate Capital PartnersPercent of portfolio:6.3%Bristol Gate Capital Partners, a Toronto hedge fund with AUM of $1.7 billion, initiated a position inApplied Materials(AMAT, $138.13) in the first quarter.And what a commitment it was. The new purchase of 783,931 shares, worth $105 million at the end of Q1, vaulted the position to Bristol Gate's top holding, accounting for 6.3% of its portfolio.Applied Materials, which provides manufacturing equipment and technology to the semiconductor industry, is an allied play on the global chip shortage. Indeed, relentless demand for semiconductors from a wide range of industries has helped AMAT stock jump about 60% for the year-to-date.The Street is heavily bullish on the name, too. Analysts' consensus recommendation stands at Buy, according to S&P Global Market Research. The high opinion stems in part from the Street's forecast for EPS to increase at an average annual rate of nearly 19% over the next three to five years.\"We believe underlying secular drivers are robust, broad-based and multi-year in nature,\" writes B. Riley analyst Craig Ellis, who rates AMAT at Buy.Johnson & JohnsonMarket value:$445.7 billionBillionaire investor:ACR Alpine Capital ResearchPercent of portfolio:6.3%ACR Alpine Capital Research, a large advisory with $2.5 billion in AUM, has been a long-time fan of blue-chipJohnson & Johnson(JNJ, $169.25). The St. Louis-based asset manager first invested in the Dow stock at the end of 2010, and it added incrementally to the position in Q1.ACR upped its stake in the multifaceted pharma giant by 1%, or 8,790 shares, bringing its total holdings to 704,842 shares. The stake, worth $115.8 million at quarter's end, is at the tail end of the advisory's top 10 stock picks, taking up 6.3% of ACR's total portfolio value.Analysts have a consensus recommendation of Buy on JNJ. Among the arguments in favor of the stock, bulls point to its strong pharmaceutical pipeline, as well as a rebound in demand for medical devices as patients undergo elective procedures put off during the pandemic.\"We expect the recovery in elective procedures and patient visit volumes to accelerate as the pandemic is starting to get under control in the U.S., which should result in a strong recovery in Medical Devices sales and solid growth in Pharma revenues,\" writes CFRA Research analyst Sel Hardy, who rates shares at Buy.Investors and analysts alike no doubt also appreciate the company's commitment to delivering income to investors. JNJ announced a 5% quarterly dividend increase in April 2021, to $1.06 per share from $1.01 per share. That marked this Dividend Aristocrat's 59th consecutive year of dividend increases.XilinxMarket value:$31.2 billionBillionaire investor:Canyon Capital AdvisorsPercent of portfolio:7.0%Canyon Capital Advisors, with AUM of $20.9 billion, has propelled founders Joshua Friedman and Mitchell Julis to Forbes' list of highest-earning hedge fund millionaires.So it's of interest that the Los Angeles-based fund significantly pared back on its two largest stock picks in Q1 – while greatly increasing its bet on chipmakerXilinx(XLNX, $127.00).In October 2020, Advanced Micro Devices (AMD) and Xilinx announced a deal in which AMD would acquire the latter in an all-stock transaction valued at $35 billion.Canyon first bought shares in Xilinx in the fourth quarter of 2020, at which point the stake accounted for 4.6% of the fund's portfolio value. Then in Q1, Canyon upped its XLNX holdings by 89%, or 672,829 shares.The hedge fund's total stake of 1.4 million shares, worth $176.3 million at the end of Q1, now accounts for 7.0% of its portfolio value.Canyon, with ownership of 0.58% of XLNX's shares outstanding, is a top-30 stockholder in the soon-to-be-acquired company. AMD and Xilinx expect their deal to close at the end of 2021.Analysts' consensus recommendation on XLNX stands at Hold, pending the deal close. They do, however, rate AMD at Buy, and generally applaud the strategic rationale of merging the two chipmakers' complementary assets.D.R. HortonMarket value:$34.4 billionBillionaire investor:George Soros (Soros Fund Management)Percent of portfolio:7.4%Legendary hedge-fund tycoon George Soros, with an estimated net worth of $8.6 billion, per Forbes, today spends his days running Soros Fund Management.The New York-based family office – a sort of private hedge fund – has $5.3 billion in AUM, and one of its biggest stock picks is a bet on the severe shortage of new homes for sale.Soros first took a stake in homebuilderD.R. Horton(DHI, $95.29) during the first quarter of 2019, and he apparently remains bullish on the outlook. After all, the billionaire increased his DHI stake by 19%, or 703,850 shares, in the first quarter.Soros Fund Management's most recent investment makes DHI its second-largest holding, at 7.4% of the portfolio. The stake of 4.4 million shares – worth $392.8 million at the end of Q1 – equals 1.2% of the homebuilder's shares outstanding. As such, Soros Fund Management is D.R. Horton's 15th largest shareholder.With a consensus recommendation of Buy, per S&P Global Market Intelligence, the Street is also bullish on the name.\"With inventory constraints growing across the industry and buyer demand still nearly insatiable, we think DHI remains in an extraordinarily strong position to gain further market share and leverage its sector-leading scale,\" writes Raymond James analyst Buck Horne, who rates shares at Outperform (the equivalent of Buy).MicrosoftMarket value:$1.9 trillionBillionaire investor:Chase Coleman III (Tiger Global Management)Percent of portfolio:7.4%Hedge-fund legend Chase Coleman III, with a net worth of $10.3 billion, according to Forbes, upped his bet onMicrosoft(MSFT, $249.68) in the first quarter of 2021.And he did so in a compelling fashion.Coleman's Tiger Global Management ($79 billion AUM) increased its stake in MSFT by 15%, or 1.8 million shares, in the first three months of the year. The hedge fund now owns a total of 13.7 million shares, worth $3.2 billion at the end of Q1.The MSFT stake, which accounts for 7.4% of Tiger Global's portfolio value, is second only to its bet on Chinese e-commerce company JD.com (JD), which is top among Coleman's stock picks at 9.9% of the portfolio.Tiger Global first bought MSFT in the fourth quarter of 2016, and adding to the stake certainly makes sense. Wall Street analysts mostly adore this component of the Dow Jones Industrial Average.After all, MSFT – the second-largest U.S. company by market value after Apple (AAPL) – lands among the pro's11 best Nasdaq stocks you can buy. Analysts' consensus recommendation on MSFT comes to Strong Buy, with 26 Strong Buy calls, 11 Buys and one Hold rating.TeslaMarket value:$602.3 billionBillionaire investor:Ark InvestPercent of portfolio:7.6%Ark Invest features prominently in the financial news these days, thanks to the strong performance of several of its actively managed exchange-traded funds.Indeed, as Kiplinger has noted, 2020 was the year of Cathie Wood, CEO and founder of Ark Invest, who steered its then-five separate actively managed innovation-themed funds to the ranks ofthe best-performing equity ETFsof the year.In addition to ETFs, Ark offers managed accounts and other products and services aimed at high net worth investors. Thanks to the various products and services it offers, the firm has amassed more than $55 billion in AUM.So it says something when Ark's single-largest holding isTesla(TSLA, $625.22) – especially since the firm is increasing its exposure to the electric vehicle maker at an accelerating pace.Ark boosted its TSLA position by 39%, or 1.7 million shares, during the first quarter of 2021. The stake, which accounts for 7.6% of Ark Investment Management's equity portfolio, was worth nearly $4 billion at the end of Q1.It's not hard to see why Wood likes TSLA so much. Her investment approach focuses on innovation, and Tesla, led by the mercurial Elon Musk, is nothing if not innovative.ComcastMarket value:$263.4 billionBillionaire investor:Rothschild & Company Wealth Management UKPercent of portfolio:9.0%Rothschild & Company Wealth Management UK, a London-based hedge fund with $16.4 billion in AUM, is increasingly bullish onComcast(CMCSA, $57.34).Welcome to the club.The nation's largest cable company regularly makes the list ofhedge funds' favorite stock picks. That's because its combination of content, broadband, pay TV, theme parks and movies is unparalleled by rivals, and gives thisblue-chip stocka huge strategic advantage.CMCSA's diversification came in especially handy last year when the pandemic walloped theme parks, cinemas and spending on advertising.\"While the pandemic has materially impacted Comcast, the company's steady cable division continues to provide vital connectivity for its large base of 23 million subscribers,\" writes Argus Research analyst Joseph Bonner (Buy).Rothschild first bought shares in the cable operator in the first quarter of 2019, and most recently upped its bet by 2%, or 194,324 shares. The hedge fund's total holdings of 9.2 million shares, worth $500.2 million at the end of Q1, accounted for 9.0% of its portfolio. CMCSA is now Rothchild's sixth-largest position.Analysts' consensus recommendation on the stock comes to Buy, per S&P Global Market Intelligence, with 20 Strong Buy ratings, nine Buys, four Holds and one Strong Sell. The Street expects the company to deliver average annual EPS growth of nearly 16% over the next three to five years.AptivMarket value:$40.7 billionBillionaire investor:Caxton AssociatesPercent of portfolio:9.4%Billionaire philanthropist Bruce Kovner, with an estimated net worth of $6.6 billion, retired from his management role at Caxton Associates a decade ago. But the hedge fund he founded continues to rake in the bucks with his global macroeconomic trading strategies.Indeed, Caxton last year closed its flagship fund to new money after posting record 40% gains during the pandemic. And the firm shows no signs of slowing down.Caxton, with AUM of $25.7 billion, has ownedAptiv(APTV, $150.42) since the first quarter of 2019, but it really went all in earlier this year.Caxton upped its stake in APTV by 61%, or 285,618 shares. Indeed, the purchase made APTV the fund's top stock pick, accounting for 9.4% of the portfolio, up from 4.2% three months ago. Caxton's 747,843 shares were worth $103.1 million at the end of Q1.Shares in Aptiv, which makes safety, connectivity and green technology for vehicles, have essentially doubled over the past 52 weeks, and analysts say they have more room to run.\"Aptiv indeed is not only benefitting from accelerating industry adoption of vehicle electrification, advanced driver-assistance systems, and connected vehicle technologies, but also achieving dominant win rates in several of these areas based on its complete system knowledge, and software-based flexible architectures,\" writes Deutsche Bank analyst Emmanuel Rosner (Buy).AdobeMarket value:$241.2 billionBillionaire investor:Atalan Capital PartnersPercent of portfolio:9.6%Atalan Capital Partners, a New York hedge fund with AUM of $2 billion, boosted its stake inAdobe(ADBE, $504.58) in Q1, which vaulted the software company into the No. 2 spot among its stock picks.Atalan increased its holdings by 38%, or 82,000 shares, in Q1, lifting its total stake to 295,000 shares worth $140.2 million as of March 31. The position accounts for 9.6% of the portfolio.Atalan first picked up ADBE in the second quarter of 2020, which was not the best timing. Shares are up just about 16% since June 30 of last year, lagging the S&P 500 by roughly 20 percentage points.That's not to say ADBE stock won't continue to be a winner in the longer run. Analysts tend to be heavily bullish on the name, thanks to its dominance in its field. After all, Adobe is the undisputed leader in making software for designers and other creative types. Its software arsenal includes Photoshop, Premiere Pro for video editing and Dreamweaver for website design, among others.\"As a result of its early-mover position and strategic M&A transactions, Adobe has established itself as the unchallenged leader in Creative software,\" writes Stifel analyst Jeffrey Parker Lane (Buy). \"We view Adobe as one of the most compelling investment cases in our coverage areas.\"The Street's consensus recommendation stands at Buy, with an annual EPS growth forecast of more than 15% over the next three to five years.Thermo Fisher ScientificMarket value:$184.5 billionBillionaire investor:Cryder Capital PartnersPercent of portfolio:9.7%Thermo Fisher Scientific(TMO, $469.50), is sometimes called the \"Amazon of the healthcare industry\" because of its wide-ranging portfolio of life sciences products, analytics and laboratory instruments.As such, it has been highly active in the fight against COVID-19, which in turn has raised its profile and investor interest. And although TMO has been a holding of Cryder Capital Partners since 2015, the hedge fund remains an incremental buyer.London-based Cryder Capital, with $1 billion in AUM, lifted its stake in TMO by 2%, or 6,398 shares, during the first three months of the year. The hedge fund now holds a total of 298,587 shares, worth $136.3 million as of March 31. Despite a high weight of 9.7%, TMO is just seventh largest among the fund's stock picks.Analysts' consensus recommendation stands at Strong Buy, according to S&P Global Market Intelligence. Argus Research is just one research shop in the bull camp.\"Thermo is seeing strong demand for COVID-19 testing solutions as well as for instruments and supplies used by developers of vaccines and other treatments,\" writes analyst David Toung (Buy). \"But the company is also investing its substantial cash flow in technology upgrades, capacity expansions and acquisitions.\"With an average target price of $557.17, the Street gives TMO stock implied upside of about 18% in the next 12 months or so.VisaMarket value:$484.8 billionBillionaire investor:Valley Forge Capital ManagementPercent of portfolio:10.2%Visa(V, $227.30) routinely makes most lists of analysts', hedge funds' or billionaires' favorite stocks.Berkshire Hathaway(BRK.B)owns a stake worth more than $2 billion, although chairman and CEO Warren Buffett readily credits the holding to one of his stock-picking lieutenants.And indeed, there is much to like about this Dow stock. Visa operates the world's largest payments network, and thus is well-positioned to benefit from the growth of cashless transactions and digital mobile payments.The Street's consensus recommendation is a high-conviction Buy. Of the analysts covering the stock tracked by S&P Global Market Intelligence, 21 call V a Strong Buy, 12 rate it at Buy, four say Hold and one calls it a Sell.Valley Forge Capital Management, a hedge fund in Wayne, Pennsylvania, with $1.1 billion in AUM, is certainly a big believer. Visa accounts for 10.2% of its equity portfolio.The fund increased its Visa stake by 88%, or 477,181 shares, in Q1. It now holds more than 1 million shares worth $215 million as of March 31. Mind you, Valley Forge Capital is hardly a novice in this stock. The fund has counted Visa among its stock picks since 2016.Although the pandemic greatly curtailed spending in a number of Visa's categories – most notably travel and entertainment – those headwinds should now be in the past. Indeed, the gradual global reopening – and accelerating secular growth in cashless payments, helped by the perception that cash is \"dirty\" – make a solid bull case for Visa stock.IntelMarket value:$230.7 billionBillionaire investor:Cavalry Management GroupPercent of portfolio:10.4%Intel(INTC, $57.12) has fallen far behind the competition on any number of fronts, which is why analysts and investors were so delighted when the chipmaker hired Pat Gelsinger, former CEO of VMWare (VMW), to take over in February.Heck, some observers said it was the best decision the troubled company made in more than a decade. And, indeed, this Dow stock has been a disappointing performer. Shares are up just 3% over the past three years vs. a gain of 54% for the S&P 500.So props to Cavalry Management Group for making a bold bet on the semiconductor company earlier this year. The San Francisco hedge fund with $2.6 billion in AUM initiated a large enough position to instantly make Intel its top stock pick.Cavalry Management bought 1.7 million shares during the first three months of 2021. With a value of $111.6 million at the end of Q1, INTC accounted for more than 10% of the hedge fund's investments.Cavalry largely focuses on large-cap tech stocks, so Intel certainly fits well with its broader strategy. Other moves the fund made in Q1 included more than tripling its stake in Microsoft, and almost doubling its holdings in Ericsson (ERIC).The Street is generally more cautious on INTC than Cavalry Management is. Analysts' consensus recommendation stands at Hold, per S&P Global Market Intelligence.PayPal HoldingsMarket value:$305.5 billionBillionaire investor:Dorsey Asset ManagementPercent of portfolio:11.8%Digital mobile payments and the expansion of cashless transactions are one of the hottest areas of growth in financial tech. And although the sector offers no shortage of promising new names, old-timerPayPal Holdings(PYPL, $260.02) still gets plenty of analyst – and billionaire investor – love.Explosive growth in mobile transactions, the monetization of its Venmo property and incremental revenue growth in its Xoom business all help make for a compelling bull case on PYPL, analysts say.\"Simply put, PayPal should continue to benefit from the secular shift to e-commerce that should drive a roughly 20% revenue compound annual growth rate (CAGR), which, coupled with margin expansion and capital allocation (mergers & acquisitions plus stock buybacks), should result in an earnings CAGR north of 20% over the next several years,\" writes Raymond James analyst John Davis, who rates the stock at Outperform (the equivalent of Buy).Dorsey Asset Management, with $1.3 billion in AUM, embraces the bull case on PYPL in a big way. The Chicago-based hedge fund increased its stake in PayPal by 81%, or 209,025 shares, in Q1. Its total holdings of 465,266 shares, worth $113 million as of March 31, comprises 11.8% of its stock investments.That's up from 7.9% of the portfolio three months ago. PYPL, which Dorsey has owned since the second quarter of 2018, is now its fifth-largest position.Analysts' consensus recommendation on the stock stands at Buy, according to S&P Global Market Intelligence.Howard HughesMarket value:$5.8 billionBillionaire investor:Bill Ackman (Pershing Square Capital)Percent of portfolio:12.1%No one doubts Bill Ackman's investing acumen. His Pershing Square Capital hedge fund has allowed the investor to amass a personal fortune of $3 billion, per Forbes.And he's never been one to shy away from the media. So his increasing stake inHoward Hughes Corp.(HHC, $105.83) is far from a state secret. Indeed, Ackman has owned shares in the master-planned community developer since it was spun off from General Growth Properties in 2010.Given Ackman's propensity for being anactivist investor, his latest purchase is eyebrow-raising news, nonetheless.The hedge-fund billionaire increased his stake in HHC by 23%, or 2.6 million shares, in Q1. Pershing Square's stake of 13.5 million shares was worth $1.3 billion at the first quarter's end.Most notably, Ackman now holds almost a quarter of HHC's shares outstanding. That makes the hedge fund the company's largest investor by a wide margin. Asset manager Vanguard, at No. 2, owns just 10.8% of HHC.Meanwhile, HHC, at 12.1% of its portfolio, is now Pershing Square Capital's sixth-largest position.For those keeping score at home, HHC stock has doubled over the past 52 weeks vs. a gain of about 38% for the S&P 500. For the year-to-date, it's up by more than a third. That compares with the broader market's gain of about 12% so far this year.Only three analysts cover HHC, according to S&P Global Market Intelligence. One rates it at Strong Buy, while the other two say Buy.Lowe'sMarket value:$137.7 billionBillionaire investor:Two Creeks Capital ManagementPercent of portfolio:12.2%Two Creeks Capital Management, a New York hedge fund with AUM of $2.8 billion, made a big addition to its stake inLowe's(LOW, $194.83) in the first quarter – a move most analysts would regard as wise.The nation's second-largest home improvement retailer after Home Depot (HD) benefited greatly from the work-from-home/stuck-at-home reality of pandemic life. Analysts say many of the do-it-yourself habits consumers adopted during COVID times are here to stay. Lowe's is also being aided by the ultra-tight housing market.The Street gives LOW a consensus recommendation of Buy. Argus Research, which counts itself in the Buy camp, says Lowe's has several strong tailwinds behind it.\"We believe that the major drivers of post-pandemic sales growth remain the same,\" writes Argus Research analyst Christopher Graja. \"There has been significant underinvestment in housing. About 70% of U.S. homes are more than 25 years old and likely in need of upgrades and repairs. Millennials are starting families.\"Income investors know the power of Lowe's dividend over the longer haul. The Dividend Aristocrat has paid a cash distribution every quarter since going public in 1961, and that dividend has increased annually for almost 60 years.The bullish investment thesis led Two Creeks to up its stake in this stock pick by 14%, or 132,811 shares, in Q1. The hedge fund's total stake of 1.1 million LOW shares, worth $200 million at the end of Q1, accounts for 12.2% of its portfolio, representing its third-largest holding.AlphabetMarket value:$1.6 trillionBillionaire investor:Metropolis CapitalPercent of portfolio:13.3%It should come as no surprise that hedge funds are big believers in Google parentAlphabet(GOOGL, $2,356,85). Metropolis Capital, a U.K.-based investor with $1.4 billion in AUM, is just one of about 225 hedge funds upping its stake in the internet giant in Q1.Metropolis thinks highly enough of the search leader that it increased its stake by 22%, or 13,679 shares. The firm now holds a total of 74,868 shares worth $154.4 million, or 13.3% of its total portfolio, as of March 31.Alphabet happens to be in good company at this hedge fund. GOOGL is Metropolis' second-largest stock pick after Berkshire Hathaway (BRK.B).If nothing else, Alphabet's pandemic performance in totality bolstered the case that GOOGL is not a one-trick pony. Its numerous other endeavors likewise shore up the case. For example, Alphabet is a key player in cloud-based services, and home to Nest Labs and self-driving car startup Waymo. Artificial intelligence, machine learning and virtual reality are other areas of heavy investment.\"We continue to favor Google as a core large-cap growth holding given the strong digital advertising backdrop, continued strength from Cloud, ongoing share repurchases (with the newly authorized $50 billion program) and a reasonable valuation,\" writes Canaccord Genuity analyst Maria Ripps (Buy).Analysts' consensus recommendation on the name stands at Strong Buy. Of the 45 analysts issuing opinions on the stock tracked by S&P Global Market Intelligence, 32 rate it at Strong Buy, 12 say Buy and one has it at Hold.Walt DisneyMarket value:$324.6 billionBillionaire investor:Kirkoswald Asset ManagementPercent of portfolio:16.5%Coronavirus took a huge bite out of some ofWalt Disney's(DIS, $178.65) most important businesses: namely, its theme parks and studios. But after encouraging quarterly results, analysts say business is set to bounce back in a big way.Disneyland and other California amusement parks have reopened with restrictions. And admissions at Florida's Disney World continue to climb.\"With mask mandates lifted and capacity constraints loosened further, we would not be surprised to see a step change in attendance in the near future,\" writes Deutsche Bank analyst Bryan Kraft (Buy).But that's nothing compared to what DIS has on its hands in thestreaming mediawars.Disney+ is a smashing success. The streaming platform, which launched in November 2019, has already amassed almost 100 million subscribers – a staggering rate of growth. Consider that Disney+ now has about half as many subscribers as Netflix (NFLX) – but Netflix had a roughly 12-year head start.Kirkoswald Asset Management, a New York hedge fund with AUM of $4 billion, decided to get in on DIS asa recovery stock pickin Q1. It initiated a stake of 5,200 shares, worth almost $1 million, during the first three months of the year.The new stake immediately made DIS its second-largest position among $5.8 million in managed securities.Most of the Street would approve of Kirkoswald's investment. Analysts have a consensus Buy recommendation on this Dow stock.Berkshire HathawayMarket value:$661.0 billionBillionaire investor:Southeast Asset AdvisorsPercent of portfolio:16.8%If you can't beat 'em, join 'em.It's hard to compete with Warren Buffett when it comes toasset allocation. As CEO and chairman ofBerkshire Hathaway(BRK.B, $289.44), he's arguably the greatest long-term investor of all time.So it's little wonder that so many hedge funds, large advisories and other billion-dollar-plus pools of money throw in their lots with the Oracle of Omaha.Southeast Asset Advisors, an investment manager and hedge fund based in Thomasville, Georgia, with $1.6 billion in AUM, has been a BRK.B shareholder since 2008. Indeed, BRK.B, at 16.8% of its portfolio, is the fund's top holding.And it's only getting bigger.Southeast increased its stake in BRK.B by 2%, or 7,747 shares, in Q1. It now holds 365,149 shares worth $93.3 million. Only Alphabet Class C shares (GOOG) come close to the firm's BRK.B stake, accounting for 11.7% of the portfolio.BRK.B has been an outstanding performer both in 2021 and over the past 52 weeks. The stock is up 25% for the year-to-date, essentially doubling the S&P 500's gains. And over the past year? BRK.B returned 57% vs. a price increase of less than 40% for the broad-market gauge.Only four analysts cover BRK.B stock, per S&P Global Market Intelligence. Their consensus recommendation comes to Buy.AlibabaMarket value:$580.4 billionBillionaire investor:Conifer ManagementPercent of portfolio:20.7%Conifer Management, a New York hedge fund with $7.7 billion in AUM, has more than a fifth of its portfolio invested in Chinese e-commerce giantAlibaba(BABA, $213.96).Indeed, after upping its stake by 147%, or 884,845 shares, in Q1, BABA is Conifer's top holding. Its total stake of 1.5 million shares was worth $336.7 million at the end of the first quarter.Conifer initiated its stake in BABA only in the final quarter of last year. To the hedge fund's credit, this stock pick is a highly defensible investment idea.Alibaba is sometimes called the Amazon of China. There are important differences between the two, but they do share the enviable trait of being undisputed titans ine-commerce.And like Amazon, Alibaba has never shied away from investing heavily to both build out its existing businesses and enter new ones. As a result, BABA finds itself spreading beyond its core e-commerce business into cloud computing, digital payments and more.It also helps that BABA and investors can now move past a $2.75 billion fine imposed by Chinese regulators for violating anti-monopoly laws.Some analysts worry about decelerating revenue in the company's cloud services business, but the majority of the Street sees recent share-price weakness as a buying opportunity.The consensus recommendation of 49 analysts tracked by S&P Global Market Intelligence comes to Strong Buy on BABA stock.MastercardMarket value:$357.4 billionBillionaire investor:Valley Forge Capital ManagementPercent of portfolio:22.6%If Valley Forge Capital Management likes Visa – as noted above – it absolutely adores competitorMastercard(MA, $360.58).The Wayne, Pennsylvania-based hedge fund with $1.1 billion in AUM almost doubled its stake in this stock pick in the first quarter. And with more than a fifth of its portfolio tied up in the payments processor, Mastercard is Valley Forge's top holding.The hedge fund bought another 665,544 shares, representing a 98% increase, in Q1, bringing its total holdings to 1.3 million shares. The position was worth $477.9 million as of March 31.Valley Forge, which owns 0.14% of MA's shares outstanding, has been an investor in the company since 2016. It's a bet that appears to have done quite well. Mastercard stock's five-year total return – price appreciation plus dividends – comes to 30.8%, according to Morningstar data. That beats its sector by 5.7 percentage points and leads the broader market by 13.4 percentage points.Like Visa, Mastercard has relentless growth in digital mobile payments and other cashless transactions at its back.\"Mastercard is a key beneficiary of the long-term secular shift toward electronic forms of payments, and that new technology is helping accelerate the shift,\" writes William Blair analyst Robert Napoli (Outperform)And, just like Visa, MA has a lot of fans on the Street. Analysts' consensus recommendation stands at Buy.FacebookMarket value:$932.1 billionBillionaire investor:Altarock PartnersPercent of portfolio:24.4%There's a strong bull case to be made forFacebook(FB, $328.73), the social media giant that forms a digital-ad duopoly with Google. Just ask Altarock Partners.This hedge fund, based in Beverly, Massachusetts, with AUM of $3.1 billion, has almost a quarter of its portfolio socked away in Facebook stock. After buying another 465,800 shares, a 27% increase, in Q1, the hedge fund is sitting on 2.2 million shares worth $641.4 million as of March 31.That makes FB Altarock's second-largest holding.And just who is at No. 1?None other than Google parent Alphabet, which commands 25.1% of Altarock's investment portfolio.The hedge fund first bought FB in the fourth quarter of last year, so it's building up its position on the stock pick pretty rapidly. And well it should, if analysts are right about this name.The Street's consensus recommendation on FB stands at Strong Buy, as analysts forecast the company to deliver truly impressive profit growth for some time.\"We believe Facebook's share gains during the pandemic and new initiatives in e-commerce can drive many years of above-market growth,\" writes Stifel analyst John Egbert (Buy). \"We are comfortable with the potential outcomes of antitrust inquiries and believe FB shares offer investors a rare combination of growth and value relative to its peers.\"SeagenMarket value:$28.2 billionBillionaire investor:Felix and Julian Baker (Baker Bros. Advisors)Percent of portfolio:29.7%Seagen(SGEN, $155.35), a biotechnology firm specializing in oncology treatments, couldn't get a bigger vote of confidence than being the top holding of Baker Bros. Advisors.This New York-based hedge fund with $35.8 billion in AUM is led by billionaire biotech investors Julian and Felix Baker. The brothers may keep a low profile, but they're plenty famous in the world ofbiotech stocks. A series of successful investments have allowed the Bakers to build an estimated combined fortune of about $4 billion, according to Forbes.And judging by their latest regulatory filings, the brothers have great expectations for Seagen, too. The stock pick accounts for nearly 30% of the total value of the Baker Bros.' holdings, up from 28.5% three months ago.The increase stems in part from Baker Bros. buying another 347,745 shares in SGEN in the first quarter of 2021. The fund's total holdings of 47.6 million shares were worth more than $7 billion at the end of Q1.The stake gives Baker Bros. ownership of 26.3% of SGEN's shares outstanding, which makes it the biotech company's largest shareholder by a wide margin. The second-largest investor – Capital Research and Management – holds only 8.6% of SGEN's shares outstanding.The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.TRENDING TOPICSTRENDING ARTICLES","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150783185,"gmtCreate":1624927880447,"gmtModify":1703848056960,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"going stronk please like and comment","listText":"going stronk please like and comment","text":"going stronk please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/150783185","repostId":"1182036516","repostType":4,"repost":{"id":"1182036516","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624892087,"share":"https://ttm.financial/m/news/1182036516?lang=&edition=fundamental","pubTime":"2021-06-28 22:54","market":"us","language":"en","title":"Nvidia shares rose more than 5% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1182036516","media":"Tiger Newspress","summary":"Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.\n\n","content":"<p>Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.</p>\n<p><img src=\"https://static.tigerbbs.com/05201fd147f1f824ea42bb1d0bcac789\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Three major chip makers have reportedly stepped up to say they support&nbsp;Nvidia‘s&nbsp;proposed acquisition of the U.K.-based chip-design house Arm.</p>\n<p>Last September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from&nbsp;SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.</p>\n<p>But the U.K.’s&nbsp;<i>Sunday Times</i>&nbsp;over the weekend&nbsp;reported&nbsp;that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based&nbsp;MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.</p>\n<p>Citi analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.</p>\n<p>“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”</p>\n<p>Malik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares rose more than 5% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares rose more than 5% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-28 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.</p>\n<p><img src=\"https://static.tigerbbs.com/05201fd147f1f824ea42bb1d0bcac789\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Three major chip makers have reportedly stepped up to say they support&nbsp;Nvidia‘s&nbsp;proposed acquisition of the U.K.-based chip-design house Arm.</p>\n<p>Last September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from&nbsp;SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.</p>\n<p>But the U.K.’s&nbsp;<i>Sunday Times</i>&nbsp;over the weekend&nbsp;reported&nbsp;that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based&nbsp;MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.</p>\n<p>Citi analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.</p>\n<p>“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”</p>\n<p>Malik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182036516","content_text":"Nvidia shares rose more than 5% to a new high on Report Three Key Chip Makers Endorse Bid for Arm.\n\nThree major chip makers have reportedly stepped up to say they support Nvidia‘s proposed acquisition of the U.K.-based chip-design house Arm.\nLast September, Nvidia (ticker: NVDA) announced a deal to acquire Arm from SoftBank Group(SFTBY) for $40 billion in cash and stock in a transaction that would make SoftBank the largest investor in Nvidia. The deal has attracted considerable scrutiny from both regulators and other chip companies, given Arm’s position as a leading provider of microprocessor designs to the chip industry. Almost all smartphones use processors based on Arm designs.\nBut the U.K.’s Sunday Times over the weekend reported that three important Arm customers—Broadcom(AVGO), Marvell (MRVL), and Taiwan-based MediaTek(2454.TW)—have endorsed the transaction. None of the companies involved could immediately be reached for comment.\nCiti analyst Atif Malk wrote in a research note Sunday that the report is a big step forward for the proposed deal. He thinks the U.K. likely will approve the combination, given Nvidia’s public commitment to investing more in Arm’s U.K. operations. But he still sees considerable hurdles, in particular in China.\n“With the U.S. continuing to be aggressive against China winning in a tech race, we see China less likely to support a deal that would see them potentially losing access to Arm,” he wrote in a research note. “If Nvidia finds a way to keep the Arm China subsidiary as a separate entity without access to any [graphics processor or artificial intelligence] IP then there is a path to get both U.S. and China regulatory approval.”\nMalik says he says the path to approval remains narrow. He now sees a 30% chance of approval, up from a previous estimate of 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117735218,"gmtCreate":1623160335534,"gmtModify":1704197361534,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"liked","listText":"liked","text":"liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117735218","repostId":"1195023067","repostType":4,"repost":{"id":"1195023067","kind":"news","pubTimestamp":1623155236,"share":"https://ttm.financial/m/news/1195023067?lang=&edition=fundamental","pubTime":"2021-06-08 20:27","market":"us","language":"en","title":"Apple is encroaching on Facebook’s territory like never before with new social features","url":"https://stock-news.laohu8.com/highlight/detail?id=1195023067","media":"cnbc","summary":"KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you ","content":"<div>\n<p>KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple is encroaching on Facebook’s territory like never before with new social features</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple is encroaching on Facebook’s territory like never before with new social features\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 20:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/06/08/apple-ios-15-new-social-features-will-compete-more-with-facebook.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1195023067","content_text":"KEY POINTS\n\nApple announced several new features for iMessage and FaceTime, including a way for you to co-watch streaming movies with a friend over your phone.\nThe new features will launch this fall as part of Apple’s iOS 15 update for iPhones.\nThey will also set Apple up to compete more directly with Facebook, which has increased its complaints about Apple’s policies as the two companies start to overlap more.\n\nStarting this fall, thedecade-long spatbetweenAppleandFacebookwill start a new chapter. And this part of the story has Apple encroaching on Facebook's territory in ways it never has before.\nOn Monday, Apple revealed several new social features that will come to iPhones and iPadswith the launch of iOS 15this fall.\nSoon, iPhone users will be able to holdFaceTime video calls with Android and Windows users for the first time. They will also be able to use a new feature called SharePlay, which lets you hold a FaceTime call and watch a streaming movie, listen to music, or share your screen with your contacts. IMessage is getting a boost as well, with new features that make it easier to share web links, photos, Apple Music tracks and Apple News articles with your contacts.\nIn short, Apple is laying the groundwork for a suite of social features designed to let you do a lot of what you would normally do on Instagram and Facebook, only with more emphasis on privacy. Think of it as a watered-down social network without all the bloat and annoying stuff you find in other apps.\nIt's the kind of stuff that will drive Facebook CEO Mark Zuckerberg absolutely crazy.\nZuckerberg has already said heconsiders Apple a major competitor, largely because of apps like FaceTime and iMessage that come preinstalled on the more than 1 billion Apple gadgets in use around the world.\nOn top of that, Facebook late last year started ananti-Apple PR and advertising blitzover a new iOS privacy feature that limits how companies like Facebook can use your personal data to send you targeted ads. (Facebook makes most of its money from ads, and needs that targeting data for its ads to be effective.)\nIt's no coincidenceZuckerberg took a swipe at the 30% feeApple collects from many app makers on the iPhone just hours before Apple's big event on Monday.\nApple's new social features in iOS 15 are also coming well before Zuckerberg can complete Facebook's pivot to privacy,which he announced more than two years ago. In Zuckerberg's view, there will be two types of social sharing on the internet in the future: private communication, such as messaging in Facebook apps like WhatsApp and Messenger, and public communication, like posts on Instagram or the core Facebook service.\nApple's announcements on Monday proved you don't need Facebook for a lot of the stuff you already do on Facebook. Why log into Facebook or Instagram and give up personal data when you can just as easily share photos, messages, and videos right there in iOS 15?\nIf Zuckerberg was right and there will be a large swath of communication that takes place on a \"privacy-focused\" version of the internet, Apple has largely beaten Facebook to that future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158339769,"gmtCreate":1625128218151,"gmtModify":1703736691193,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"airbnb good buy!","listText":"airbnb good buy!","text":"airbnb good buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/158339769","repostId":"2147817357","repostType":4,"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183027967,"gmtCreate":1623295368659,"gmtModify":1704200304959,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183027967","repostId":"1117452441","repostType":4,"repost":{"id":"1117452441","kind":"news","pubTimestamp":1623294390,"share":"https://ttm.financial/m/news/1117452441?lang=&edition=fundamental","pubTime":"2021-06-10 11:06","market":"us","language":"en","title":"Grab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm","url":"https://stock-news.laohu8.com/highlight/detail?id=1117452441","media":"cnbc","summary":"SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for","content":"<div>\n<p>SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab and GoTo IPOs could spawn more Southeast Asian startups, says venture capital firm\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 11:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","BABA":"阿里巴巴"},"source_url":"https://www.cnbc.com/2021/06/10/grab-goto-ipos-could-spawn-more-southeast-asian-unicorns-500-startups.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1117452441","content_text":"SINGAPORE — The public listings for two of Southeast Asia's tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups.\nContrary to concerns thatregional heavyweights may \"gobble up\"smaller start-ups and stymie innovation, Vishal Harnal told CNBC that \"couldn't be further from the truth.\" Rather, he said, the initial public offerings of Grab and GoTo could boost the ecosystem and produce more billion-dollar start-ups.\nSingapore-based ride-hailing companyGrab announced in Aprilthat it would go public through a special purpose acquisition company merger valued at $39.6 billion —  the largest ever blank-check deal. Meanwhile, thenewly-merged Indonesia on-demand platform GoTo Groupconfirmed to CNBC that it would go public this year.\n\"While there will be (mergers and acquisitions), while these companies will acquire smaller start-ups, they're going to invest in far more companies than they acquire, and it's going to lead to a lot more billion-dollar companies — or unicorns — being born as a result of that,\" Harnal told \"Street Signs Asia\"Monday.\n\n They're going to invest in far more companies than they acquire, and it's going to lead to a lot more billion-dollar companies.Vishal HarnalMANAGING PARTNER, 500 STARTUPS\n\nThat's because the founders of successful companies will have newfound liquidity to invest in the ecosystem, either actively or as angel investors — those who invest in early stage businesses. Meanwhile, staff who have seen their employers grow from seed funding to IPO may be more inclined to build their own companies.\nHarnal likened the process to that which played out in China among its famous tech stocks known collectively as BAT –Baidu,Alibaba and Tencent.\nA passenger takes a ride on a Gojek motorcycle taxi in Jakarta on May 24, 2018.Bay Ismoyo | AFP | Getty Images\nAccording to 500 Startups research, out of the nearly 150 active and former unicorns created in China, 40% were invested by BAT companies. In total, BAT companies have invested in 915 tech companies since going public.\nIn contrast, there was less than half that number of mergers and acquisitions, with just 14 occurring in companies worth more than $1 billion.\n\"We saw this happening in China with BAT – Baidu, Alibaba, Tencent. Now in Southeast Asia, we've got the equivalent, GSG – Grab, Sea and GoTo,\" Harshal said, referencing the Singapore-based internet giantSea Group.\n\"The more money that companies like GSG spend in educating the ecosystem, in ensuring technology adoption, and investing in expanding the internet economy,\" he said. \"The more inroads it creates for newer start-ups to build companies and leverage on those companies that now exist.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178889385,"gmtCreate":1626796890347,"gmtModify":1703765468547,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/178889385","repostId":"1184882386","repostType":4,"repost":{"id":"1184882386","kind":"news","pubTimestamp":1626790245,"share":"https://ttm.financial/m/news/1184882386?lang=&edition=fundamental","pubTime":"2021-07-20 22:10","market":"us","language":"en","title":"What If This Is The Economic End-Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1184882386","media":"zerohedge","summary":"A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged","content":"<p>A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-20% drop in stocks, summarized the current economic state simply as \"mid cycle\"...</p>\n<p><img src=\"https://static.tigerbbs.com/d95f296e4d1300cd3c95485a2333d270\" tg-width=\"906\" tg-height=\"571\" width=\"100%\" height=\"auto\">... which of course is the best place to be, as the initial euphoric surge higher in stocks tapers to a slow and steady grind as the economy chugs along at a modest pace.</p>\n<p>But what if he is wrong? After all, yesterday the NBER determined that the covid recession - at just 2 months - was the fastest on record (even as 14 million Americans are out of a job and still collect unemployment benefits) and we are already well into the mid cycle, if not approaching the end.</p>\n<p><img src=\"https://static.tigerbbs.com/e47d11bc07779a51cede0a73e7ddf627\" tg-width=\"971\" tg-height=\"562\" width=\"100%\" height=\"auto\">Also it is none other than Wilson's own employer Morgan Stanley, which has also said recently that this cycle will be \"<b>hotter but shorter</b>\" than usual.</p>\n<p><img src=\"https://static.tigerbbs.com/41879c4f66b33597ee236bdd52841004\" tg-width=\"904\" tg-height=\"490\" width=\"100%\" height=\"auto\"></p>\n<p>Does it not stand to reason then, that the economic cycle is now so truncated - courtesy of $30 trillion in global stimulus - that we have blasted right through the midcycle phase and are now nearing the end?</p>\n<p>That is the question Deutsche Bank's credit strategist Jim Reid asked overnight, when he described this recovery as \"undoubtedly the most unusual in history with many sectors of the economy already running ahead of their pre-recession trend\" even though several serviced based ones are still well behind though. More importantly, according to Reid and DB economists,<i>the output and employment gap will likely close in the next couple of quarters which will be the quickest for both in observable economic history.</i></p>\n<p>Reid then takes a look at where real GDP, nominal GDP, CPI, unemployment, retail sales, equities, household wealth, housing, treasuries and commodities are against all other recoveries for most variables goes back over 100 years. The chart below shows real GDP and as Reid explains, \"for most of these, this current post covid recovery is near the top\"<b>making this recovery neck and neck with the fastest post-WWII expansion.</b></p>\n<p><img src=\"https://static.tigerbbs.com/48279d702e3f7b92c743f063b26661ad\" tg-width=\"868\" tg-height=\"411\" width=\"100%\" height=\"auto\">As Reid puts it, \"clearly this cycle saw a big drawdown due to the pandemic but so did the GFC and its notable that the post-GFC recovery was around the weakest at the same stage\" which begs the question: \"should this be seen as the start of a new cycle or a continuation of the last cycle after a period of covid related hibernation?<b>The answer to this will give us clues as to how long this cycle lasts, future Fed activity, and on the inflationary consequences of the current strong rebound.\"</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What If This Is The Economic End-Cycle</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat If This Is The Economic End-Cycle\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 22:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/what-if-economic-end-cycle><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-...</p>\n\n<a href=\"https://www.zerohedge.com/markets/what-if-economic-end-cycle\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/what-if-economic-end-cycle","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184882386","content_text":"A few months ago, Morgan Stanley's chief equity strategist Michael Wilson, who also recently emerged as the biggest Wall Street bear warning that the \"rolling corrections\" in themarket presage a 10-20% drop in stocks, summarized the current economic state simply as \"mid cycle\"...\n... which of course is the best place to be, as the initial euphoric surge higher in stocks tapers to a slow and steady grind as the economy chugs along at a modest pace.\nBut what if he is wrong? After all, yesterday the NBER determined that the covid recession - at just 2 months - was the fastest on record (even as 14 million Americans are out of a job and still collect unemployment benefits) and we are already well into the mid cycle, if not approaching the end.\nAlso it is none other than Wilson's own employer Morgan Stanley, which has also said recently that this cycle will be \"hotter but shorter\" than usual.\n\nDoes it not stand to reason then, that the economic cycle is now so truncated - courtesy of $30 trillion in global stimulus - that we have blasted right through the midcycle phase and are now nearing the end?\nThat is the question Deutsche Bank's credit strategist Jim Reid asked overnight, when he described this recovery as \"undoubtedly the most unusual in history with many sectors of the economy already running ahead of their pre-recession trend\" even though several serviced based ones are still well behind though. More importantly, according to Reid and DB economists,the output and employment gap will likely close in the next couple of quarters which will be the quickest for both in observable economic history.\nReid then takes a look at where real GDP, nominal GDP, CPI, unemployment, retail sales, equities, household wealth, housing, treasuries and commodities are against all other recoveries for most variables goes back over 100 years. The chart below shows real GDP and as Reid explains, \"for most of these, this current post covid recovery is near the top\"making this recovery neck and neck with the fastest post-WWII expansion.\nAs Reid puts it, \"clearly this cycle saw a big drawdown due to the pandemic but so did the GFC and its notable that the post-GFC recovery was around the weakest at the same stage\" which begs the question: \"should this be seen as the start of a new cycle or a continuation of the last cycle after a period of covid related hibernation?The answer to this will give us clues as to how long this cycle lasts, future Fed activity, and on the inflationary consequences of the current strong rebound.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184411769,"gmtCreate":1623721368551,"gmtModify":1704209520009,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184411769","repostId":"1180739794","repostType":4,"repost":{"id":"1180739794","kind":"news","pubTimestamp":1623720576,"share":"https://ttm.financial/m/news/1180739794?lang=&edition=fundamental","pubTime":"2021-06-15 09:29","market":"us","language":"en","title":"This cannabis stock is a new Reddit favorite","url":"https://stock-news.laohu8.com/highlight/detail?id=1180739794","media":"CNN Business","summary":"New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen","content":"<p><b>New York (CNN Business)&nbsp;</b>-&nbsp;Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.</p>\n<p>As backers tout the growing number of states legalizing recreational and medical marijuana, some investors are holding out for the dream scenario of federal legalization — even though that might be a stretch in the near term.</p>\n<p>But are investors going a little crazy?Tilray&nbsp;(TLRY)&nbsp;is now up more than 130% this year. That's much higher than the gains for rivalsCanopy Growth&nbsp;(CGC)&nbsp;and&nbsp;Cronos&nbsp;(CRON), which have the backing of consumer products giantsConstellation Brands(STZ)andAltria(MO), respectively.</p>\n<p>Short-sellers are targeting Tilray. And Redditors have gleefully tried to squeeze the shorts — investors who borrow stocks and sell them with hopes of buying them back at a lower price.</p>\n<p>If a stock suddenly starts to rise, short-sellers have no choice but to buy it back or face prohibitively large losses. That's a big reason behind the recent spikes in&nbsp;AMC(AMC),GameStop(GME)&nbsp;and other stocks that the Reddit community has glommed onto this year.</p>\n<p>One Reddit user&nbsp;wrote in a post&nbsp;last week that Tilray \"is a movement,\" adding that the company has \"fantastic stats\" and is \"a worthy opponent to AMC\" as a meme stock.</p>\n<p>The short-sellers have seemingly taken control in this battle lately though. After a 6% pop in Tilray's stock last Wednesday, share prices have fallen for the past three trading days.</p>\n<p>But some backers aren't deterred by the recent pullback. One Redditor on the site's Tilray board&nbsp;wrote the following message&nbsp;to any would be short sellers: \"Weed Stocks to Bears: I'm not leaving.\"</p>\n<p>The post, which also mentioned cannabis stocksAurora(ACB)andSundial Growers(SNDL), showed a clip of Leonardo DiCaprio's inspirational speech to employes from \"The Wolf of Wall Street\" in which his Jordan Belfort character exclaimed he wasn't going anywhere.</p>\n<p>The Reddit community also seems to appreciate that Tilray CEO Irwin Simon is acknowledging their support. In an interview with CNBC last week, Simon said \"we love having them as part of our shareholder base\" in response to a question about the retail investor interest in the stock.</p>\n<p>One commenter referred to Simon last week as a \"diamond\" — the ultimate Reddit compliment.</p>\n<p>\"[He] wants to build a global green giant. This dude wants to take us to tendie town gentleman,\" the poster said, using the Reddit lingo \"tendie\" to describe trading profits.</p>\n<p>\"This company has a shot to literally rocket to the top as a fundamental and strong global brand,\" the Reddit user added.</p>\n<p>Still, Tilray's faithful may have a tough time convincing the Wall Street establishment that this is a stock worth owning.</p>\n<p>Analysts who cover the stock are lukewarm on its prospects. Only four have a buy rating on Tilray, compared with 13 holds and one sell. What's more, the consensus target price is about $19 — right around where the stock is currently trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This cannabis stock is a new Reddit favorite</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis cannabis stock is a new Reddit favorite\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 09:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.\nAs backers tout...</p>\n\n<a href=\"https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://edition.cnn.com/2021/06/14/investing/tilray-reddit-cannabis-stocks/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180739794","content_text":"New York (CNN Business) - Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.\nAs backers tout the growing number of states legalizing recreational and medical marijuana, some investors are holding out for the dream scenario of federal legalization — even though that might be a stretch in the near term.\nBut are investors going a little crazy?Tilray (TLRY) is now up more than 130% this year. That's much higher than the gains for rivalsCanopy Growth (CGC) and Cronos (CRON), which have the backing of consumer products giantsConstellation Brands(STZ)andAltria(MO), respectively.\nShort-sellers are targeting Tilray. And Redditors have gleefully tried to squeeze the shorts — investors who borrow stocks and sell them with hopes of buying them back at a lower price.\nIf a stock suddenly starts to rise, short-sellers have no choice but to buy it back or face prohibitively large losses. That's a big reason behind the recent spikes in AMC(AMC),GameStop(GME) and other stocks that the Reddit community has glommed onto this year.\nOne Reddit user wrote in a post last week that Tilray \"is a movement,\" adding that the company has \"fantastic stats\" and is \"a worthy opponent to AMC\" as a meme stock.\nThe short-sellers have seemingly taken control in this battle lately though. After a 6% pop in Tilray's stock last Wednesday, share prices have fallen for the past three trading days.\nBut some backers aren't deterred by the recent pullback. One Redditor on the site's Tilray board wrote the following message to any would be short sellers: \"Weed Stocks to Bears: I'm not leaving.\"\nThe post, which also mentioned cannabis stocksAurora(ACB)andSundial Growers(SNDL), showed a clip of Leonardo DiCaprio's inspirational speech to employes from \"The Wolf of Wall Street\" in which his Jordan Belfort character exclaimed he wasn't going anywhere.\nThe Reddit community also seems to appreciate that Tilray CEO Irwin Simon is acknowledging their support. In an interview with CNBC last week, Simon said \"we love having them as part of our shareholder base\" in response to a question about the retail investor interest in the stock.\nOne commenter referred to Simon last week as a \"diamond\" — the ultimate Reddit compliment.\n\"[He] wants to build a global green giant. This dude wants to take us to tendie town gentleman,\" the poster said, using the Reddit lingo \"tendie\" to describe trading profits.\n\"This company has a shot to literally rocket to the top as a fundamental and strong global brand,\" the Reddit user added.\nStill, Tilray's faithful may have a tough time convincing the Wall Street establishment that this is a stock worth owning.\nAnalysts who cover the stock are lukewarm on its prospects. Only four have a buy rating on Tilray, compared with 13 holds and one sell. What's more, the consensus target price is about $19 — right around where the stock is currently trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135780413,"gmtCreate":1622184402132,"gmtModify":1704181068499,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"g","listText":"g","text":"g","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135780413","repostId":"1148985369","repostType":4,"isVote":1,"tweetType":1,"viewCount":271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120490958,"gmtCreate":1624330554874,"gmtModify":1703833692003,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"oh no","listText":"oh no","text":"oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120490958","repostId":"1123368698","repostType":4,"repost":{"id":"1123368698","kind":"news","pubTimestamp":1624328854,"share":"https://ttm.financial/m/news/1123368698?lang=&edition=fundamental","pubTime":"2021-06-22 10:27","market":"us","language":"en","title":"Will This Reverse Stock Split Be a Rare Winner?","url":"https://stock-news.laohu8.com/highlight/detail?id=1123368698","media":"fool","summary":"Reverse stock splits aren't generally seen as a good sign. When a stock has to resort to cutting its","content":"<p>Reverse stock splits aren't generally seen as a good sign. When a stock has to resort to cutting its number of shares outstanding to boost its price, it's often an indicator that the company doesn't think its business can support the kind of growth necessary to get its stock moving in the right direction without such moves.</p>\n<p>Last Friday,<b>General Electric</b>(NYSE:GE)confirmed that it will become the latest company to roll the dice on a reverse split. We'll examine some details on thereverse stock split&nbsp; and what it means for investors, but first, let's take a quick look at how the broader market did to begin the week.</p>\n<p>A good start on Wall Street</p>\n<p>Monday brought bullish investors back to the investing world after tough conditions last week sent stocks reeling. By the time the closing bell rang, the<b>Dow Jones Industrial Average</b>(DJINDICES:^DJI),<b>S&amp;P 500</b>(SNPINDEX:^GSPC), and<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)were up significantly.</p>\n<table>\n <thead>\n  <tr>\n   <th><p><b>Index</b></p></th>\n   <th><p><b>Percentage Change</b></p></th>\n   <th><p><b>Point Change</b></p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td><p>Dow</p></td>\n   <td><p>+1.76%</p></td>\n   <td><p>+587</p></td>\n  </tr>\n  <tr>\n   <td><p>S&amp;P 500</p></td>\n   <td><p>+1.40%</p></td>\n   <td><p>+58</p></td>\n  </tr>\n  <tr>\n   <td><p>Nasdaq Composite</p></td>\n   <td><p>+0.79%</p></td>\n   <td><p>+111</p></td>\n  </tr>\n </tbody>\n</table>\n<p>DATA SOURCE: YAHOO! FINANCE.</p>\n<p>Doing the splits</p>\n<p>General Electric's announcement confirmed that the industrial conglomerate will move forward with its 1-for-8 reverse split as approved at its May annual shareholder meeting. GE's plan is to make the reverse stock split effective after trading ends on Friday, July 30. Investors will get their first chance to trade the split-adjusted shares the following Monday, August 2.</p>\n<p>CFO Carolina Dybeck Happe tried to explain the reason for the reverse split. She noted that although GE has divested several of its major business units in recent years, in particular the GE Capital financial unit, it hasn't made any corresponding adjustments to its outstanding share count. The result is a share base that inappropriately reflects the enterprise's former size rather than its more compact current configuration. After the split, GE will have just 1.1 billion shares outstanding, with a stock price that should come in just over $100 per share based on where shares closed on Monday.</p>\n<p>Can GE grow again?</p>\n<p>In the past, many companies that have done reverse stock splits have seen their share prices continue to fall. Often, the move only provides extra fodder for bearish investors looking to make money by selling a stock short.</p>\n<p>However, there've been somenotable success stories. Perhaps the biggest involves<b>Booking Holdings</b>(NASDAQ:BKNG), which notably did a 1-for-6 reverse split in the early 2000s following the tech bust. The online travel giant's stock has been a huge multibagger since then as the business regained traction in the mid-2000s and afterward.</p>\n<p>In order to beat the odds,General Electric will have to execute well on its growth strategy. That requires seeing the key aviation segment regain its past prowess, while also taking advantage of rising demand in power and renewable energy to bolster its overall presence in that key market. GE also has high aspirations for its healthcare business, as it hopes that an innovative spirit will get rewarded in the long run.</p>\n<p>GE has been a huge disappointment for shareholders since the mid-2010s, and despite a sizable bounce, the stock remains far below its best levels historically. That gives General Electric some room to rebound if it can get its business back on track. However, patient investors have to hope that the reverse stock split will prove to be a positive catalyst to affirm confidence in the future of the business in order to justify taking more time waiting for GE to turn itself around completely.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will This Reverse Stock Split Be a Rare Winner?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill This Reverse Stock Split Be a Rare Winner?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/will-this-reverse-stock-split-be-a-rare-winner/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Reverse stock splits aren't generally seen as a good sign. When a stock has to resort to cutting its number of shares outstanding to boost its price, it's often an indicator that the company doesn't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/will-this-reverse-stock-split-be-a-rare-winner/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GE":"GE航空航天"},"source_url":"https://www.fool.com/investing/2021/06/21/will-this-reverse-stock-split-be-a-rare-winner/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123368698","content_text":"Reverse stock splits aren't generally seen as a good sign. When a stock has to resort to cutting its number of shares outstanding to boost its price, it's often an indicator that the company doesn't think its business can support the kind of growth necessary to get its stock moving in the right direction without such moves.\nLast Friday,General Electric(NYSE:GE)confirmed that it will become the latest company to roll the dice on a reverse split. We'll examine some details on thereverse stock split  and what it means for investors, but first, let's take a quick look at how the broader market did to begin the week.\nA good start on Wall Street\nMonday brought bullish investors back to the investing world after tough conditions last week sent stocks reeling. By the time the closing bell rang, theDow Jones Industrial Average(DJINDICES:^DJI),S&P 500(SNPINDEX:^GSPC), andNasdaq Composite(NASDAQINDEX:^IXIC)were up significantly.\n\n\n\nIndex\nPercentage Change\nPoint Change\n\n\n\n\nDow\n+1.76%\n+587\n\n\nS&P 500\n+1.40%\n+58\n\n\nNasdaq Composite\n+0.79%\n+111\n\n\n\nDATA SOURCE: YAHOO! FINANCE.\nDoing the splits\nGeneral Electric's announcement confirmed that the industrial conglomerate will move forward with its 1-for-8 reverse split as approved at its May annual shareholder meeting. GE's plan is to make the reverse stock split effective after trading ends on Friday, July 30. Investors will get their first chance to trade the split-adjusted shares the following Monday, August 2.\nCFO Carolina Dybeck Happe tried to explain the reason for the reverse split. She noted that although GE has divested several of its major business units in recent years, in particular the GE Capital financial unit, it hasn't made any corresponding adjustments to its outstanding share count. The result is a share base that inappropriately reflects the enterprise's former size rather than its more compact current configuration. After the split, GE will have just 1.1 billion shares outstanding, with a stock price that should come in just over $100 per share based on where shares closed on Monday.\nCan GE grow again?\nIn the past, many companies that have done reverse stock splits have seen their share prices continue to fall. Often, the move only provides extra fodder for bearish investors looking to make money by selling a stock short.\nHowever, there've been somenotable success stories. Perhaps the biggest involvesBooking Holdings(NASDAQ:BKNG), which notably did a 1-for-6 reverse split in the early 2000s following the tech bust. The online travel giant's stock has been a huge multibagger since then as the business regained traction in the mid-2000s and afterward.\nIn order to beat the odds,General Electric will have to execute well on its growth strategy. That requires seeing the key aviation segment regain its past prowess, while also taking advantage of rising demand in power and renewable energy to bolster its overall presence in that key market. GE also has high aspirations for its healthcare business, as it hopes that an innovative spirit will get rewarded in the long run.\nGE has been a huge disappointment for shareholders since the mid-2010s, and despite a sizable bounce, the stock remains far below its best levels historically. That gives General Electric some room to rebound if it can get its business back on track. However, patient investors have to hope that the reverse stock split will prove to be a positive catalyst to affirm confidence in the future of the business in order to justify taking more time waiting for GE to turn itself around completely.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164946542,"gmtCreate":1624168471886,"gmtModify":1703830046572,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"wow, excited for this news","listText":"wow, excited for this news","text":"wow, excited for this news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164946542","repostId":"2144779308","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163892034,"gmtCreate":1623866713028,"gmtModify":1703822024262,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"so truee","listText":"so truee","text":"so truee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163892034","repostId":"1160215752","repostType":4,"repost":{"id":"1160215752","kind":"news","pubTimestamp":1623854569,"share":"https://ttm.financial/m/news/1160215752?lang=&edition=fundamental","pubTime":"2021-06-16 22:42","market":"us","language":"en","title":"Stocks usually fall during Powell’s press conference and Cramer thinks it may happen again","url":"https://stock-news.laohu8.com/highlight/detail?id=1160215752","media":"cnbc","summary":"Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-deci","content":"<div>\n<p>Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks usually fall during Powell’s press conference and Cramer thinks it may happen again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks usually fall during Powell’s press conference and Cramer thinks it may happen again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 22:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/06/16/stocks-usually-fall-during-powells-press-conference-and-cramer-thinks-it-may-happen-again.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1160215752","content_text":"Stocks tend to fall slightly when Federal Reserve Chairman Jerome Powell speaks during his post-decision press conferences, history shows. And CNBC’s Jim Cramer believes we could be setting up for a similar performance, and possibly even worse.\nBespoke Investment Group looked at the intraday data and found theS&P 500typically is higher going into the 2:30 p.m. ET press conference, but then, on average, turns lower when Powell’s briefing begins. After the turn lower, the benchmark ends Powell press conference days lower by 2 basis points, according to Bespoke. (1 basis point is 0.01%)\n“Powell taking the podium has been the equivalent of ‘last call’ at a bar,” the firm said in a note.\nThis time, the Fed chief is faced with one of the tougher tightrope walks in his tenure as markets expect him to address the bubbling inflationary pressures that he previously characterized as transitory. At the same time, many believe Powell could upset the market if he signals that the central bank will start tapering their ultra-easy monetary policy. Investors will parse through tiny shifts in sentiment during Powell’s delicate dance this afternoon.\nThe Fed’s statement on policy and forecasts will be released at 2 p.m. ET Wednesday and Powell will take the podium at 2:30 p.m.\nBillionaire investors Paul Tudor Jonestold CNBC on Mondaythat this is the most important press conference in Powell’s career, and if he’s not careful, it could lead to another taper tantrum that could cause a correction in stocks.\nCramer echoed the sentiment on Wednesday, saying Powell could trigger a sell-off in the stock market as reporters will likely grill him on inflation.\n“I think that a lot of the heckling, which is what I regard the questions of the press being, is going to be about oil and inflation and at some point if Powell breaks his resolve and says, ‘Yes, I’m looking at oil,’ the traders will come in at 2:43 and smash the market.” Cramer said. “Press has to give Powell a hard time. At one point Powell slips up, the market goes down big.”\nTo be sure, the market’s performance during Powell’s briefing has been less negative in the pandemic era. The average for the past year’s Fed days has seen the S&P 500 hit its highs of the day after the press conference begins, and while there has been a sharp reversal off those highs, by the end of the day, the S&P 500 has only been modestly below its pre-announcement levels, according to Bespoke.","news_type":1},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184985406,"gmtCreate":1623681044805,"gmtModify":1704208578921,"author":{"id":"3579171490775446","authorId":"3579171490775446","name":"bobz","avatar":"https://static.tigerbbs.com/5c60856a9f2fe3f72bcecb074e333b8a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579171490775446","authorIdStr":"3579171490775446"},"themes":[],"htmlText":"nicee","listText":"nicee","text":"nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184985406","repostId":"2143780519","repostType":4,"repost":{"id":"2143780519","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1623679234,"share":"https://ttm.financial/m/news/2143780519?lang=&edition=fundamental","pubTime":"2021-06-14 22:00","market":"us","language":"en","title":"Novavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants","url":"https://stock-news.laohu8.com/highlight/detail?id=2143780519","media":"Investors","summary":"Novavax said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing.","content":"<p><b>Novavax</b> said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.</p>\n<p>The study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.</p>\n<p>\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.</p>\n<p>In morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.</p>\n<h2>NVAX Stock Yo-Yoes On Vaccine Test</h2>\n<p>Overall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.</p>\n<p>There were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.</p>\n<p>Further, the vaccine was 91% effective in people at high risk of severe disease.</p>\n<p>NVAX stock initially rose to its highest point in a month.</p>\n<h2>Protective Against Variants</h2>\n<p>Novavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.</p>\n<p>Another 10 were other variants. All of these occurred in the placebo group.</p>\n<p>Bullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson &amp; Johnson's vaccine was temporarily suspended due to blood clots.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Stock Yo-Yos After Biotech Says Covid Vaccine Protects Against Variants\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-06-14 22:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Novavax</b> said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.</p>\n<p>The study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.</p>\n<p>\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.</p>\n<p>In morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.</p>\n<h2>NVAX Stock Yo-Yoes On Vaccine Test</h2>\n<p>Overall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.</p>\n<p>There were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.</p>\n<p>Further, the vaccine was 91% effective in people at high risk of severe disease.</p>\n<p>NVAX stock initially rose to its highest point in a month.</p>\n<h2>Protective Against Variants</h2>\n<p>Novavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.</p>\n<p>Another 10 were other variants. All of these occurred in the placebo group.</p>\n<p>Bullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson &amp; Johnson's vaccine was temporarily suspended due to blood clots.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143780519","content_text":"Novavax said Monday its Covid vaccine was more than 93% protective against troublesome variants in final-phase testing. But NVAX stock yo-yoed on the news.\nThe study took place in the U.S. and Mexico, and sets Novavax up to request authorization for its coronavirus vaccine in the U.S. Novavax has already begun rolling reviews in Canada, Australia, New Zealand, the U.K. and Europe.\n\"Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines,\" Chief Executive Stanley Erck said in a written statement.\nIn morning trading on the stock market today, NVAX stock jumped as high as 9.4%. But shares were down a fraction near 209.70 in recent action.\nNVAX Stock Yo-Yoes On Vaccine Test\nOverall, Novavax said its vaccine was 90.4% effective. That was based on a test of 29,960 people at 119 sites in the U.S. and Mexico. There were 77 cases of Covid among study participants, with 63 in the placebo group and 14 in the vaccine group. Cases in the vaccine group were mild.\nThere were 10 moderate and four severe cases, all of which occurred in the placebo group. That means the vaccine was 100% protective against moderate and severe Covid-19. Novavax noted all hospitalizations and deaths occurred in the placebo group.\nFurther, the vaccine was 91% effective in people at high risk of severe disease.\nNVAX stock initially rose to its highest point in a month.\nProtective Against Variants\nNovavax sequenced 54 out of the 77 positive Covid cases. Of those, 35 were \"variants of concern,\" which includes mutations first discovered in the U.K., South Africa, Japan/Brazil and California. Another 17 were \"variants of interest.\" The vaccine was 93.2% protective against these.\nAnother 10 were other variants. All of these occurred in the placebo group.\nBullishly for NVAX stock, the vaccine was generally well tolerated. This is key as U.S. officials look into a heart condition possibly tied to vaccines from Pfizer and Moderna, and after Johnson & Johnson's vaccine was temporarily suspended due to blood clots.","news_type":1},"isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}